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1. Summary 
Survivin was discovered as a member of the Inhibitor of Apoptosis Protein (IAP) family 
showing high expression in almost all human cancers. Although primarily considered as a 
protein implicated apoptosis and cell cycle/mitotic spindle checkpoint regulation, Survivin is 
now recognized as a nodal factor involved in a multitude of cellular circuits. By this, Survivin 
covers a radiation resistance factor in a variety of cancer entities and enhances tumor cell 
survival upon radiation exposure by impacting DNA double-strand break (DNA DSB) repair. 
Following irradiation, nuclear accumulation of Survivin was mechanistically been linked to 
the activity of the DNA-dependent protein kinase, catalytic subunit (DNA-PKcs), a key 
component of DNA DSB repair pathway non-homologous end joining (NHEJ).  
In this study, we aimed to unravel the determinants of the Survivin-DNA-PKcs 
interrelationship on a molecular level by computational investigations of the regions of 
interaction and biochemical approaches. 3D crystallographic structures of Survivin and 
catalytic PI3K domain of DNA-PKcs were virtually docked using advanced global docking 
algorithms, simulated by molecular dynamics, and were evaluated according to binding free 
energies (∆G) and the spatial accessibility/physical proximity. Next, multiple residues derived 
from these analyses were mutated, and the functional consequences of the mutagenesis were 
assayed by flow cytometry-based Förster resonance energy transfer (FACS-FRET) and co-
immunoprecipitation (co-IP) experiments. Radiation survival and DNA damage repair 
capacity were assayed by 3D colony formation assays and DNA foci analysis (γH2AX/53BP1), 
respectively. The effects of the Survivin-DNA-PKcs interrelationship were further analyzed by 
in vitro DNA-PKcs kinase activity assays and Liquid Chromatography-Mass Spectrometry (LC-
MS2/3)-based multi-proteomic techniques. Finally, a virtual drug screening approach was 
employed in search for novel small-molecule radiosensitizers targeting the Survivin-DNA-PKcs 
interaction.  
Molecular docking and advanced in silico analyses uncovered residues serine(S)20 and 
tryptophan(W)67 located in the baculovirus inhibitor of apoptosis protein repeat (BIR) 
domain of dimerized Survivin to interact with the PI3K domain of DNA-PKcs. Mutagenesis of 
these residues significantly decreased the interaction compared to wild-type (wt) Survivin, 
was correlated with an increased radiosensitivity of colorectal cancer cells and a hampered 
DNA repair capacity, measured by γH2AX/53BP1 foci analysis, after knockdown of 
endogenous Survivin. By contrast, overexpression of wt Survivin rescued radiation survival 
and DNA repair. In addition, advanced molecular docking and dynamics simulation analyses 
revealed a heterotetramer model, where Survivin binds to the surface of pre-existing DNA-
PKcs dimer. Moreover, by investigating the effects of Survivin on DNA-PKcs’ downstream 
regulatory functions, differentially abundant phosphopeptides and proteins were identified for 
multiple pathways, predominantly for DNA damage/repair. Binding of Survivin to a pre-
existing DNA-PKcs dimer was lead to a conformational change on the PI3K domain and 
resulted in a differential change in substrate specificity. Particularly, the previously little-
known DNA-PKcs’ S/T-Hydr (hydrophobic residues: G, A, V, L, I, P, F, M, W) motif substrates 
including the FOXO3 S253 phosphosite displayed high conservation within the detected 
phosphosites. Further, proteomics analyses indicated that the Survivin-DNA-PKcs 
interrelationship not only displays post-translational but also protein expression-level 
regulatory properties. Ultimately, the virtual drug screening approach uncovered small-
molecule compounds having strong binding affinity to S20, and W67 residues and 
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consequently might show promise for the development of future radiation sensitizing 
therapeutic approaches. 
In summary, in this study, we identified specific residues of Survivin involved in the 
interaction with the PI3K domain of DNA-PKcs by implementing in vivo live cell protein 
interaction quantification and in silico structure-based molecular docking technologies. 
Besides that, findings on radiosensitivity, DNA foci formation, kinase activity, and 
phosphoproteomics and proteomics analyses further strengthen the notion that Survivin is a 
fine-tuning regulator of DNA DSB repair and impacts on substrate specificity by fostering the 
S/T-Hydr motif phosphorylation. Large-scale proteomics and phosphoproteomics studies 
further discovered novel candidate proteins and phosphosites, enlightening the underlying 
mechanistic relation between Survivin and DNA-PKcs in response to irradiation and may pave 
the way to novel Survivin-related cancer and DNA damage response marker discoveries. 
 
Zusammenfassung 
Survivin, das kleinste Mitglied der Inhibitor of Apoptosis Protein (IAP)-Familie ist durch eine 
hohe Expression in fast allen untersuchten humanen Tumoren gekennzeichnet. Obwohl 
Survivin primär als ein Protein mit Funktionalität in der Regulation von Apoptose und 
Zellzyklus/mitotischen Spindelkontroll- punkt beschrieben ist, wird das Protein aktuell als ein 
wesentlicher Knotenfaktor in einer Vielzahl zellulärer Reaktionskaskaden angesehen. In 
diesem Zusammenhang stellt Survivin in einer Vielzahl von Tumorentitäten einen 
Resistenzfaktor dar, der das Überleben der malignen Zellen nach Strahlenexposition 
verbessert indem er die Reparatur von DNA-Doppelstrangbrüchen (DNA-DSB) zu modulieren 
vermag. Dabei konnte eine nukleäre Akkumulation von Survivin nach Bestrahlung 
mechanistisch mit der Aktivität der DNA-abhängigen Proteinkinase (DNA-PKcs), einer 
Schlüsselkomponente des DNA-DSB Reparatur- Mechanismus der Nicht-Homologen 
Endverknüpfung (NHEJ), assoziiert werden. 
Ziel der Studie war die Aufklärung der molekularen Determinanten der Survivin-DNA-PKcs 
Wechsel- Beziehung durch computergestützte Analysen der Interaktionsregionen und 
biochemische Ansätze. Dazu wurden die Bindung kristallographischer 3D-Strukturen von 
Survivin und die katalytische PI3Kinase-Domäne der DNA-PKcs virtuell mit Hilfe 
fortgeschrittener Algorithmen und molekular-dynamischer Berechnungen simuliert und in 
Abhängigkeit von freien Bindungsenergien (∆G) und der räumlichen 
Zugänglichkeit/physischen Nähe bewertet. Anschließend wurden als Ergebnis dieser Analysen 
unter- schiedliche Aminosäuren von Survivin mutiert und die funktionellen Konsequenzen 
dieser Mutagenese mittels durchflusszytometrischer Förster-Resonanzenergietransfer (FACS-
FRET) und Ko-Immunpräzipitations (co-IP) Experimenten untersucht. Das Überleben nach 
Bestrahlung und die Fähigkeit zur Reparatur von DNA-Schäden wurden mit 3-dimensionalen-
Koloniebildungstests bzw. der Quantifizierung von DNA-Schadensmarker γH2AX/53BP1 
analysiert, während die Effekte der Interaktion auf die Kinaseaktivität der DNA-PKcs durch in-
vitro Kinase-Aktivitätsmessungen und Massenspektrometrie (LC-MS2/3) basierten multi-
Proteomik-Ansätzen evaluiert wurden. Schließlich erfolgte mit Hilfe eines virtuellen Wirkstoff-
Screening-Ansatzes auf Grundlage der Survivin-DNA-PKcs-Interaktion eine Suche nach 
neuartigen niedermolekularen Hemmstoffen der Interaktion mit möglicher 
strahlensensibilisierender Wirkung.  
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Durch molekulare Bindungs- und in-silico Analysen konnte eine Bindung von Survivin an die 
PI3Kinase-Domäne der DNA-PKcs nachgewiesen werden, die überwiegend durch eine 
Interaktion der Aminosäuren Serin (S)20 und Tryptophan (W)67 der Baculovirus-IAP repeat 
(BIR) Domäne von dimerisierten Survivin vermittelt wird. Im Vergleich zum Wildtyp (wt) 
Survivin verringerte eine spezifische Mutagenese dieser Aminosäuren signifikant die 
Interaktion mit der DNA-PKcs, korrelierte mit einer erhöhten Strahlen- sensibilität von 
kolorektalen Tumorzellen und einer verminderten DNA-Reparaturkapazität nach Hemmung 
von endogenem Survivin. Im Vergleich dazu konnte durch eine Überexpression von wt 
Survivin das klonogene Zellüberleben und die DNA-Reparaturkapazität wiederhergestellt 
werden. Darüber hinaus führten weiterführende molekulare Bindungsanalysen und 
dynamische Simulationen zur Entwicklung eines Heterotetramer-Modells, bei dem Survivin an 
die Oberfläche eines bereits existierenden DNA-PKcs-Dimers zu binden vermag. In 
Untersuchungen des Effekts dieser Bindung auf nachgeschaltete regulatorische Funktionen 
der DNA-PKcs konnte eine große Anzahl differentiell regulierter Phospho- peptide identifiziert 
werden, die vorwiegend Reaktionswegen der DNA-Schadensantwort/Reparatur betreffen. 
Dabei führt die Bindung von Survivin an ein präformiertes DNA-PKcs-Dimer zu einer 
Konformationsänderung der PI3K-Domäne, resultierte in einer signifikanten Steigerung der 
Kinaseaktivität und einer differentiellen Änderung der Substratspezifität. Insbesondere bisher 
wenig beschriebene DNA-PKcs S/T-Hydr (hydrophobe Aminosäuren: G, A, V, L, I, P, F, M, W) 
Motive einschließlich der FOXO3 Aminosäure S253 zeigten eine hohe Konservierung 
innerhalb der detektierten Phosphorylierungsstellen. Darüber hinaus zeigten 
Proteomanalysen, dass die Survivin-DNA-PKcs-Interaktion nicht nur post- translationale, 
sondern auch regulatorische Funktionen auf Proteinexpressionsebene ausüben kann. 
Schließlich konnten in ersten virtuellen Wirkstoff-Screening-Ansatz niedermolekulare 
Verbindungen identifiziert werden, die eine hohe Bindungsaffinität zu den Amiosäuren S20 
und W67 aufweisen und für zukünftige strahlensensibilisierende Therapieansätze 
vielversprechend sein könnten. 
Zusammenfassend konnte erstmals unter Verwendung einer Methodik zur Quantifizierung 
einer Proteineninteraktion in lebenden Zellen und durch in-silico strukturbasierte 
Bindungsanalysen spezifische Aminosäuren von Survivin identifiziert werden, die an der 
Wechselwirkung mit der PI3K-Domäne der DNA-PKcs beteiligt sind. Darüber hinaus 
bestätigen die Ergebnisse der Strahlensensibilitätsuntersuchungen, der Nachweis von DNA 
Reparatur-Foci, DNA-PKcs Aktivitätsmessungen und (Phospho)proteomik-Analysen die 
Vorstellung, dass Survivin einen (Fein)regulator der DNA-DSB Reparatur und insbesondere 
der Substratspezifität der DNA-PKcs hin zu S/T-Hydr-Motiven darstellt. Umfangreiche 
(Phospho)proteomik-Analysen führten zudem zur Aufdeckung neuer Kandidatenproteine und 
Phosphorylierungsstellen. Dies könnte dazu beitragen die zugrundeliegenden mechanistischen 
Beziehungen zwischen Survivin und DNA-PKcs weiter aufzuklären und den Weg zur 
Entdeckung neuer, Survivin-assoziierter Tumor und DNA-Schadenreaktionsmarkern und 
Therapieansätze zu ebnen. 
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2. Introduction 
 
2.1. DNA damage response 
 
2.1.1.  Irradiation, DNA DSB repair and DNA-PKcs 
 
125 years ago, physicist Wilhelm Conrad Röntgen has discovered a novel art of ionizing 
radiation (IR) known as X-Rays or Röntgen-Rays today (Röntgen, 1895). IR is a type of high-
energy radiation that generates ions via releasing electrons from molecules that causes the 
breaking of covalent bonds. IR is measured in Gray (Gy) units and is defined as the amount of 
radiation energy absorbed by one kilogram (kg) of tissue. IR directly damages the 
deoxyribonucleic acid (DNA) structure by inducing DNA damage such as base damage, single-
strand breaks (SSBs), DNA crosslinks, and most importantly double-strand breaks (DSBs) 
(Borrego-Soto et al., 2015; Jeggo and Lobrich, 2006). 
IR-induced DNA DSBs initiate a cellular DNA damage stress response (DDR) by activating 
DNA repair pathways aiming to maintain genomic stability and fix the damage. Functional, 
disruption of DNA repair pathways ends up with anti-proliferative responses by regulation of 
cell cycle checkpoints, cellular senescence, and a variety of cell death pathways (Kantidze et 
al., 2018). Dependent on the cell cycle phase status, one of the two main DNA DSB repair 
pathways, homologous recombination (HR) or non-homologous end joining (NHEJ) is used 
for repair. HR is in service for S-phase diploid cells, while because of the absence of a 
homology donor nearby, haploid and G1/G2/M-phase diploid cells are repaired by NHEJ 
(Lieber, 2010). NHEJ functions throughout the cell cycle process, while during the late S/G2 
phase, HR is more dominant (Brandsma and Gent, 2012). 
Around 35 years ago, a study reported the discovery of a global increase of phosphorylation 
upon addition of double-stranded DNA (dsDNA) into cell extract phosphorylation assay. Of 
particular importance, this study revealed for the first time that some kinases have 
dependencies on the presence of dsDNA to function properly (Walker et al., 1985). Within a 
couple of years, specific identification, partial purification and characterization, and activity of 
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) were reported (Carter et al., 
1990; Lees-Miller and Anderson, 1989). DNA-PKcs is a serine/threonine protein kinase 
belonging to the phosphatidylinositol-3-kinase (PI3K)-like kinase (PIKK) family and is a major 
regulator of DDR. Lupus Ku autoantigen protein p70/80 (KU70/80) heterodimer binds to 
DNA and recruits the DNA-PKcs to the damage site to form an active DNA-PK holoenzyme 
(Hartley et al., 1995). The PI3K domain of DNA-PKcs is located at the C-terminus and flanked 
upstream by a FRAP-ATM-TRRAP (FAT) (Hammel et al., 2010) domain and downstream by a 
FAT C-terminal domain (FATC). All the members of PIKK family further include variable 
lengths of large helical supersecondary structured hydrophobic Huntingtin, Elongation Factor 
3, PP2 A, and TOR1- (HEAT)-repeat domains (Sibanda et al., 2017) (Figure 1). 
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Figure 1. Schematic representation of the DNA-PKcs’ subunits. 4128 amino acids long DNA-PKcs 
contains N-terminal, Cradle and Head units and a variety of different subspecialized domains/regions 
within these units. (Abbreviations: HEAT1/2, Huntingtin, Elongation Factor 3, PP2 A, and TOR1 
repeat; TRD1/2/3, tetratricopeptide repeat domain 1/2/3; PQR, autophosphorylation sites; ABCDE, 
auto/transphosphorylation sites; FAT, FRAP-ATM-TRRAP domain; FRB, FKBP12-rapamycin binding 
domain; PI3K, phosphatidylinositol-3-kinase; FATC, FAT C-terminal domain). Figure modified from 
(Sibanda et al., 2017). 
 
When a DNA DSB occurred, KU70/80 heterodimer was first thought to bind DNA DSB ends 
because of the high abundance (400,000 molecules/cell) and strong binding affinity 
(dissociation constant (Kd): ~10-9 M) for dsDNA ends (Blier et al., 1993; Falzon et al., 1993; 
Lieber, 2010; Mimori and Hardin, 1986). Moreover, recently it has been reported that the C-
terminal region of KU80 is responsible for recognizing the DNA DSB ends and to generate an 
extended flexible arm that connects DNA-PKcs to the KU70/80-DNA complex (Hammel et al., 
2010; Hammel et al., 2016; Radhakrishnan and Lees-Miller, 2017). The recruitment of DNA-
PKcs to the KU70/80-DNA complex is dependent on the presence of DNA DSB ends because in 
the absence of these ends a stable KU70/80-DNA-PKcs complex can not be established 
(Lieber, 2010; Yaneva et al., 1997). For the DNA DSB end processing stage of NHEJ repair, it 
is still unclear whether Artemis-based nuclease activity or polymerase (λ or µ)-based filling of 
overhangs are used. Artemis is a nuclease characterized by a variety of abilities such as 5´ and 
3´ endonuclease activity, 5´ exonuclease activity, and hairpin opening activity (Lieber, 2010; 
Ma et al., 2002). On the other hand, polymerases λ and µ both are able to bind to KU70/80-
DNA complex, and particularly polymerase µ has template-independent synthesis ability, 
which perfectly fits the needs of NHEJ (Lieber, 2010; Ma et al., 2004; Zhao et al., 2020). After 
the processing step, ultimately an X-ray repair cross complementing 4 (XRCC4)-DNA ligase 
IV-XRCC4-like factor (XLF) complex has to be recruited to ligate the processed ends. XLF 
stimulates the initial heterodimerization of XRCC4-DNA ligase IV, and interacts with XRCC4 
by generating a bridge on DNA ends (Ahnesorg et al., 2006; Roy et al., 2015). The flexibility 
of DNA ligase IV permits ligation of a wide range of DNA end structures, even single strands 
of both ends. However, one consequence of this flexibility is that it may cause ligation of one 
or both strands of the left and right duplexes, which stimulates transient or permanent 
termination of the NHEJ ligation process. It seems likely that the dynamic NHEJ processor 
complexes need multiple rounds of actions to fix the damage (Lieber, 2010). NHEJ factors are 
in close functional relation to accurately carry out the repair function. XRCC4/XLF interaction 
is vital for DNA-PKcs since xlf-deficient cells or XRCC4 interaction-deficient XLF cause a 
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malfunction in terms of DNA-PKcs autophosphorylation (Roy et al., 2015). Furthermore, for 
the activation of the end-processing endonuclease process, Artemis requires either 
autophosphorylation of DNA-PKcs (Goodarzi et al., 2006) or DNA-PKcs- or Ataxia 
telangiectasia mutated- (ATM)-dependent phosphorylation (Jiang et al., 2015). DNA ligase IV 
which is a vital component of the NHEJ end-ligation step was found to be phosphorylated by 
DNA-PKcs whose deletion in V3 cells diminished the DNA ligase IV phosphorylation. The 
phosphorylation of DNA ligase IV by DNA-PKcs, particularly on T650 residue, was found to be 
essential for its stability (Wang et al., 2004). Additionally, the accumulation of XRCC4 at the 
DNA DSB site was found to be dependent on KU70/80 via direct interaction (Mari et al., 
2006). Moreover, according to recent small angle X-ray scattering (SAXS) analyses, mainly 
KU80 was found to interact with the C-terminus region of XLF (Nemoz et al., 2018) (Figure 
2). 
 
Figure 2. Non-homologous end joining (NHEJ) repair pathway. After DNA double-strand break 
(DSB) generation, NHEJ starts with the recognition of both DNA ends by the KU70/80 heterodimers, 
which then recruit the DNA-PKcs. If the ends are incompatible, Artemis and/or Pol λ or µ can be 
recruited as well to either trim or fill up the ends, respectively. Eventually, the XRCC4-DNA ligase IV-
XLF complex ligates the break. Figure adapted from (Brandsma and Gent, 2012). 
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Notably, the PI3K domain of DNA-PKcs is vital both, on a cellular and organism level. 
Expression of catalytically inactive kinase-dead (KD) DNA-PKcs (DNA-PKcs KD/KD) leads to 
embryonic lethality in mice via causing severe neuronal apoptosis and several defects in the 
G0/G1 phase of the cell cycle when NHEJ is more prominent. Furthermore, it causes 
increased genomic instability by showing a massive fraction of chromosomal abnormalities, 
severe NHEJ defects, including hypersensitivity to IR, and abrogation of end-ligation (Jiang et 
al., 2015). Biochemical studies revealed the DNA-PKcs’ preference for phosphorylating a 
serine or threonine followed by a glutamine residue (S/T-Q) both in vitro and in vivo, with the 
exception of phosphorylation of some non-S/T-Q motifs only in vitro (Lees-Miller and 
Anderson, 1989). 
Autophosphorylation sites of DNA-PKcs mostly cluster in the cradle unit, such as S2056 and 
T2609, which are particularly essential for activation. S2056 and T2609 activation 
phosphorylation sites of DNA-PKcs are phosphorylated by itself and ATM/Ataxia 
telangiectasia and RAD3-related (ATR) kinases, respectively in response to IR and ultraviolet 
(UV) (Chen et al., 2005; Chen et al., 2007a; Yajima et al., 2006). Another 
autophosphorylation site, T3950, is located in the kinase domain and regulates the kinase 
activity. Despite that the kinase domain is located in the C-terminal region, deletion of the N-
terminal and cradle units also hamper the kinase activity, which indicate the importance of N-
terminal unit and autophosphorylation sites. The kinase activity of DNA-PKcs is essential for 
the phosphorylation of a variety of substrates including H2A histone family member X 
(H2AX), tumor protein P53 binding protein 1 (53BP1), ATM, polynucleotide kinase 3’-
phosphatase (PNKP), KU70/80, DNA ligase IV, and XRCC4 which mainly regulate the DNA 
damage response (Davis et al., 2014). Moreover, it has many additional functions, e.g. it 
confers a negative regulatory effect on ATM on both, translational and post-translational 
level. DNA-PKcs/prkdc-deficient cells clearly show decreased ATM protein expression. 
Moreover, S85, T86, T372, T373, T1985, S1987, and S1988 phosphorylation of ATM by DNA-
PKcs represses ATM activation both in vitro and in vivo. Overexpression of ATM with the 
related phospho-mimetic mutations in atm-deficient cells fails to restore cell survival, DNA 
DSB end resection, or intra-S-phase checkpoint activation in response to DNA damage (Zhou 
et al., 2017a). Corroborating findings revealed as well that siRNA-mediated inhibition of 
DNA-PKcs hyperactivates ATM by increased phosphorylation of S1981 autophosphorylation 
site (Finzel et al., 2016). 
The expected final step of NHEJ is the ligation of broken DNA ends, but the missing link was 
how DNA ends are brought together? The process called synapsis was studied by a variety of 
groups for many years yielding novel aspects. The first hypothesis to enlighten the process 
arised from electron microscopy (EM) studies by DeFazio and colleagues that suggested a 
DNA-PKcs dimerization (DeFazio et al., 2002). This hypothesis was further supported by other 
EM/cryogenic EM (cryo-EM) studies postulating that the DNA-PKcs either alone or as a 
holoenzyme with KU70/80 dimerized by the N-terminal HEAT repeats and/or mid part of 
cradle (Baretic et al., 2019; Sibanda et al., 2017; Spagnolo et al., 2006). By a different 
experimental approach, using SAXS, Hammel and colleagues further reported that DNA-PKcs 
was dimerized by the head domain, which incorporates the PI3K domain (Hammel et al., 
2010). That was also supported by a recent cryo-EM study that indicated the FAT/kinase 
domain regions of DNA-PKcs to generate a self-heterodimer to autophosphorylate the PQR 
cluster (Baretic et al., 2019). Indeed, DNA-PKcs is not the only member of the PIKK family 
which dimerizes. According to crystallographic data, ATM and ATR seem to dimerize as well. 
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ATM was found to dimerize via long helical hairpin regions in the tetratricopeptide repeat 
domain 3 (TRD3) sub-domain located within the FAT and kinase (FATKIN) domain (Baretic 
et al., 2017; Wang et al., 2016; Waterman et al., 2020). However, ATR was found to generate 
a heterodimer with ATRIP (Wang et al., 2017; Waterman et al., 2020). In contrast to the 
DNA-PKcs dimerization hypotheses and findings, a recent study suggested a synapsis model 
predicting of a complex containing KU70/80, XRCC4, DNA ligase IV, XLF, and Paralog of 
XRCC4 and XLF (PAXX) but not DNA-PKcs by employing a single-molecule FRET (sm-FRET) 
method (Zhao et al., 2019). It is well known that synapsis processes are highly dynamic and 
this hypothesis definitely needs further investigations to elucidate its dynamic mechanism and 
mediators. 
 
2.1.2.  IAP family, Survivin and relations with DNA damage response 
 The inhibitor of apoptosis protein (IAP) family was first discovered by the characterization of 
a novel domain of baculoviral IAP repeat (BIR), which takes the name from the gene of a 
baculovirus that inhibit virally infected Spodoptera frugiperda insect cells (Crook et al., 1993). 
The IAP family is structurally characterized by a varying numbers of BIR domains. After the 
recent discovery of Baculoviral IAP repeat-containing protein 1 (gene name birc8), the IAP 
family currently consists of eight members such as neuronal apoptosis inhibitory protein 
(NAIP)/birc1, cellular IAP 1 (cIAP1)/birc2, cellular IAP 2 (cIAP2)/birc3, X-chromosome-linked 
IAP (XIAP)/birc4, Survivin/birc5, BIR repeat-containing ubiquitin-conjugating enzyme 
(BRUCE)/Apollon/birc6, LIVIN/birc7 and human IAP-like 2 (hILP2)/TS-IAP/birc8 (Oberoi-
Khanuja et al., 2013; Srinivasula and Ashwell, 2008) (Figure 3). 
Besides the well-known function of IAP family members to inhibit apoptosis mainly mediated 
by BIR domains, they also consist of a variety of different domains which equip them with 
different functional abilities. Anti-apoptotic nucleoside triphosphatase (NTPase) NAIP/birc1 
includes a NAIP-C2TA-HETE-TEP1 nucleotide-binding and oligomerization domain (NACHT) 
which functions in a guanosine triphosphate (GTP)-dependent manner in apoptosis inhibition 
and major histocompatibility complex (MHC) class II transcription activation (Koonin and 
Aravind, 2000). Leucine-rich repeat (LRR) containing domains are conserved regions mainly 
playing roles on signalling pathways of innate immunity and host-pathogen recognition (Ng 
and Xavier, 2011). cIAP1/2 and hILP2 proteins consist ubiquitin-associated (UBA) domains 
that stimulate either the proteasomal degradation or protein stabilization via binding to 
ubiquitinated proteins (Su and Lau, 2009). Caspase recruitment domains (CARD) 
predominantly serve as protein-protein interaction region playing roles in the regulation of 
immune response signalling pathways, inflammation and apoptosis (Palacios-Rodriguez et al., 
2011). BRUCE has an ubiquitin conjugating (UBC) domain which works sequentially with the 
ubiquitin  facilitates the conjugation step of activation/conjugation/ligation cascade process of 
ubiquitination via catalysing the covalent attachment of ubiquitin to the target protein 
(Passmore and Barford, 2004). Really interesting new gene (RING) domain containing 
cIAP1/2, XIAP, LIVIN and hILP2 have E3 ubiquitin ligase activity which mediates 
ubiquitination and intrinsic protein degradation/stabilization dynamics. Further, RING 
domains mediate signal transduction, protein-protein interactions, transcription and 
recombination (Stone et al., 2005) (Figure 3). 
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Figure 3. Domain architecture of the inhibitor of apoptosis (IAP) family members. IAPs are 
represented with their functional domains. Baculoviral IAP repeat (BIR), NAIP-C2TA-HETE-TEP1 
nucleotide-binding and oligomerization domain (NACHT), leucine-rich repeats (LRR), ubiquitin-
associated domain (UBA), caspase recruitment domain (CARD), really interesting new gene domain 
(RING), ubiquitin conjugating domain (UBC). Figure adapted from (Oberoi-Khanuja et al., 2013). 
 
Survivin, encoded by the birc5 gene, is a 16.5 kDa protein of 142 amino acid residues 
primarily described in the late nineties as a member of the mammalian IAP family (Ambrosini 
et al., 1997). In contrast to other members of the family, Survivin harbors only a single BIR 
domain that is reported to confer protein-protein interactions with caspases or kinases and an 
extended amphipathic α-helical coiled-coil domain at the C-terminus, common in microtubule-
associated proteins (LaCasse et al., 1998; Verdecia et al., 2000). The conserved BIR domain 
(18-88 amino acids region) works as an interaction hub for many protein-protein interactions 
of Survivin to function correctly and maintain self-consistency. SMAC/DIABLO, which is 
essential for the anti-apoptotic function of Survivin, binds directly to the BIR domain, and 
D71R point mutation inhibits this interaction (Song et al., 2003). Further, as a chromosomal 
passenger complex (CPC) member, Survivin´s BIR domain residues D70 and D71 function as 
an anchorage to centromeres, which results in the proper karyokinesis during mitosis (Wang 
et al., 2010). Besides, binding of the ATPase domain of HSP90 to the BIR domain provides 
both, consistency for Survivin and regulation of cell cycle and apoptosis. Inhibition of this 
interaction leads to proteasomal degradation of Survivin, mitochondrial-dependent apoptosis, 
and cell cycle arrest with mitotic defects (Fortugno et al., 2003). These findings suggest a 
potential protein-protein interaction role mainly for the BIR domain of Survivin.   
Although Survivin was primarily reported to constitute a bifunctional protein involved in the 
regulation of cell division/proliferation and apoptosis, it is now evident that it is a prime 
example of a multifunctional nodal protein implicated in multiple tumor signaling pathways. 
These cover transcriptional networks, autophagy, and stemness (Altieri, 2008, 2010; 
Wheatley and Altieri, 2019). In that context, one of the signature features of Survivin is its 
direct or indirect relationship with a multitude of protein partners, including tubulins, nuclear 
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and heat shock proteins, multiple kinases, caspases and other members of the IAP family such 
as the XIAP and cIAP-1 (Altieri, 2008, 2010; Jung et al., 2015; Rodel et al., 2012). Although 
the BIR domain of Survivin does not bind directly to caspases, in both homodimer and 
monomer forms, increased Survivin expression and prior mitochondrial residence reduce the 
caspase activity. For example, via prevention of the release of Apoptotic protease-activating 
factor 1 (APAF1) from mitochondria or direct association with XIAP and Hepatitis B X-
interacting protein (HBXIP) in a complex with XIAP-associated factor 1 (XAF1), Survivin is 
reported to inhibit Caspase 3/7, 8 and 9 activities whereas association with second 
mitochondria-derived activator of caspases (SMAC)/direct IAP binding protein with low pI 
(DIABLO) counteracts this inhibitory activity (Dohi et al., 2004; Du et al., 2000; Hehlgans et 
al., 2015; Song et al., 2003; Wheatley and Altieri, 2019). Moreover, Survivin was found to 
orchestrate nuclear factor kappa B (NF-κB) dependent expression of fibronectin, integrin 
signalling, activation of focal adhesion kinase (FAK) and SRC or up-regulation of AKR 
thymoma serine/threonine-specific protein kinase (AKT) pathway to mediate tumor cell 
migration and metastatic dissemination (Chu et al., 2012; Hehlgans et al., 2013; Mehrotra et 
al., 2010; Wheatley and Altieri, 2019) (Figure 4). 
 
Figure 4. Schematic representation of the cellular functions of Survivin. Survivin acts in a variety 
of cellular pathways such as regulation of apoptosis (intrinsic and extrinsic), autophagy, DNA repair 
and cytokinesis via dynamic protein interactions in mitochondria, the cytoplasm and nucleus. 
(Abbreviations: FADD, FAS-associated death domain protein; cIAP1/2, cellular inhibitor of apoptosis 
protein 1/2; APAF1, apoptotic protease-activating factor 1; AIP, APAF1 inhibitory protein; SMAC, 
second mitochondria-derived activator of caspases; HBXIP, hepatitis B X-interacting protein; XIAP, X-
chromosome-linked inhibitor of apoptosis protein; mTOR, mammalian target of rapamycin; HSP90, 
heat shock protein 90; Shepherdin, peptidomimetic antagonist of the HSP90-Survivin complex; DNA-
PKcs, DNA-dependent protein kinase catalytic subunit; INCENP, inner centromere protein; Aurora B, 
aurora kinase B). Figure adapted from (Wheatley and Altieri, 2019). 
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Survivin works as a protector against either apoptotic or autophagic cell death. Cytoplasmic 
localization is essential for this activity, while nuclear relocation abrogates it. The basal level 
of autophagy is vital to remove defective organelles and unfolded/misfolded proteins. In the 
catabolic recycling system, an excessive amount of autophagy kills the cells, which might be a 
tumor suppression approach in a cancer-dependent manner (Chun and Kim, 2018). Survivin 
expression increases via hyperactivated AKT-PKB-PI3K signalling in response to cytokine 
treatment and results in the inhibition of autophagic death. In accordance, the association of 
Survivin with coiled-coil myosin-like BCL2-interacting protein (BECLIN-1) inhibits the 
excessive amount of autophagy, while inhibition of Survivin with small molecule YM155 
inhibitor increases the interrelationship, which makes it a target as an autophagy-dependent 
cancer treatment (Wheatley and Altieri, 2019). Recently, the role of Survivin on autophagy 
was further investigated. It could be shown that Survivin works as a bridging molecule to 
provide interaction between autophagy related 12 (ATG-12) and ATG-5, and this interaction 
prevents the ATG-12/ATG-5/ATG16L1 heterotrimeric interaction that results in the 
suppression of autophagy-induced DNA damage (Lin et al., 2019).   
Moreover, Survivin contains various phosphorylation sites such as Serine (S) 20 (Protein 
kinase A, Polo like kinase 1 and Aurora Kinase C), Threonine (T) 34 (p34cdc2/cyclin-
dependent kinase 1 and cyclin-dependent kinase 15) and T117 (Aurora kinase B) to facilitate 
both, protein stability and trafficking among various subcellular compartments (Colnaghi and 
Wheatley, 2010; Dohi et al., 2007; O'Connor et al., 2002; Park et al., 2014; Raab et al., 2015; 
Sasai et al., 2016; Wheatley et al., 2007). 
In the clinical setting, it has consistently been demonstrated that Survivin is overexpressed in 
the majority of solid and liquid human tumors and significantly correlates with tumor onset, 
more aggressive and advanced pathologic features, metastasis and worse prognosis as well as 
impaired patients’ survival (Kanwar et al., 2013; Miura et al., 2011; Rodel et al., 2012). In 
addition, due to its prognostic and predictive relevance along with a prominent role at 
disparate cellular networks, Survivin is considered to be a target for a molecular cancer drug 
development with the first inhibitors (antisense oligonucleotides, small molecules and 
immunotherapy) currently under clinical phase I/II/III investigation (http://clinicaltrials.gov) 
(Kanwar et al., 2011). Additionally, Survivin has been found on the surface of circulating 
exosomes in malignant glioma patients. A decrease in Survivin-positive exosomes following 
Survivin immunotherapy was reported to be associated with longer progression-free survival 
suggesting Survivin as potential prognostic marker in serum biopsies (Galbo et al., 2017).  
Beyond that, it has been shown in a multitude of both, in vitro and in vivo models that 
Survivin constitutes a radiation resistance factor and that attenuation of the protein 
radiosensitizes malignant cells (Rodel et al., 2012). The underlying mechanism(s) and 
molecular requirements, however, far exceed a simple inhibition of irradiation-induced 
caspase-dependent apoptotic cell death, including caspase-independent pathways like 
modulation of DNA damage repair (Chakravarti et al., 2004; Rodel et al., 2011). Thus, recent 
studies further demonstrate that a nuclear accumulation of Survivin following irradiation and 
an interaction with components of the DNA DSB repair apparatus like DNA-PKcs regulates 
DNA DSB repair, at least in part, by modulating DNA-PKcs kinase activity (Capalbo et al., 
2010; Reichert et al., 2011). 
Not only Survivin but also other IAP family members are directly involved in the DNA damage 
response and repair. In line with the characteristics of the IAP family members, BRUCE the 
largest member of the IAP family with a 528 kDa molecular weight, is a multifunctional 
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protein which regulates development (Hao et al., 2004; Lotz et al., 2004), cytokinesis (Pohl 
and Jentsch, 2008) and as recently reported DNA damage response (Ge et al., 2015) besides 
its apoptosis inhibitory role. BRUCE was found to act as a scaffold for DNA DSB-induced 
deubiquitination of BRCT-repeat inhibitor of TERT expression 1 (BRIT1) by ubiquitin specific 
peptidase 8 (USP8). Further, the complex BRUCE-BRIT1-USP8 facilitates chromatin relaxation 
for timely DNA repair in response to DNA DSB (Ge et al., 2015). The other member of IAP 
family that contributes to the DNA damage response is cIap1 which alongside three BIR 
domains, harbors a RING domain to modulate ubiquitin ligase activity and a CARD domain 
(Lopez et al., 2011). CIAP1 functions in the regulation of cell cycle (Samuel et al., 2005), 
nuclear factor kappa B (NF-κB) activation (Tang et al., 2003), and differentiation (Plenchette 
et al., 2004). Recently it has been reported that silencing of cIAP1/birc2 impedes IR-induced 
transforming growth factor (TGF)-beta-activated kinase 1 (TAK1) activation and I-kappa B 
kinase (IKK) T-loop phosphorylation by ATM in DNA damage induced NF-κB pathway 
activation (Hinz et al., 2010). According to the previous findings on Survivin (Capalbo et al., 
2010; Reichert et al., 2011; Wang et al., 2018c), the current study and studies on other IAPs 
such as Bruce and cIap1 mentioned above suggest potential regulatory roles for IAP proteins 
in DNA damage response and repair processes. 
 
2.2. Aim of the thesis 
Survivin is a multifunctional protein which plays essential roles in several cellular processes 
such as programmed cell death, cell cycle regulation, chromosome segregation, mitosis, 
cellular stress response and in particular DNA damage response (Wheatley and Altieri, 2019). 
Recently it was revealed that upon irradiation Survivin accumulated in the nucleus and 
participated in the regulation of DNA damage response by interacting with DNA-PKcs 
(Capalbo et al., 2010; Chakravarti et al., 2004; Iwasa et al., 2008; Reichert et al., 2011; Rodel 
et al., 2005; Wang et al., 2018c). However on the molecular level characterization, 
mechanistic functions and the downstream regulatory effects of this interrelationship still 
remain unknown. To fill in the gaps of knowledge on the irradiation-dependent DNA damage 
response roles of Survivin at the molecular level, we aimed to investigate in more detail the 
interaction of Survivin with DNA-PKcs, its role in radiation responsiveness/survival of tumor 
cells and the large-scale regulatory effects on DNA damage response. 
Crystallographic structures of Survivin and DNA-PKcs were subjected to in silico molecular 
docking/dynamics simulations. Experimentally, a variety of amino acid and domain/region 
deletion mutants of Survivin and DNA-PKcs were generated and stably/transiently expressed 
in the colorectal cancer cell lines SW480, DLD-1 and HCT-15. Cells were subjected to 
functional analyses, including in vivo FACS-FRET, more physiological three-dimensional (3D) 
colony-forming assays, 3D immunofluorescence staining of γH2AX/53BP1 DNA repair foci, co-
immunoprecipitation, in vitro kinase, multi-omics (phosphoproteomics and proteomics) and 
virtual drug screening analyses. Here we show that the BIR domain of Survivin and more 
specifically S20 and W67 amino acids located in the BIR domain of Survivin are essential for 
the regulation of 3D radiation survival and DNA damage repair via generating a 
heterotetramer complex interacting with catalytic PI3K domains of two DNA-PKcs’ molecules 
and possibly modulating the kinase activity of DNA-PKcs. Eventually, this interaction leads to 
the regulation of critical cellular pathways such as DNA damage repair, apoptosis, cell cycle 
and transcriptional/post-transcriptional regulation. 
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3. Materials and Methods 
 
3.1. Materials 
 
3.1.1.  Devices/Instruments 
Device/Instrument Model/Description Manufacturer 
Agarose gel electrophoresis 
chamber 
- PEQLAB Biotechnologie, 
Erlangen 
Centrifuges 3-1810 
Mini Spin 
UNIVERSAL 320R 
MEGA STAR 1.6R 
Ultracentrifuge, L8-M, SW32 Ti 
rotor 
Neo Lab, Korea 
Eppendorf AG, Hamburg 
Hettich, Tuttlingen 
VWR, Darmstadt 
Beckman Coulter, Krefeld 
Column oven - Sonation 
Electrophoresis chamber for 
SDS gels + accessories 
Mini-PROTEAN® Tetra Vertical 
Electrophoresis Cell 
Bio-Rad, Munich 
ELISA reader TECAN infinite M200 pro TECAN, Männedorf, 
Switzerland 
Flow cytometer CytoFLEX S Beckman Coulter, Krefeld 
Freezing container Mr. Frosty™ Thermo Fisher Scientific, 
Dreieich 
Gel electrophoresis power 
supply 
Power Pack P25 T Biometra, Göttingen 
Heat sealer Futura Junior Audion, Weesp, the Netherlands 
Hotplate/stirrer C-MAG HS 7 
- 
IKA Labortechnik, Staufen 
VWR, Darmstadt 
Imaging System Odyssey® Fc Imaging System LI-COR, Lincoln, NE, USA 
Incubator HERA cell 240 + 240i Thermo Fisher Scientific, 
Dreieich 
Laminar flow hood HERA safe Thermo Fisher Scientific, 
Dreieich 
Linear accelerator Synergy Elekta, Crawley, UK 
Magnet for Dynabeads DynaMag™-2 Magnet Thermo Fisher Scientific, 
Dreieich 
Mass Spectrometer Orbitrap Fusion™ Lumos™ 
Tribrid™ Mass Spectrometer 
(connected to EASY-nLC 1200 
nano HPLC system) 
Thermo Fisher Scientific, 
Dreieich 
Microscopes AxioVert A1 
Axio Imager Z1 with AxioCam 
MRc 
Zeiss, Jena 
Zeiss, Jena 
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Axio Observer Z1 Inverted 
Phase Contrast Fluorescence 
Zeiss, Jena 
pH meter pH Meter 765 Calimatic Knick, Berlin 
Phosphorimager Fujifilm BAS-1500 GE Life Sciences, Japan 
Scales CP324S 
PRACTUM612-1S 
Sartorius, Göttingen 
Sartorius, Göttingen 
Semi-dry transfer system Trans-Blot® Turbo™ Transfer 
System 
TE-77 
Bio-Rad, Munich 
 
 
GE Healthcare, USA 
Shakers IKA® shaker MTS 4 
IKA® KS 260 basic 
IKA® LOOPSTER digital 
Mixer HC 
ES-20 
Biometra TS1 
Vibramax 100 
IKA Labortechnik, Staufen 
IKA Labortechnik, Staufen 
IKA Labortechnik, Staufen 
STARLAB, Hamburg 
BioSan, Riga, Latvia 
Analytik Jena, Jena 
Heidolph Instruments, 
Schwabach 
Shaker for bacteria MaxQ 4450 Thermo Fisher Scientific, 
Dreieich 
Sonication device Bioruptor Plus 
Bandelin Sonorex RK 31 
Diagenode S.A., Belgium 
BANDELIN electronic, Berlin 
Thermocycler Primus 96 advanced 
 
Pro Flex 
PeQLab Biotechnologie, 
Erlangen 
 
Applied Biosystems, Darmstadt 
Vortex-Genie 2 - Scientific Industries, Bohemia 
NY, USA 
Water bath Typ W/B 5 Gesellschaft für Labortechnik, 
Burgwedel 
 
3.1.2.  Consumables 
Consumable Manufacturer 
100 mm cell culture dishes Sarstedt, Nümbrecht 
15/50 ml tubes Greiner Bio-One, Frickenhausen 
Cell scraper M TPP, Trasadingen, Switzerland 
CELLSTAR® 6/12/24/96-well cell culture plates Greiner Bio-One, Frickenhausen 
CELLSTAR® 96-well cell culture plates, white 
polystyrene wells flat bottom 
Greiner Bio-One, Frickenhausen 
CELLSTAR® Filter Top T25/T75 cell culture Greiner Bio-One, Frickenhausen 
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flasks 
C-Chip Disposable Hemocytometer, Digital Bio NanoEnTek, Seoul, South Korea 
Cloning cylinders SciencewareR, Pequannock, NJ, USA 
Cover foil, Easy seal (80x140 mm) Greiner Bio-One, Frickenhausen 
CryoPure Tube 1.8 ml Sarstedt, Nümbrecht 
Culture slides 8 chambers BD Falcon, Erembodegem, Belgium 
FACS tubes, flow cytometry Sarstedt, Nümbrecht 
Filter paper Whatman, Kent, UK 
Glass beakers Schott, Mainz 
Microscope cover glasses (24x60 mm) Marienfeld, Lauda-Königshofen 
Microscopic slides Thermo Fisher Scientific, Dreieich 
Mini-PROTEAN® TGX™ Precast Gels Bio-Rad, Munich 
PCR tubes (0.2 ml) Thermo Fisher Scientific, Dreieich 
Petri dish (sterile, 92x16 mm) Sarstedt, Nümbrecht 
Pipette-tips, TipOne®, graduated, blue 1000µl/ 
yellow 200µl / white 20µl  
Starlab, Hamburg 
Polystyrene Round-Bottom tubes (14 ml) Becton Dickinson, Heidelberg 
Reaction tubes (0.5/1.5/2.0 ml) Eppendorf, Hamburg 
Sarstedt, Nümbrecht 
LoBind reaction tubes (1.5 ml) Eppendorf, Hamburg 
Trans-Blot® Turbo™ Mini Nitrocellulose Transfer 
Packs (mini format 0.2 µm nitrocellulose) 
Bio-Rad, Munich 
AmershamTM ProtranTM Premium 0.45 µm 
Nitrocellulose membrane 
Sigma-Aldrich, Munich 
 
3.1.3.  Reagents 
Reagent Manufacturer 
3-(N-morpholino)propanesulfonic acid (MOPS) Carl Roth, Karlsruhe 
4′.6-Diamidin-2-phenylindol (DAPI) Molecular Probes, Eugen, OR, USA 
Agarose NEEO Ultra-Quality Carl Roth, Karlsruhe 
Glacial Acetic acid J. T. Baker (Fisher Scientific), Schwerte 
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Acetonitrile Sigma-Aldrich, Munich 
Albumin Fraction V (pH 7) AppliChem, Darmstadt 
Ammonium peroxodisulfate (APS) Carl Roth, Karlsruhe 
Ampicillin Carl Roth, Karlsruhe 
32P ATP (250 µCi) PerkinElmer, Waltham, MA, USA 
Benzonase® Nuclease Merck Millipore, Darmstadt 
Bromophenol blue AppliChem, Darmstadt 
Bovine Serum Albumin (BSA) AppliChem, Darmstadt 
Calcium chloride AppliChem, Darmstadt 
Chloroacetamide Thermo Fisher Scientific, Dreieich 
Chloroform Fisher Scientific, Hampton, New Hampshire, USA 
cOMPLETE mini EDTA-free protease inhibitor Sigma-Aldrich, Munich 
Cultrex 3D Culture Matrix BME Reduced Growth 
Factor Basement Membrane Extract Pathclear 
R&D Systems, Wiesbaden 
CytoFLEX Sheath Fluid Beckman Coulter, Brea, CA, USA 
Deoxynucleotides (dNTP) (10 mM) Thermo Fisher Scientific, Dreieich 
Dichloroacetic acid (DCA) AppliChem, Darmstadt 
Dimethyl sulfoxide (DMSO) AppliChem, Darmstadt 
Dithiothreitol (DTT) Sigma-Aldrich, Munich 
DNA-PK inhibitor (KU 0060648) Tocris Bioscience, Bristol, UK 
DNase I Thermo Fisher Scientific, Dreieich 
Dulbecco’s Modified Eagle Medium (DMEM) Thermo Fisher Scientific, Dreieich 
Dulbecco’s Phosphate Buffered Saline (PBS) Thermo Fisher Scientific, Dreieich 
Dynabeads™ Protein G Thermo Fisher Scientific, Dreieich 
Empore™ C18 (Octadecyl) resin material 3M, St. Paul, Minnesota, USA 
EPPS Sigma-Aldrich, Munich 
Ethylenediaminetetraacetic acid (EDTA) AppliChem, Darmstadt 
EDTA Disodium Salt 2-hydrate (Na2EDTA)  
Ethidium bromide (EtBr) Carl Roth, Karlsruhe 
Fetal bovine serum (FBS) Thermo Fisher Scientific, Dreieich 
Formaldehyde – Solution 37% AppliChem, Darmstadt 
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Formic acid Fisher Scientific, Hampton, New Hampshire, USA 
Geneticin (G418) AppliChem, Darmstadt 
Glycerine Carl Roth, Karlsruhe 
Glycine AppliChem, Darmstadt 
Halt™ Protease Inhibitor Single-Use Cocktail Thermo Fisher Scientific, Dreieich 
Hydrogen chloride (HCl) AppliChem, Darmstadt 
Hydroxylamine Sigma-Aldrich, Munich 
Isopropanol Sigma-Aldrich, Munich 
jetPRIME Transfection Reagent Polyplus-transfection SA, Illkirch-Graffenstaden, 
France 
Kanamycin Carl Roth, Karlsruhe 
LB medium Carl Roth, Karlsruhe 
LB agar Carl Roth, Karlsruhe 
LysC Fujifilm Wako Chemicals, Osaka, Japan 
Methylene blue C.I. 52015 AppliChem, Darmstadt 
MgCl2 Sigma-Aldrich, Munich 
Milk powder Carl Roth, Karlsruhe 
Nonidet P-40 AppliChem, Darmstadt 
Non-reducing Lane Marker, Sample Buffer Thermo Fisher Scientific, Dreieich 
Opti-MEM I Thermo Fisher Scientific, Dreieich 
Penicillin 10.000 Units, Streptomycin 10 mg/ml 
(P/S) 
Sigma-Aldrich, Munich 
peqGREEN  DNA/RNA Dye PEQLab Biotechnologie, Erlangen 
PhosSTOP phosphatase inhibitor Roche Diagnostics, Mannheim 
Pierce® ECL, Western Blotting Substrate Thermo Fisher Scientific, Dreieich 
Polyethylenimine, Linear, Transfection Grade (PEI 
25K) 
Polysciences, Inc., Warrington, USA 
Ponceau S AppliChem, Darmstadt 
Propidium iodide Thermo Fisher Scientific, Dreieich 
ReproSil-Pur Basic 1.9 µm C18 particles Dr. Maisch HPLC GmbH, Ammerbuch 
RNAse/DNase-free water Thermo Fisher Scientific, Dreieich 
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Roti-Fect PLUS Carl Roth, Karlsruhe 
Rotiphoresis gel 30 Carl Roth, Karlsruhe 
Roswell Park Memorial Institute (RPMI)-1640 
medium 
Thermo Fisher Scientific, Dreieich 
Rubidium chloride Sigma-Aldrich, Munich 
SepPak C18 column Waters, Milford, Massachusetts, USA 
Silicon for cloning cylinders Momentive performance materials, Albany, NY, 
USA 
Sodium hydroxide (NaOH) Sigma-Aldrich, Munich 
Sodium chloride (NaCl) Sigma-Aldrich, Munich 
Sodium dodecylsulfate (SDS) pellets Carl Roth, Karlsruhe 
Sodium dodecylsulfate (SDS) 20% solution AppliChem, Darmstadt 
Sodium fluoride Sigma-Aldrich, Munich 
Sodium orthovanadate Sigma-Aldrich, Munich 
TCEP Thermo Fisher Scientific, Dreieich 
Tetramethylethylenediamin (TEMED) Carl Roth, Karlsruhe 
Tandem Mass Tag (TMT) reagent Thermo Fisher Scientific, Dreieich 
Trichloroacetic acid (TCA) AppliChem, Darmstadt 
Trifluoroacetic acid (TFA) Sigma-Aldrich, Munich 
Trypan Blue Stain 0.4% Thermo Fisher Scientific, Dreieich 
Trypsin/Ethylene diamine tetraacetic acid (EDTA, 
0.25%) 
Thermo Fisher Scientific, Dreieich 
Trypsin Promega, Madison, WI, USA 
Tween® 20 AppliChem, Darmstadt 
Tris hydroxymethyl aminomethane (Tris) Carl Roth, Karlsruhe 
Triton X-100 AppliChem, Darmstadt 
Urea Carl Roth, Karlsruhe 
Vectashield® Mounting Medium Vector, Burlingame, CA, USA 
WesternSure® PREMIUM Chemiluminescent 
Substrate 
LI-COR, Lincoln, NE, USA 
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3.1.4.  Solutions and buffers 
 
Agarose gel electrophoresis 
DNA loading dye Blue Run (5x) 
 1.25 ml  1 M Tris/HCl, pH 7.0 
 15 ml  0.5 M EDTA 
 25 mg  Bromophenol blue 
 12.5 ml  Glycerine 
 adjust volume to 50 ml with distilled water 
 
Tris acetate EDTA (TAE) buffer (50x) 
 242 g  Tris (in 500 ml distilled water) 
 100 ml  0.5 M Na2EDTA, pH 8.0 
 57.1 ml glacial acetic acid 
 adjust volume to 1 l with distilled water 
 
Growth media for bacteria 
LB agar plates 
 35 g  LB agar 
 adjust volume to 1 l with distilled water 
 
LB medium 
 20 g  LB medium 
 adjust volume to 1 l with distilled water 
 
Immunostaining 
Blocking/antibody dilution solution 5% BSA in PBS 
DAPI staining solution   1000 ng/ml in PBS 
Fixing/permeabilisation solution  3.7% Formaldehyde/0.25% Triton X-100 in PBS 
 
Preparation of competent Escherichia coli (E. coli) 
MOPS I solution 
 10 ml  0.5 M MOPS 
 5 ml  0.1 M RbCl 
 adjust volume to 50 ml with distilled water and pH to 7.0 with 1 M NaOH. 
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MOPS II solution 
 10 ml  0.5 M MOPS 
 5 ml  0.1 M RbCl 
 5 ml  0.7 M CaCl2 
 adjust volume to 50 ml with distilled water and pH to 6.5 with 1 M NaOH 
 
SDS-PAGE and immunoblotting 
1 M Tris HCl, pH 6.8 
 60.6 g  Tris 
 dissolve in 450 ml distilled water  
 adjust volume to 500 ml with distilled water and pH to 6.8 with HCl 
 
1 M Tris HCl, pH 8.8 
 121.2 g  Tris 
 dissolve in 900 ml distilled water 
 adjust volume to 1000 ml with distilled water and pH to 8.8 with HCl 
 
Antibody diluent (5% BSA) 
 0.5 g  BSA 
 adjust volume to 10 ml with TBS-T 
 
IP lysis buffer (1x) 
 2 ml  1 M Tris, pH 8.2 
 15 ml  1 M NaCl 
 1 ml  Triton X-100 
 adjust volume to 100 ml distilled water 
 
Milk powder solution (5% Milk Powder) 
 0.5 g  milk powder 
 adjust volume to 10 ml with TBS-T 
 
Ponceau solution 
 0.5 g  Ponceau S 
 37.5 ml TCA  
 adjust volume to 250 ml with distilled water 
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Radio-immunoprecipitation assay (Pandey et al., 2015) buffer (10x) 
 1.752 g NaCl 
 2 ml  Nonidet P-40 
 1 g  DCA 
 1 ml  SDS (20% solution) 
 6.67 ml 1.5 M Tris, pH 8.0 
 adjust volume to 20 ml distilled water 
 
Reducing electrophoresis buffer (6x) 
 25 ml  Glycerine 
 4.63 g  DTT 
 5.14 g  SDS pellet 
 17.5 ml 1 M Tris/HCl, pH 6.8 
 0.25 mg Bromophenol blue 
 adjust volume to 50 ml with distilled water 
 
SDS electrophoresis buffer (10x) 
 30.3 g  Tris 
 144 g  Glycine 
 10 g  SDS pellets 
 adjust volume to 1 l with distilled water 
 
Tris-buffered saline (TBS, 10x), pH 7.5 
 87.7 g  NaCl 
 12.1 g  Tris 
 dissolve in 900 ml distilled water   
 adjust volume to 1000 ml with distilled water and pH to 7.5 with HCl 
 
TBS-Tween 20 (TBS-T) 
 100 ml  TBS (10x) 
 1 ml  Tween 20 
 adjust volume to 1 l with distilled water 
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3.1.5.  Plasmids, Oligonucleotides, siRNAs and Antibodies 
 
Table 1. Characteristics of plasmids used for site-directed mutagenesis and cellular transfection assays. 
Plasmid Description Reference 
pEYFP-N1  MCS at N-terminus of EYFP tag Clontech 
pEYFP-C1 MCS at C-terminus of EYFP tag Clontech 
pECFP-N1  MCS at N-terminus of ECFP tag Clontech 
pECFP-C1 MCS at C-terminus of ECFP tag Clontech 
pECFP-EYFP ECFP and EYFP fusion construct Kind gift from Prof. Dr. Michael 
Schindler – University Hospital 
Tubingen (Banning et al., 2010) 
pEYFP-Survivin-N1 Survivin at N-terminus of EYFP 
tag 
Provided by Melanie Hoffmann – 
Master study - University Hospital 
Frankfurt (Hoffmann, 2017) 
pEYFP-Survivin-C1 Survivin at C-terminus of EYFP tag Provided by Melanie Hoffmann – 
Master study - University Hospital 
Frankfurt (Hoffmann, 2017) 
pECFP-Survivin-N1 Survivin at N-terminus of ECFP 
tag 
Provided by Melanie Hoffmann – 
Master study - University Hospital 
Frankfurt (Hoffmann, 2017) 
pECFP-Survivin-C1 Survivin at C-terminus of ECFP tag Provided by Melanie Hoffmann – 
Master study - University Hospital 
Frankfurt (Hoffmann, 2017) 
pEYFP-Survivin S20A-N1 S20A mutated Survivin at N-
terminus of EYFP tag 
Generated in this study 
pEYFP-Survivin S20D-N1 S20D mutated Survivin at N-
terminus of EYFP tag 
Generated in this study 
pEYFP-Survivin W25A-N1 W25A mutated Survivin at N-
terminus of EYFP tag 
Generated in this study 
pEYFP-Survivin F27A-N1 F27A mutated Survivin at N-
terminus of EYFP tag 
Generated in this study 
pEYFP-Survivin L28A-N1 L28A mutated Survivin at N-
terminus of EYFP tag 
Generated in this study 
pEYFP-Survivin E29A-N1 E29A mutated Survivin at N-
terminus of EYFP tag 
Generated in this study 
pEYFP-Survivin C31A-N1 C31A mutated Survivin at N-
terminus of EYFP tag 
Generated in this study 
pEYFP-Survivin T34A-N1 T34A mutated Survivin at N-
terminus of EYFP tag 
Generated in this study 
pEYFP-Survivin T34D-N1 T34D mutated Survivin at N-
terminus of EYFP tag 
Generated in this study 
pEYFP-Survivin D53A-N1 D53A mutated Survivin at N-
terminus of EYFP tag 
Generated in this study 
pEYFP-Survivin W67A-N1 W67A mutated Survivin at N-
terminus of EYFP tag 
Generated in this study 
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pEYFP-Survivin E76A-N1 E76A mutated Survivin at N-
terminus of EYFP tag 
Generated in this study 
pEYFP-Survivin K79A-N1 K79A mutated Survivin at N-
terminus of EYFP tag 
Generated in this study 
pEYFP-Survivin T117A-
N1 
T117A mutated Survivin at N-
terminus of EYFP tag 
Generated in this study 
pEYFP-Survivin T117D-
N1 
T117D mutated Survivin at N-
terminus of EYFP tag 
Generated in this study 
pEYFP-Survivin S20D-
W67A-N1 
S20D and W67A mutated Survivin 
at N-terminus of EYFP tag 
Generated in this study 
pEYFP-Survivin S20D-
C31A-D53A-N1 
S20D, C31A, and D53A mutated 
Survivin at N-terminus of EYFP 
tag 
Generated in this study 
pEYFP-Survivin C31A-
D53A-N1 
C31A and D53A mutated Survivin 
at N-terminus of EYFP tag 
Generated in this study 
pEYFP-Survivin C31A-
D53A-W67A-N1 
C31A, D53A, and W67A mutated 
Survivin at N-terminus of EYFP 
tag 
Generated in this study 
pEYFP-Survivin ∆BIR-N1 BIR domain deleted Survivin at N-
terminus of EYFP tag 
Generated in this study 
pEYFP-PI3K-N1 PI3K domain of DNA-PKcs at N-
terminus of EYFP tag 
Provided by Melanie Hoffmann – 
Master study - University Hospital 
Frankfurt (Hoffmann, 2017) 
pEYFP-PI3K-C1 PI3K domain of DNA-PKcs at C-
terminus of EYFP tag 
Provided by Melanie Hoffmann – 
Master study - University Hospital 
Frankfurt (Hoffmann, 2017) 
pECFP-PI3K-N1 PI3K domain of DNA-PKcs at N-
terminus of ECFP tag 
Provided by Melanie Hoffmann – 
Master study - University Hospital 
Frankfurt (Hoffmann, 2017) 
pECFP-PI3K-C1 PI3K domain of DNA-PKcs at C-
terminus of ECFP tag 
Provided by Melanie Hoffmann – 
Master study - University Hospital 
Frankfurt (Hoffmann, 2017) 
pEYFP-HEAT1-N1 HEAT1 repeat of DNA-PKcs at N-
terminus of EYFP tag 
Provided by Melanie Hoffmann – 
Master study - University Hospital 
Frankfurt (Hoffmann, 2017) 
pEYFP-FATC-N1 FATC domain of DNA-PKcs at N-
terminus of EYFP tag 
Provided by Melanie Hoffmann – 
Master study - University Hospital 
Frankfurt (Hoffmann, 2017) 
pEYFP-PI3K-ATM-N1 PI3K domain of ATM at N-
terminus of EYFP tag 
Provided by Melanie Hoffmann – 
Master study - University Hospital 
Frankfurt (Hoffmann, 2017) 
p3xFlag-CMV10-Survivin Survivin at C-terminus of 3xFlag 
tag 
Sigma Aldrich - Generated in this 
study by inserting the Survivin to 
EcoRI/KpnI restriction sites  
p3xFlag-CMV14-PI3K PI3K domain of DNA-PKcs at N-
terminus of 3xFlag tag 
Sigma Aldrich - Generated in this 
study by inserting the PI3K to 
EcoRI/KpnI restriction sites 
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pEGFP-N1  MCS at N-terminus of EGFP tag 
(contains neomycin/kanamycin 
resistance gene)  
Clontech 
pEGFP-Survivin-N1 Survivin at N-terminus of EGFP 
tag 
(contains neomycin/kanamycin 
resistance gene) 
Provided by Chrysi Petraki – 
Doctorate study (Petraki, 2014) / Dr. 
Stephanie Hehlgans - University 
Hospital Frankfurt 
pEGFP-Survivin S20D-N1 S20D mutated Survivin at N-
terminus of EGFP tag 
(contains neomycin/kanamycin 
resistance gene) 
Provided by Chrysi Petraki – 
Doctorate study (Petraki, 2014) / Dr. 
Stephanie Hehlgans - University 
Hospital Frankfurt 
pEGFP-Survivin W67A-N1 W67A mutated Survivin at N-
terminus of EGFP tag 
(contains neomycin/kanamycin 
resistance gene) 
Generated in this study 
pEGFP-Survivin S20D-
W67A-N1 
S20D and W67A mutated Survivin 
at N-terminus of EGFP tag 
(contains neomycin/kanamycin 
resistance gene) 
Generated in this study 
pEGFP-Survivin ∆BIR-N1 BIR domain deleted Survivin at N-
terminus of EGFP tag 
(contains neomycin/kanamycin 
resistance gene) 
Provided by Chrysi Petraki – 
Doctorate study (Petraki, 2014) / Dr. 
Stephanie Hehlgans - University 
Hospital Frankfurt 
 
Table 2. Characteristics of oligonucleotides used for cloning and site-directed mutagenesis. 
Oligo Sequence (5’  3’)  Tm (oC) Manufacturer 
S20A-Fw tcaaggaccaccgcatcgctacattcaagaactgg 79.27 Eurofins Genomics, Ebersberg 
S20A-Rev ccagttcttgaatgtagcgatgcggtggtccttga 79.27 Eurofins Genomics, Ebersberg 
S20D-Fw ctcaaggaccaccgcatcgatacattcaagaactggcc 78.97 Eurofins Genomics, Ebersberg 
S20D-Rev ggccagttcttgaatgtatcgatgcggtggtccttgag 78.97 Eurofins Genomics, Ebersberg 
W25A-Fw atctctacattcaagaacgcccccttcttggagggctgc 74.7 Eurofins Genomics, Ebersberg 
W25A-Rev gcagccctccaagaagggggcgttcttgaatgtagagat 74.7 Eurofins Genomics, Ebersberg 
F27A-Fw attcaagaactggcccgccttggagggctgcg 74.6 Eurofins Genomics, Ebersberg 
F27A-Rev cgcagccctccaaggcgggccagttcttgaat 74.6 Eurofins Genomics, Ebersberg 
L28A-Fw attcaagaactggcccttcgccgagggctgcgcctgca 78.1 Eurofins Genomics, Ebersberg 
L28A-Rev tgcaggcgcagccctcggcgaagggccagttcttgaat 78.1 Eurofins Genomics, Ebersberg 
E29A-Fw aagaactggcccttcttggccggctgcgcctgca 76.7 Eurofins Genomics, Ebersberg 
E29A-Rev tgcaggcgcagccggccaagaagggccagttctt 76.7 Eurofins Genomics, Ebersberg 
C31A-Fw ttcttggagggcgccgcctgcaccccgga 76.6 Eurofins Genomics, Ebersberg 
C31A-Rev tccggggtgcaggcggcgccctccaagaa 76.6 Eurofins Genomics, Ebersberg 
T34A-Fw gctgcgcctgcgccccggagcgg 81.67 Eurofins Genomics, Ebersberg 
T34A-Rev ccgctccggggcgcaggcgcagc 81.67 Eurofins Genomics, Ebersberg 
T34D-Fw gggctgcgcctgcgacccggagcggatg 81 Eurofins Genomics, Ebersberg 
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T34D-Rev catccgctccgggtcgcaggcgcagccc 81 Eurofins Genomics, Ebersberg 
D53A-Fw actgagaacgagccagccttggcccagtgtttctt 73 Eurofins Genomics, Ebersberg 
D53A-Rev aagaaacactgggccaaggctggctcgttctcagt 73 Eurofins Genomics, Ebersberg 
W67A-Fw ttcaaggagctggaaggcgccgagccagatgacga 75.3 Eurofins Genomics, Ebersberg 
W67A-Rev tcgtcatctggctcggcgccttccagctccttgaa 75.3 Eurofins Genomics, Ebersberg 
E76A-Fw atgacgaccccatagaggcccataaaaagcattcgtcc 72.7 Eurofins Genomics, Ebersberg 
E76A-Rev ggacgaatgctttttatgggcctctatggggtcgtcat 72.7 Eurofins Genomics, Ebersberg 
K79A-Fw cccatagaggaacataaagcccattcgtccggttgcgcttt 74.4 Eurofins Genomics, Ebersberg 
K79A-Rev aaagcgcaaccggacgaatgggctttatgttcctctatggg 74.4 Eurofins Genomics, Ebersberg 
T117A-Fw gccaagaacaaaattgcaaaggaagccaacaataagaa
gaaagaat 
78.02 Eurofins Genomics, Ebersberg 
T117A-Rev attctttcttcttattgttggcttcctttgcaattttgttcttggc 78.02 Eurofins Genomics, Ebersberg 
T117D-Fw gagccaagaacaaaattgcaaaggaagacaacaataag
aagaaagaatttgagg 
78.96 Eurofins Genomics, Ebersberg 
T117D-Rev cctcaaattctttcttcttattgttgtcttcctttgcaattttgttc
ttggctc 
78.96 Eurofins Genomics, Ebersberg 
HEAT1-Fw cggaattcggcggcatggcgggctccggagccggt 74.3 Eurofins Genomics, Ebersberg 
HEAT1-Rev ggggtaccgtgtttataaccttgcacggtcc 70.8 Eurofins Genomics, Ebersberg 
FATC-Fw cggaattcggcggcatgctgaaaaaaggagggtcatgg 74.9 Eurofins Genomics, Ebersberg 
FATC-Rev ggggtaccgtcatccagggctcccatcct 73.7 Eurofins Genomics, Ebersberg 
PI3K-Fw cggaattcggcggcatggaacaccctttcctggtgaag 75.9 Eurofins Genomics, Ebersberg 
PI3K-Rev ggggtaccgtatttttccaatcaaaggagggc 69.5 Eurofins Genomics, Ebersberg 
PI3K-ATM-
Fw 
cggaattcggcggcatggtggaccacacaggagaat 75.2 Eurofins Genomics, Ebersberg 
PI3K-ATM-
Rev 
ggggtaccgtcctctgctgtaaatacaaagct 69.5 Eurofins Genomics, Ebersberg 
Surv-Fw ggggtaccggcggcatgggtgccccgacgttgc 80.7 Eurofins Genomics, Ebersberg 
Surv-Rev cgggatcccgatccatggcagccagctgctc 76.1 Eurofins Genomics, Ebersberg 
∆BIR-Fw1 catgggtgccccgacgttgccccctgcctggcagccctttct
ct 
82.5 Eurofins Genomics, Ebersberg 
∆BIR-Rev1 ctagagagaaagggctgccaggcagggggcaacgtcgg
ggcacccatggtac 
83.6 Eurofins Genomics, Ebersberg 
∆BIR-Fw2 gctctagatctgtcaagaagcagtttgaaga 65.5 Eurofins Genomics, Ebersberg 
∆BIR-Rev2 cgggatcccgatccatggcagccagctgctc 76.1 Eurofins Genomics, Ebersberg 
 
Table 3. Characteristics of sequencing primers for confirmation of mutations/deletions. 
Oligo Sequence (5’  3’)  Tm (oC) Manufacturer 
pEGFPC1for gatcactctcggcatggac 58.8 Eurofins Genomics, Ebersberg 
pEGFPC1rev cattttatgtttcaggttcaggg 57.1 Eurofins Genomics, Ebersberg 
CMVfor cgcaaatgggcggtaggcgtg 65.7 Eurofins Genomics, Ebersberg 
pEGFPN1rev gtccagctcgaccaggatg 61 Eurofins Genomics, Ebersberg 
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Table 4. Characteristics of siRNAs used for control or knockdown of endogenous Survivin expression. 
siRNA Sequence (5’  3’)  Manufacturer 
Catalog 
number 
AllStars Neg. Control 
siRNA (20 nmol) 
- QIAGEN, Hilden 1027281 
BIRC5 Survivin 3 
siRNA 
Sense: GCAGGUUCCUUAUCUGUCAtt 
Antisense: UGACAGAUAAGGAACCUGCag 
Ambion, Austin, 
TX, USA 
s1458 
 
Table 5. Characteristics of primary antibodies used for immunoblotting, immunoprecipitation and 
immunofluorescence staining. 
Target Host Type 
Stock 
solution 
[µg/ml] 
Dilution 
Molecular 
weight 
[kDa] 
Manufacturer 
Catalog 
number 
Anti-β-
Actin 
mouse IgG 1000 1:10 000 42 Sigma-Aldrich A5441 
Anti-
Survivin 
rabbit IgG 200 1:1000 16.5 R&D Systems AF886 
Anti-
phospho-
H2AX 
(Ser139) 
mouse IgG1 1000 1:1000 17 Millipore 05-636 
Anti-
53BP1 
rabbit IgG 1 1:1000 250 
Novus 
Biologicals 
NB100-304 
Anti-
FOXO3 
rabbit IgG 15 1:1000 82-97 Cell Signaling 2497S 
Anti-
phospho-
FOXO3 
(Ser253) 
rabbit IgG 908 1:500 97 Cell Signaling 9466S 
Anti-GFP rabbit IgG 2000 1:2000 27 Abcam ab290 
Anti-FLAG rabbit IgG 84 1:1000 1 Cell Signaling 2368S 
Anti-FLAG 
(HRP) 
mouse IgG1 1100 1:1000 1 Abcam ab49763 
Anti-DNA-
PKcs 
mouse IgG 200 1:500 470 Thermo MS-370-P1 
Isotype 
control 
rabbit IgG 400 1:100 - 
Santa Cruz 
Biotechnology 
SC-2027 
Isotype 
control 
mouse IgG 400 1:100 - 
Santa Cruz 
Biotechnology 
SC-2025 
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Table 6. Characteristics of secondary antibodies used for immunofluorescence staining. 
Target Host Type Dilution Label Manufacturer 
Catalog 
number 
Anti-rabbit  goat IgG 1:500 Alexa FluorR 488 Life technologies A11034 
Anti-mouse  goat IgG 1:500 Alexa FluorR 594 Life technologies  A11032 
 
Table 7. Characteristics of secondary antibodies used for immunoblotting. 
Coupled enzyme Specificity Host Type Dilution Manufacturer 
Catalog 
number 
Horse radish peroxidase rabbit goat IgG 1:1000 Southern Biotech 4050-05 
Horse radish peroxidase mouse goat IgG 1:1000 Southern Biotech 1030-05 
 
3.1.6.  Commercial kits 
Description Manufacturer 
High-Select™ Fe-NTA Phosphopeptide Enrichment Kit Thermo Fisher Scientific, Dreieich 
Micro BCA™ Protein Assay Kit Thermo Fisher Scientific, Dreieich 
NucleoBond® Xtra Midi Plus EF Macherey-Nagel, Dueren 
NucleoSpin® Plasmid Kit Macherey-Nagel, Dueren 
NucleoSpin® Gel and PCR Clean-Up Kit Macherey-Nagel, Dueren 
NucleoSpin® RNA Macherey-Nagel, Dueren 
Pierce™ BCA™ Protein-Assay, (RAC) Thermo Fisher Scientific, Dreieich 
Pierce™ High pH Reversed-Phase Peptide Fractionation Kit Thermo Fisher Scientific, Dreieich 
PCR Mycoplasma Test Kit AppliChem, Darmstadt 
SignaTECT® DNA-Dependent Protein Kinase Assay Promega, Madison, WI, USA 
 
3.1.7.  Enzymes and respective buffers 
Description Manufacturer 
PfuUltra High-Fidelity DNA Polymerase Strategene, La Jolla, CA, USA 
PfuUltra HF Reaction Buffer (10x) Strategene, La Jolla, CA, USA 
DNA-dependent protein kinase (DNA-PK) 199 U/µl Promega, Madison, WI, USA 
T4 DNA Ligase New England Biolabs, Frankfurt 
T4 DNA Ligase Buffer (10x) New England Biolabs, Frankfurt 
ApaLI, 10 U/µl New England Biolabs, Frankfurt 
NEB Buffer 10x New England Biolabs, Frankfurt 
EcoRI 10 U/µl New England Biolabs, Frankfurt 
HindIII 10 U/µl New England Biolabs, Frankfurt 
KpnI 10 U/µl New England Biolabs, Frankfurt 
BamHI 10 U/µl New England Biolabs, Frankfurt 
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3.1.8.  Electrophoresis markers 
Description Manufacturer 
ProSieve QuadColor Protein Marker Lonza, Cologne 
GelPilot 1kb Plus Ladder QIAGEN, Hilden 
 
3.1.9.  Cells 
 
Bacteria 
Escherichia coli (E. coli) DH5α (Promega, Madison, WI, USA) were used for all site-directed 
mutagenesis and cloning procedures. 
 
Human cell lines 
SW480: The SW480 cell line was established from a primary adenocarcinoma of the 
colon by A. Leibovitz in the 1970s (Leibovitz et al., 1976). It has two p53 
mutations, a G/A mutation at codon 273 and a C/T mutation at codon 309. 
The cells were cultured in DMEM supplemented with 10% FBS, 50 U/ml 
penicillin, 50 µg/ml streptomycin and 1000 µg/ml G418 (for stably transfected 
cells) at 37 °C in a humidified atmosphere containing 5% CO2. The cells were 
obtained from the American Type Culture Collection (ATCC, Promochem, 
Germany). 
DLD-1:  DLD-1 cell line was established from colorectal adenocarcinoma by D.L. Dexter 
and colleagues during a period from 1977-1979 (Dexter et al., 1979). It is 
positive for p53 antigen expression by having a C -> T mutation resulting in 
Ser -> Phe at position 241. The cells were cultured in DMEM supplemented 
with 10% FBS, 50 U/ml penicillin, 50 µg/ml streptomycin and 1000 µg/ml 
G418 (for stably transfected cells) at 37 °C in a humidified atmosphere 
containing 5% CO2. The cells were obtained from the American Type Culture 
Collection (ATCC, Promochem, Germany). 
HCT-15:  HCT-15 cell line like DLD-1 was established from colorectal adenocarcinoma by 
D.L. Dexter and colleagues during a period from 1977-1979 (Dexter et al., 
1979). DNA fingerprinting evidence indicates that this line and DLD-1 are 
derived from the same individual; however, isoenzymology and cytogenetic 
data are not same. The cells were cultured in RPMI supplemented with 10% 
FBS, 50 U/ml penicillin, and 50 µg/ml streptomycin at 37 °C in a humidified 
atmosphere containing 5% CO2. The cells were obtained from the American 
Type Culture Collection (ATCC, Promochem, Germany). 
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3.2. Methods 
 
3.2.1.  Cell Culture 
SW480 and DLD-1 cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM; 
Invitrogen, Karlsruhe, Germany) containing glutamax-I (L-alanyl-L-glutamine) while HCT-15 
cells were maintained in Roswell Park Memorial Institute (RPMI) 1640 Medium, both 
supplemented with 10% fetal bovine serum (FBS), 50 U/ml penicillin and 50 µg/ml 
streptomycin at 37 °C in a humidified atmosphere containing 5% CO2. 
For freezing, cells resuspended in precooled cryomedium (DMEM/RPMI + 20% FBS + 5% 
DMSO) and transferred into a cryotube, followed by storage in a freezing container at -80 °C 
for gradient cool-down. Three days later, the cryotube was transferred into storage boxes and 
kept at -80 °C. For thawing, cells were resuspended in prewarmed medium, followed by 
centrifugation (100 x g, 3 min, RT); then resuspended in 12 ml fresh medium and plated on a 
T-75 flask.  
 
3.2.2.  Transfection 
Many cell lines exhibit different transfection efficiencies in response to the usage of different 
transfection reagents. For that reason, Polyethylenimidine (PEI) and Roti-Fect PLUS 
transfection reagents were used for SW480 colorectal cancer cells, JetPRIME transfection 
reagent for DLD-1 and HCT-15 colorectal cancer cells and Roti-Fect PLUS transfection reagent 
for all knockdown experiments.    
PEI procedure (for 6-well plate): 2 µg plasmid DNA (1 µg/µl) were mixed with 3 volume (6 µl) 
of PEI (1 µg/µl) in 500 µl medium without FBS (DMEM + 1% P/S) and incubated in the dark 
at room temperature for 20 min. After incubation, the transfection mix was added to 40-50% 
confluent SW480 colorectal cancer cells dropwise. After 24h incubation at 37 °C and 5% CO2, 
medium was renewed with normal medium (DMEM + 10% FBS + 1% P/S) and incubated for 
another 24h at 37 °C and 5% CO2. After incubation, cells were harvested. 
Roti-Fect PLUS procedure (for 6-well plate): 2 µg plasmid DNA (1 µg/µl) was mixed with 123 µl 
of Opti-MEM. In a second tube 5 µl Roti-Fect PLUS was mixed with 120 µl Opti-MEM and 
incubated at room temperature for 5 min. After incubation, the content of the tubes was 
combined, mixed and incubated at room temperature for 20 min. Next, transfection mix was 
added to 40-50% confluent SW480 colorectal cancer cells dropwise and supplemented with 
1ml Opti-MEM. After an 8h incubation at 37 °C and 5% CO2, 1.25 ml of 20% FBS medium 
(Opti-MEM + 20% FBS) was added (to adjust to a final concentration of 10% FBS),  and 
incubated for another 40h at 37 °C and 5% CO2. For knockdown experiments, the procedure 
was highly similar with a minor exception: 2.5 µl of 20 nM siRNA was mixed with 122.5 µl of 
Opti-MEM instead of 2 µg plasmid DNA. 
JetPRIME procedure (for 6-well plate): 2 µg plasmid DNA (1 µg/µl) was mixed with 200 µl of 
JetPRIME buffer, spinned down for 10s and incubated in the dark at room temperature for 5 
min. Afterwards, 4 µl of JetPRIME transfection reagent was added, mixed, spinned down for 
10s, and incubated in the dark at room temperature for 10 min. Then, transfection mix was 
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added to 40-50% confluent DLD-1 and HCT-15 colorectal cancer cells dropwise and 
supplemented with 1.8 ml medium (Opti-MEM + 10% FBS). After 48h incubation at 37 °C 
and 5% CO2 cells were harvested. 
 
3.2.3.  Stable cell line generation 
For stable transfection of SW480 and DLD-1 colorectal cancer cells, the constructs (pEGFP-N1, 
Survivin-EGFP, Survivin∆BIR-EGFP, Survivin-S20D-EGFP, Survivin-W67A-EGFP and Survivin-
S20D-W67A-EGFP) were linearized using 30 µg of plasmid DNA, 10 µl 10x NEBuffer, 4 µl 
ApaLI enzyme (10 U/µl), 1 µl BSA (100x) and volumes were adjusted to 100 µl with 
RNase/DNase-free water in 1.5 ml tubes. After incubation at 37 °C overnight, samples were 
subjected to agarose gel electrophoresis, the linearized plasmid was resected and subjected to 
Gel clean-up using the NucleoSpin® Gel and PCR Clean-Up Kit (Macherey-Nagel) following 
the manufacturer’s instructions. SW480 and DLD-1 colorectal cancer cells with 50-60% 
confluency were then stably transfected with corresponding linearized vectors using JetPRIME 
transfection reagent followed by incubation for 24 h at 37 °C and 5% CO2. The next day, cells 
were transferred to 100 mm petri dishes where colonies were allowed to grow. For the 
selection of transfected cells, the DMEM medium supplemented with 10% FBS and 1% P/S 
was supplemented with 1000 µg/ml G418 (Geneticin: Commonly used for neomycin 
resistance gene selection).  
The fluorescence intensities of clones were visually checked with a fluorescence microscope, 
then silicon-embedded cloning cylinders were carefully placed on the selected colonies. Cells 
within the cloning cylinders were detached with 60 µl trypsin/EDTA, incubated for 5 min at 
37 °C and 5% CO2, resuspended with 60 µl medium (DMEM + 10% FBS + 1% P/S + 1000 
µg/ml G418) and transferred into 12-well plates (one clone per well) along with 1 ml 
medium (DMEM + 10% FBS + 1% P/S + 1000 µg/ml G418). When cells were grown to a 
confluency of approximately 60-80% they were transferred to T-25 flasks and later (when 80-
100% confluent) harvested for cryostocks. The corresponding protein expressions of clones 
were verified via flow cytometry, and ≥60% EGFP+ clones further verified by immunoblotting 
(Figure 18). 
 
3.2.4.  Competent E.coli DH5α preparation and transformation 
 
Preparation of competent Escherichia coli (E. coli) DH5α cells 
For the preparation of competent E. coli DH5α, 5 ml LB medium were inoculated with a cryo 
stock of E. coli DH5α, followed by overnight incubation at 37 °C while shaking at 250 rpm. 
The following day, 400 µl of the overnight culture was transferred into 200 ml LB medium. 
Incubation at 37 °C while shaking at 250 rpm was continued until an optical density (OD)600 
of 0.2 was reached. The cells were then pelleted at 4100 x g and 4 °C for 10 min and 
resuspended in 20 ml MOPS I buffer. After 10 min incubation on ice, the cells were 
centrifuged again at 4100 x g and 4 °C for 10 min, followed by resuspension of the pellet in 
20 ml MOPS II buffer. Due to the CaCl2 in the MOPS buffer, membrane permeability is 
changed which leads to the possibility of DNA uptake through the membrane (Mandel and 
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Higa, 1970). After another incubation at 4 °C for 30 min and centrifugation at 4100 x g and 
4 °C for 10 min, the pellet was resuspended in 2 ml MOPS II buffer and aliquoted into 200 µl 
portions in precooled 1.5 ml tubes containing 50 µl glycerine. After mixing carefully, the 
competent cells were snap-frozen in liquid nitrogen and stored at -80 °C. 
 
Transformation 
For the transformation of chemically competent E. coli DH5α cells with plasmids, 30 µl cells 
per transformation were thawed on ice and mixed with 10 ng plasmid DNA. In case of site-
directed mutagenesis plasmids, 5 µl of the DpnI digested and ligated plasmid was used. DNA 
and cells were gently mixed and incubated on ice for 30-60 min, followed by a heat-shock for 
45 sec at 42 °C in a water bath. Then, the transformation mix was immediately cooled on ice 
for 5 min. Afterwards, 500 µl sterile LB medium was added and cells were incubated in a 
shaker by 300 rpm for 1 h at 37 °C, followed by plating on LB-agar plates containing the 
appropriate antibiotics and incubated overnight at 37 °C. 
 
3.2.5.  Site-Directed Mutagenesis 
Survivin single/multiple amino acid mutants were generated using the appropriate primers 
(Table 2) and the QuikChange II Site-Directed Mutagenesis Kit (Agilent Technologies, La 
Jolla, USA) following the manufacturer’s instructions. Briefly, PCR was performed according 
to the components and procedure in Table 8 and Table 9, followed by verification of 
amplification by agarose gel electrophoresis. Then, samples were subjected to DpnI restriction 
enzyme digestion for 1 h at 37 °C followed by overnight ligation at 16 °C. The next day, 
samples were transformed into E.coli DH5α competent cells, incubated overnight at 37 °C and 
plasmid isolation was performed by using NucleoSpin® Plasmid Kit (for large scale stocks 
NucleoBond® Xtra Midi Plus EF kit), following the manufacturer’s instructions from 
individual clones. Plasmids were digested by appropriate restriction endonucleases and 
subjected to agarose gel electrophoresis which then were further confirmed by sequencing 
(Eurofins Genomics, Ebersberg) (Figure 5). 
 
Table 8. Site-directed mutagenesis components of PCR reaction. 
Component Volume (µl) 
ddH2O 36.5 
10X Reaction Buffer 5 
Forward Primer (10 pmol) 2 
Reverse Primer (10 pmol) 2 
dNTPs mix (10 mM each) 2.5 
Template (20 ng) 1 
PfuUltra II HF Polymerase 1 
Total 50 
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Figure 5.Brief workflow of the site-directed mutagenesis method. Sense and antisense mutagenic 
primers were designed and used for the PCR amplification of wild type vectors. After DpnI restriction 
endonuclease treatment, methylated input wild type templates were digested while amplified non-
methylated mutant vectors not. Samples were further ligated with T4 Ligase on amplification end-
nicks. 
   
Table 9. Site-directed mutagenesis PCR protocol for plasmid DNA amplification with PfuUltra II HF. 
Annealing temperature and elongation time were adjusted according to primer melting temperature 
and length of the template, respectively. 
Step Temperature [°C] Time [min:sec]  
Initial denaturation 95 0:30 1x 
Denaturation 95 0:30 
18x Annealing 55 1:00 
Elongation 68 1:00/kb 
Final elongation 68 15:00 1x 
- 4 ∞  
 
Agarose gel electrophoresis 
Agarose gels were prepared using 50-80 ml of a 0.8-2% agarose gel/TAE buffer solution, 
supplemented with 5-8 µl peqGREEN in order to visualize DNA. Before loading on the gel, 
DNA was mixed with an appropriate volume of DNA loading dye (5x). Gel electrophoresis was 
performed at 100-120 V for approximately 1 h. Thereafter, DNA was visualized using the 
Odyssey Fc Imaging System and Image Studio Version 5.2 Software. The size of the DNA was 
determined with the GelPilot 1kb Plus DNA ladder. 
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3.2.6.  Preliminary Molecular Docking Analysis 
The X-ray crystal structure of Survivin -PDB: 1E31- (Chantalat et al., 2000) and DNA-PKcs -
PDB: 5LUQ- (Sibanda et al., 2017) were used as input for the molecular docking conducted in 
a preliminary approach. First, structures were pre-processed using the Protein Preparation 
Wizard (Sastry et al., 2013) in the Schrödinger Release 2018-1 (Schrödinger, LLC, New York, 
NY): In brief, missing/truncated hydrogen atoms, side chains, loops, cap-termini, disulfide 
bonds were re-created, all non-complexed ions and solvents were deleted and 
selenomethionines converted to methionines. The hydrogen bonding network was optimized 
and protonation states assigned at pH 7.0. Finally, a restrained minimization was performed 
using the OPLS3 force field (Harder et al., 2016). Prepared structures were docked by using 
PIPER (Kozakov et al., 2006) and PatchDOCK (Schneidman-Duhovny et al., 2005) programs. 
Top-ranked poses were post-processed and refined by FireDOCK (Mashiach et al., 2008). 
Then, interactions between residues were determined according to their binding energies by 
using PRIME MM-GBSA (Jacobson et al., 2004) in the Schrödinger Release 2018-1 and 
distances by Find Clashes/Contacts tool of Chimera 1.13.1 (Pettersen et al., 2004). Interaction 
pairs that have lower binding energy values and distances between backbones/side chains 
atoms lower than 5Å were qualified as potential interactors. In silico mutagenesis was 
performed by Rotamer tool of Chimera 1.13.1 (Pettersen et al., 2004) by using the Dunbrack 
Rotamer Library (Shapovalov and Dunbrack, 2011). 
   
3.2.7.  Large-scale Molecular Docking Analysis 
Preparation and Refinement of DNA-PKcs head domain: The DNA-PKcs head domain (residues 
2802 - 4128) model was extracted from the latest crystal structure of DNA-PKcs (PDB code: 
5LUQ) (Sibanda et al., 2017). As parts of the structure are not resolved, the missing residues 
were modelled using the MODELLER software (Fiser et al., 2000; Marti-Renom et al., 2000; 
Sali and Blundell, 1993; Webb and Sali, 2016). In order to ensure that the structure is 
adequately folded, i.e., it is in a low-energy conformation, an MD simulation using Gromacs 
2018 (Abraham et al., 2015) was performed. The AMBER14 force field (Maier et al., 2015) 
was used for the simulation. The head domain was simulated in a dodecahedron box with 150 
mM NaCl. The minimum distance between the box edge and the system was set to 0.6 nm. 
TIP3P was used as a water model (Jorgensen et al., 1983). The energy minimization was 
performed using the steepest descent algorithm in 10,000 steps with a step size of 1 fs. The 
equilibration was conducted over 2.5 ns (2 fs step size). In order to achieve fast equilibration 
V-rescale for temperature coupling and a Berendsen thermostat for pressure coupling were 
chosen. The system was equilibrated to 300 K temperature and 1 bar pressure. The leapfrog 
algorithm was used for integration. The MD production run was simulated over 50 ns (2 fs 
step size) using a Nose-Hoover thermostat and a Parrinello-Rahman barostat. Again, the 
leapfrog integrator was used. The RMSD (orange) and radius of gyration (gray) are plotted 
for the whole trajectory. The RMSD initially exhibited upward rising movement but converged 
against a saturated trend after approximately 30 ns, and the radius of gyration was constant 
on average. So the structure seems stable, and no structural changes are observed that can be 
used for the following analyses (Figure 6). 
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Figure 6.Initial molecular dynamics simulation of the head domain of DNA-PKcs. The simulation 
lasts over the course of 50 ns to verify the stability for the RMSD and the radius of gyration. 
 
Large-scale Molecular Docking Analysis: For the in silico large-scale protein docking analysis, 
we used the latest crystal structures from the Protein Data Bank (PDB), PDB codes: 5LUQ for 
DNA-PKcs, and 1E31 for Survivin (Chantalat et al., 2000; Sibanda et al., 2017). The crystal 
structure for 5LUQ has some smaller regions where electron density could not be sufficiently 
resolved and has a larger missing region in what is known as the cradle domain (Sibanda et 
al., 2017). Refinement was performed using the Rosetta (Gray et al., 2003) and MODELLER 
(Fiser et al., 2000; Marti-Renom et al., 2000; Sali and Blundell, 1993; Webb and Sali, 2016). 
A 50 ns molecular dynamics simulation was performed to verify the refined subdomain of 
5LUQ is stable within simulations. A detailed summary of the steps taken to refine the 
structure can be found in Section 3.2.8. Global molecular docking was performed using the 
head domain, where Survivin was docked in different poses covering the head domains' 
surface. For this approach, a global docking protocol from Rosetta was applied, where a 
coarse backbone based force field is used (Leaver-Fay et al., 2011). The generated 98884 
poses were then used as input for the local docking protocol, which in contrast uses Rosetta 
all-atom energy function (Alford et al., 2017). The subsequent analysis regarding the 
proximity of BIR domain residues and the PI3K domains was done using custom python 
scripts and relies on the bioinformatics library Biotite (Kunzmann and Hamacher, 2018).  
 
3.2.8.  Molecular Dynamics Simulation 
To analyze the stability and dynamics of the heterotetramer structure, molecular dynamics 
simulations were performed by employing Gromacs 2019.4 (Abraham et al., 2015) with the 
Charm36 force field (Vanommeslaeghe et al., 2010) and the Tip3P water model (Jorgensen et 
al., 1983). All simulations were performed inside a dodecahedron water box with periodic 
boundary conditions. The first step was energy minimization to remove potential clashes, 
followed by short equilibration in canonical (NVT) and isothermal-isobaric (NPT) ensembles 
for 100 ps, respectively. Finally, a 200 ns productive run was performed, which produces the 
trajectories used for analysis. Structural changes were measured by root mean square 
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deviation (RMSD) and radius of gyration (Rg) analyses: The trajectories were analyzed using 
the RMSD, which measures the positional deviation between simulation frame and reference 
structure to examine the stability of simulation. Furthermore, the Rg was used to measure the 
global protein changes. 
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Finally, a unique and simple quantitative measurement strategy was generated and 
implemented for the opening and closing dynamics of the active site. Briefly, the base of a 
cylindrical reference volume was fitted to the outer surface of the PI3K active site. The 
measurement of opening and closing of the active site cavity was performed by counting the 
atoms which were inside the cylindrical reference volume during the molecular dynamics 
simulations. Scripts and raw data are available at https://github.com/entropybit/survivinpkcs 
and http://www.cbs.tu-darmstadt.de/SurvivinDnaPkcs. 
 
Measuring active site opening/closing dynamics using a cylindrical probe: To measure the 
opening of the kinase active site, a cylindrical volume is fitted to the atoms defining the active 
site (Figure 7). Where the base is defined by the center of mass of the active site G3919 – 
V3930 residues´ atoms and the atoms of lysine (K)3586, aspartic acid (D)3661, leucine 
(L)3668, proline(P)3832, K3840 and glycine (G)4024 residues located around the entry to 
the active site. The center of mass of these atoms is used as the coordinate systems origin. 
Measuring whether an atom lies within the probe cylinder can easily be achieved by 
considering the cylindrical coordinate system defined by the probe cylinder. In this coordinate 
system, we have the following equation: 
 ! = "
#$%&'()#&*+'() ,, # is the radius measured from the cylinder’s main axis and ( the angle around it. Using this 
equation, the following inequalities have to be checked: # ≤ ., 
 ≤ /., 
. and /. are the radius and length of the cylindrical probe. Counting the number of atoms 
fulfilling these conditions and normalizing by the probe´s volume gives the particle number 
density: 
+'0) = ∑ 
#'0) ≤ .1 ⋅ 
 '0) ≤ /.#. ⋅ /.  
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The unit is measured in /Å³, so the number of particles per volume. This is the density of 
particles blocking the active site accessibility. 
 
 
Figure 7.Illustration the fitting of cylindrical reference volume to the active site cavity. Exemplary 
depiction of the cylindrical reference volume (red) at the active site cavity of PI3K domain within the 
head domain (cyan) of DNA-PKcs. 
 
3.2.9.  Calculation of the molecular in silico attraction between catalytic PI3K 
domain of DNA-PKcs and BIR domain of Survivin 
To analyze the interaction between the BIR domain and PI3K domain in the large-scale 
docking (98884 poses), the minimum distance between the docked Survivin and the whole 
PI3K region (6789) was calculated by the following formula: 
 6789 = *+:| − |:  ∈ =8>? ,  ∈ 789@ =8>? and 789 indicate the collection of atom coordinates from the PI3K domain and BIR 
domain of Survivin, respectively. The minimum distance between the related atoms provides 
a sensible distance measurement that examines whether and how effective these two domains 
interact with each other. The docking quality is described by increasingly negative Rosetta 
interface scores. This score is defined as the difference in Rosettas score for the structure with 
two docking poses together and separated by 100 Å, eventually mimicking no interaction 
(Gray et al., 2003). 
 
3.2.10. Virtual drug screening analysis 
The X-ray crystal structure of monomer Survivin -PDB: 2QFA- (Jeyaprakash et al., 2007) was 
used as input for the virtual drug screening analysis. Primarily, the structure was subjected to 
the Protein Preparation Wizard (Sastry et al., 2013) in the Schrödinger Release 2018-1 
(Schrödinger, LLC, New York, NY) as mentioned in Section 3.2.6. To prepare the Survivin 
structure as a receptor, Receptor Grid Generation – Glide module of Schrödinger Release 
2018-1 (Friesner et al., 2004; Friesner et al., 2006; Halgren et al., 2004) was employed by 
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setting the receptor enclosing box as the centroid of S20 and W67 residues. As input ligands, 
in total 7,919,071 drug/drug-like ligands from the repositories of Asinex (Gold&Platinium 
Collections – 263,557 ligands) (http://www.asinex.com/libraries-html/), ChemBridge (Core 
Library Stock – 2,238,050 ligands, Core Extended Library Stock – 943,422 ligands) 
(https://www.chembridge.com/screening_libraries/), Specs (ExAcD library release May 2018 
- 474,042 ligands) (www.specs.net) and MolPort (4,000,000 ligands) 
(https://www.molport.com/shop/screeening-compound-database) were used. Further, the 
ligands were prepared by LigPrep – Glide module of Schrödinger Release 2018-1 (Friesner et 
al., 2004; Friesner et al., 2006; Halgren et al., 2004). Briefly, OPLS3 force field was used, and 
possible ionization states and tautomers were generated at pH 7.0 ± 2.0 with a desaltation 
step. Specific chiralities were retained for stereoisomer computation and maximal 32 
stereoisomers were generated per ligand. Additionally, three low energy ring conformations 
were generated per ligand. Prepared receptor and ligands were further subjected to a global 
virtual screening approach by using the Virtual Screening Workflow – Glide module of 
Schrödinger Release 2018-1 (Friesner et al., 2004; Friesner et al., 2006; Halgren et al., 2004). 
Briefly, rapid ADME (absorption, distribution, metabolism, and excretion) properties of 
ligands were predicted by QikProp, followed by prefiltering by Lipinski rules (Molecular mass 
<500 Da, high lipophilicity LogP <5, hydrogen bond donors <5, hydrogen bond acceptors 
<10, molar refractivity in between 40-130) (Lipinski et al., 2001). Afterwards, prefiltered 
ligands were docked with receptors: Planarity of conjugated pi groups was enhanced and Epik 
state penalties were used for docking. Docking was performed in three steps: High-throughput 
Virtual Screening (HTVS), Standard Precision (SP), and Extra Precision (XP) with enhanced 
sampling and flexible docking configurations followed by post-docking minimization. Post-
docking processing was performed by Prime MM-GBSA in the Schrödinger Release 2018-1 
(Jacobson et al., 2004).               
 
3.2.11. Irradiation procedure 
Irradiation of cells with single photon doses ranging from 2 to 6 Gy was performed using a 
linear accelerator (Agility, ELEKTA, Crawley, UK) with 6 MeV/100 cm focus-surface distance 
and a dose rate of 4 Gy/min. Mock-irradiated cultures were kept at room temperature in the 
X-ray control room while the other samples were being irradiated. 
 
3.2.12. FACS-FRET 
Since the ground-breaking investigation and description of the Förster resonance energy 
transfer (FRET) by Theodor Förster,  this method has been established of as a potential 
biosensor for macromolecular interactions in the cell and implemented into the solutions for 
many questions in the field of cell biology. FRET is a highly sensitive method based on the 
energy transfer from an excited donor fluorophore to the acceptor fluorophore in less than 10 
nm distance, which provides a reasonable distance for potential macromolecule-
macromolecule interactions. In addition, the emission spectrum of the donor fluorophore and 
the absorption spectrum of the acceptor fluorophore have to be overlapping (Clegg, 1995; 
Jares-Erijman and Jovin, 2003; Sun et al., 2013) (Figure 8a). With the technological 
advancements currently achieved, there are many donor and acceptor pair alternatives for 
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practical usage such as CFP-YFP, GFP-RFP, far-red fluorescence proteins (FFP), Infrared FPs 
(IFP), large stokes shift (LSS) FPs, Dark FPs, phototransformable (PT) FPs and multicolor 
systems (Bajar et al., 2016; Forster, 1946). Still, there are some major limitations and 
difficulties such as spectral overlaps for some donor and acceptors, artefact proneness, and 
microscopy-based analysis limit the evaluation of a large number of cells. To overcome these 
challenges, a non-invasive, sensitive, and quantitative method FACS-FRET (Flow cytometry-
based FRET) has been adapted from Banning and co-workers. This method is easy to apply for 
many FRET experiments, allows analyzing the protein interactions in living cells, and well-
controlled, standardized, reliable and quantitative assessments which overcomes many 
limitations in FRET and proteomics (Banning et al., 2010). In the experimental approaches 
used within this thesis, the FACS-FRET methodology was applied to ECFP-EYFP based fusion 
constructs with Survivin and different domains of DNA-PKcs. By this, SW480 colorectal cancer 
cells were transfected with plasmids (Section 3.2.2) and harvested 1 h after irradiation with 
4 Gy, followed by the quantitative measurement by FACS (Figure 8b). FACS-FRET 
measurements were performed using a CytoFLEX S cytometer (Beckman Coulter) equipped 
with 405 nm, 488 nm and 638 nm lasers. To measure ECFP and FRET, cells were excited with 
the 405 nm laser and fluorescence was collected in the ECFP channel with a standard 450/45 
filter, while the FRET-signal was measured with a 525/40 filter. To measure EYFP, cells were 
excited with the 488 nm laser, while emission was taken with a 525/40 filter. For each 
sample, we evaluated a minimum of one thousand ECFP/EYFP positive cells that fell within 
the background adjusted gate, as described previously (Banning et al., 2010). Analysis was 
performed with CytExpert software version 1.2.11.0. 
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Figure 8. Overview of the FACS-FRET methodology. (a) Requirements for FRET: less than 10 nm 
proximity between the donor (ECFP) and acceptor (EYFP), and overlap of the spectra of donor 
emission and acceptor absorption. (b) Cells were co-transfected with Gene of interest (GOI)-Fusion 
protein constructs, 48 h later irradiated with 4 Gy, harvested and measured one hour after irradiation. 
Figures were modified from (Banning et al., 2010; Hoffmann, 2017). 
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3.2.13. 3D colony formation assay 
Measurement of 3D cell survival was carried out as reported before (Eke et al., 2012; 
Hehlgans et al., 2018; Hehlgans et al., 2012). In brief, single cells were plated in 0.5 µg/µl 
laminin rich extracellular matrix; Cultrex 3D Culture Matrix BME Reduced Growth Factor 
Basement Membrane Extract PathClear; supplemented with medium (DMEM + 10% FBS + 
1% penicillin/streptomycin) in 50 µl 1% agarose coated 96-well plates 24 h after siRNA 
transfection. Cells were irradiated (0, 2, 4, 6 Gy) 24 h thereafter and colonies (> 50 cells) 
were microscopically counted 7 days after plating. Experiments were performed in triplicates 
and at least three independent experiments were performed for each condition. Plating 
efficiencies were determined as numbers of colonies formed (0 Gy) / numbers of cells plated. 
Surviving fractions were calculated as numbers of colonies formed / (numbers of cells plated 
(irradiated) × plating efficiency (mock-irradiated)). Each point on survival curves represents 
the mean surviving fraction from at least three independent experiments. Survival variables α 
and β were fitted according to the linear quadratic equation (SF = exp [−α × D − β × D2] 
with D = dose using Microsoft Excel software ver. 2010 (Microsoft, Redmond, USA). 
 
3.2.14. Co-Immunoprecipitation 
Co-Immunoprecipitations were carried out using Dynabeads™ Protein G (#10004D 
ThermoFisher Scientific) and SW480 colorectal cancer cell lysates. The protocol was followed 
according to the manufacturer’s instructions; beginning with the addition of 3 µg antibody: 
Anti-GFP (#ab290 Abcam), anti-Flag (#2368S Cell Signaling Technology), anti-DNA-PKcs 
(#MS-369-P1 ThermoFisher Scientific) or 3 µg of IgG (Mouse #SC-2025, Rabbit #SC-2027 
Santa Cruz Biotechnology) and incubated in the rotating mixer at 5rpm overnight at 4oC to 
create the co-IP bead complex. SW480 colorectal cancer cells (40-50% confluency) were 
transfected with related vectors for 48 h and cell lysates prepared 1 h after single-dose 4 Gy 
irradiation. Densitometrically equal amount of lysates were added to the related antibody or 
IgG-Dynabead complexes and incubated in the rotating mixer at 5rpm overnight at 4oC. Beads 
were washed gently 5 times with 700 µl PBS followed the renewal of co-IP tubes to prevent 
non-specific binding and then the bound proteins were eluted by boiling; subsequently, the 
samples were electrophoresed (Section 3.2.15). 
 
3.2.15. Protein extraction, SDS-PAGE and Immunoblotting 
For cell lysis using radioimmunoprecipitation assay (RIPA) buffer (Pandey et al., 2015), cells 
were washed once with ice-cold PBS and scraped in RIPA buffer on ice 1 h after irradiation. 
The lysates were transferred to a precooled 1.5 ml tube and incubated on ice for 1 h, followed 
by centrifugation at 18000 x g for 15 min at 4 °C. The supernatant containing the proteins 
was then transferred into a new precooled 1.5 ml tube and stored at -80 °C. 
For the cell lysis of immunoprecipitation experiments, IP lysis buffer (1x) was used. Cells were 
washed with ice-cold PBS, scraped in ice-cold PBS and transferred to a precooled 50 ml falcon 
tube. After centrifugation at 100 x g for 5 min at 4 °C, the pellet was resuspended in IP lysis 
buffer, followed by sonication three times for 1 min (in between 10s vortexing) and 
incubation on a rotator by 5rpm speed for 1 h at 4 °C. Then, the lysates were centrifuged at 
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18000 x g for 15 min at 4 °C and the supernatant containing the proteins was transferred into 
a precooled 1.5 ml tube. Concentrations of protein samples determined with Micro BCA™ 
Protein Assay Kit following the manufacturer’s instructions then were subjected to 
densitometric immunobloting to determine the relative amounts of bait/prey proteins. 
Densitometrically equal amounts of proteins were subjected to co-IP assay (Section 3.2.14), 
and the rest of the lysate stored at -80 °C.  
For immunoblotting, sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) gels (8-10% for high, 12% for medium, 15% for low molecular weight proteins) were 
prepared according to Table 10. Briefly, protein samples including 6x reducing 
electrophoresis buffer were heated at 99 °C for 10 min then immediately cooled down in ice 
box and spinned down for 10s. Samples were loaded on the gels and electrophoresis was 
performed with 25 mA current per gel. Following SDS-PAGE, Bio-Rad Transfer-Blot Turbo 
Transfer Pack pre-designed membranes were used. The electrophoresed SDS gel was placed 
on the membrane (bubbles between gel and membrane were removed) followed by top filter 
papers soaked in transfer buffer, followed by transfer at 2.5 A and 25 V per gel for 25 min. To 
confirm the correct protein transfer and equal loading of the SDS gel, the membranes were 
next incubated in Ponceau S solution for 5 min on a shaker, subsequently washed with 
distilled water and destained with TBS-T. For blocking, the membranes were incubated in 5% 
milk powder/TBS-T at room temperature (RT) for 1 h, followed by overnight incubation at 
4 °C while shaking with the respective primary antibodies (Table 5), diluted in 5% BSA/TBS-
T. After incubation with the primary antibodies, the membranes were washed three times 
with TBS-T for 10 min at RT. Thereafter, horseradish peroxidase (HRP)-conjugated secondary 
antibodies (Table 7), diluted in 5% milk powder/TBS-T were applied to the membranes for 
1 h at RT. Finally, membranes were washed three times with TBS-T and once with TBS for 
10 min at RT. Next, the membranes were placed on an imaging tray and incubated for 3 min 
with working solutions of LI-COR WesternSure® PREMIUM Chemiluminescent Substrate. 
Odyssey Fc Imaging System and Image Studio Version 5.2 software were used for the 
detection of the chemiluminescent signal. 
 
Densitometric analysis 
Image Studio Version 5.2 software was used for the densitometrical analyses. Briefly, the 
corresponding protein bands were selected by using ‘Draw Rectangle, tool under the ‘Analysis, 
module. For the automatic background subtraction, ‘Average–Border width, parameter was 
set to ‘1, and segment parameter was set to ‘Top/Bottom,. 
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Table 10. Ingredients and pipetting scheme for SDS electrophoresis gels (8.3 cm x 7.3 cm x 1 mm). 
 Separation 
gel 
8% 
Separation 
gel 
10% 
Separation 
gel 
12% 
Separation 
gel 
15% 
Collection 
gel 
5% 
Distilled water 5.8 ml 4.7 ml 3.6 ml 2.0 ml 3.52 ml 
Rotiphorese® 
Gel 30 (37.5:1) 
4.3 ml 5.4 ml 6.5 ml 8.1 ml 0.836 ml 
1M Tris HCl 
(pH 8.8) 
6.0 ml 6.0 ml 6.0 ml 6.0 ml - 
1 M Tris HCl 
(pH 6.8) 
- - - - 0.626 ml 
10% SDS 0.162 ml 0.162 ml 0.162 ml 0.162 ml 0.05 ml 
20% APS 0.054 ml 0.054 ml 0.054 ml 0.054 ml 0.04 ml 
TEMED 0.012 ml 0.012 ml 0.012 ml 0.012 ml 0.005 ml 
 
3.2.16. Immunofluorescence staining and imaging 
Residual DNA DSBs of 3D cell cultures were counted using the foci assay as previously 
described (Hehlgans et al., 2018; Storch et al., 2010). Briefly, 3D cell cultures were isolated 
24 h after irradiation with 2 Gy. Subsequently, cells were fixed and stained with anti-
phospho-histone γH2AX antibody (clone JBW301; Millipore), anti-53BP1 antibody (NB100-
304, Novus Biologicals), then labelled with Alexa Fluor 488 goat anti-rabbit secondary 
antibody (Invitrogen), Alexa Fluor 594 goat anti-mouse secondary antibody, 4’,6-diamidino-2-
phenylindole (DAPI) and covered with Vectashield mounting medium. γH2AX/53BP1-positive 
foci were microscopically counted from at least 50 nuclei per single experiment. Fluorescence 
images of stably transfected cells were obtained using an Axio Imager Z1 microscope (Carl 
Zeiss, Göttingen, Germany) after staining the nuclei with DAPI. 
 
3.2.17. In vitro kinase assay 
 The kinase activity of DNA-PK was measured using a SignaTECT DNA-Dependent Protein 
Kinase Assay System. The biotinylated peptide substrate was incubated with 30 units purified 
DNA-PK and (γ-32P)ATP in the presence or absence of immunoprecipitated Survivin-EGFP, 
EGFP or DNA-PK inhibitor (KU 0060648, 1 µM) in a thermoshaker at 1100rpm, 30 °C for 45 
min according to the manufacturer's instructions. The biotinylated substrate was captured on 
a streptavidin membrane, washed and quantified by the Fujifilm BAS-1500 Phosphorimager 
(GE Life Sciences, Tokyo, Japan). Results were evaluated by using TINA Image Analysis 
Environment (OSMIA Project, EU IST Program) (Figure 9). 
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Figure 9. Schematic presentation of the SignaTECT® DNA-dependent Protein Kinase Assay 
Protocol. The biotinylated peptide, DNA-PK, reaction and activation buffers and γ-32P ATP were mixed, 
incubated at 30 oC and the reaction was terminated by termination buffer. Further, the sample was 
probed on the SAM2® biotin capture membrane and unbound components were washed away. 
Subsequently, the membrane was quantified by Phosphorimager. Figure modified from Promega 
(https://www.promega.de). 
 
3.2.18. Cell harvest and lysis for LC-MS 
The SW480 human colorectal carcinoma cells (wild type, stably EGFP or Surv.wt transfected) 
were transfected with control siRNA or Survivin siRNA for 48 hours followed by DNA-PK 
inhibitor treatment (1 µM) 1 h before irradiation with 4 Gy. 1 h after irradiation, cells were 
harvested with ice-cold PBS, centrifuged at 100 x g for 5 min at 4 °C, and the supernatant was 
removed. Lysis was performed according to a previously described procedure (Potel et al., 
2018). Briefly, one volume of cell pellet was resuspended with five volumes of lysis buffer 
composed of 100 mM Tris-HCl pH 8.5, 7 M Urea, 1% Triton X-100, 10U/ml DNase I, 1 mM 
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MgCl2, 100U/ml Benzonase, 1 mM Sodium Orthovanadate, 1X PhosSTOP phosphatase 
inhibitor, and 1X cOMPLETE mini EDTA-free protease inhibitor then further lyzed by 
sonication for 45 min (30 s on, 30 s off) using a Bioruptor Plus. Residual cell debris removal 
was performed by ultracentrifugation (140,000 x g for 1 h at 4 °C). The lysates were further 
incubated at room temperature for 2 h then stored at -80 °C. 
 
3.2.19. Sample preparation for LC-MS 
Lysates were incubated with 10 mM TCEP and 40 mM chloroacetamide for 30 min at 37 °C. 
Proteins were precipitated using three volumes of ice-cold methanol, one volume of 
chloroform, and 2.5 volumes of ddH2O. After centrifugation at 3,000 x g for 30 min at 4 °C, 
the upper aqueous phase was aspirated, and three volumes of ice-cold methanol added. 
Samples were mixed and proteins pelleted by centrifugation at 3,000 x g for 5 min at 4 °C. 
The supernatant was discarded and pellets were washed one additional time with ice-cold 
methanol. Protein pellets were resuspended in 8 M Urea, 10 mM EPPS pH 8.2 and protein 
concentration was determined using the BCA assay. Samples were diluted to 2 M Urea using 
digestion buffer (10 mM EPPS pH 8.2) and incubated with LysC  at 1:50 (w/w) ratio for 3 h 
at 37 °C. Digestion reactions were further diluted to 1 M Urea using digestion buffer and 
incubated at 1:125 (w/w) ratio with trypsin overnight at 37 °C. Digests were acidified using 
trifluoroacetic acid (TFA) to pH 2.0, and peptides were purified using SepPak C18 columns 
according to the manufacturer’s protocol. The elution was split into the proteome and 
phosphoproteome sample and dried separately. Proteome peptides were resuspended in TMT-
labelling buffer (0.2 M EPPS pH 8.2, 20% acetonitrile) and peptide concentration was 
determined by using µBCA assay. Phosphopeptides were enriched by using High-Select™ Fe-
NTA Phosphopeptide Enrichment Kit according to the manufacturer’s protocol. Phospho 
peptides were purified using Empore™ C18 (Octadecyl) resin material. The material was 
activated by incubation with methanol for 10 min, followed by one wash with each buffers; 
70% acetonitrile/0.1% TFA and 3% acetonitrile/0.1% TFA. Samples were resuspended in 3% 
acetonitrile/0.1% TFA, acidified to pH 2.0, and loaded on the resin material. Peptides were 
washed once with 3% acetonitrile/0.1% TFA and eluted with 70% acetonitrile. Samples were 
dried and resuspended in TMT labeling buffer. Equal amounts of proteome peptides and 
phosphopeptides were mixed with TMT reagents at a 2:1 (w/w) ratio. Reactions were 
incubated for one hour at RT and subsequently quenched by the addition of hydroxylamine to 
a final concentration of 0.5% at RT for 15 min. Samples were pooled in equimolar ratio and 
analyzed by test shot to verify equal mixing and labeling efficiency. Adjusted peptide amounts 
were used for Pierce™ High pH Reversed-Phase Peptide Fractionation Kit, according to the 
manufacturer’s protocol. Samples were dried and resuspended in 0.1% formic acid (FA) for 
LC-MS2/3 analysis. 
 
3.2.20. Liquid chromatography-mass spectrometry (LC-MS) 
All mass spectrometry data were acquired in centroid mode on an Orbitrap Fusion Lumos 
mass spectrometer hyphenated to an easy-nLC 1200 nano HPLC system using a nanoFlex ion 
source applying a spray voltage of 2.6 kV with the transfer tube heated to 300 °C and a funnel 
RF of 30%. Internal mass calibration was enabled (lock mass 445.12003 m/z). Peptides were 
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separated on a self-made 32 cm long, 75 µm ID fused-silica column, packed in house with 
ReproSil-Pur Basic 1.9 µm C18 particles and heated to 50 °C using an integrated column oven. 
HPLC solvents consisted of 0.1% formic acid in water (Buffer A) and 0.1% formic acid/80% 
acetonitrile in water (Buffer B). 
For total proteome analysis, a synchronous precursor selection (SPS) multi-notch MS3 
method was used in order to minimize ratio compression, as previously described (McAlister 
et al., 2014). Individual peptide fractions were eluted by a non-linear gradient optimized for 
each fraction, spanning from 3 to 50% B over 210 min. The effective gradient was followed by 
a step-wise increase to 95% B in 6 min, which was held for another 9 min. Full scan MS 
spectra (350-1400 m/z) were acquired with a resolution of 120,000 at m/z 200, maximum 
injection time of 100 ms, and AGC target value of 4 x 105. The 20 most intense precursors 
with a charge state between 2 and 6 per full scan were selected for fragmentation (“Top 20”) 
and isolated with a quadrupole isolation window of 0.7 Th. MS2 scans were performed in the 
Ion trap (Turbo) using a maximum injection time of 50 ms, AGC target value of 1.5 x 104, and 
fragmented using collision-induced dissociation with normalized collision energy (NCE) of 
35%. SPS-MS3 scans for quantification were performed on the 10 most intense MS2 fragment 
ions with an isolation window of 0.7 Th (MS1) and 2 m/z (MS2). Ions were fragmented using 
higher-energy collisional dissociation (HCD) with an NCE of 65% and analyzed in the 
Orbitrap with a resolution of 50,000 at m/z 200, scan range of 110-500 m/z, AGC target 
value of 1.5 x105 and maximum injection time of 120 ms. Repeated sequencing of already 
acquired precursors was limited by setting a dynamic exclusion of 45 sec and 7 ppm and 
advanced peak determination was deactivated. 
For phosphopeptide analysis, each peptide fraction was eluted by a linear gradient optimized 
for each fraction, spanning from 4 to 40% B over 120 min followed by a step-wise increase to 
95% B in 8 min which was held for another 7 min. Full scan MS spectra (350-1400 m/z) were 
acquired with a resolution of 120,000 at m/z 200, maximum injection time of 100 ms, and 
AGC target value of 4 x 105. The 20 most intense precursors per full scan with a charge state 
between 2 and 5 were selected for fragmentation (“Top 20”), isolated with a quadrupole 
isolation window of 0.7 Th and fragmented via HCD applying an NCE of 38%. MS2 scans 
were performed in the Orbitrap using a resolution of 50,000 at m/z 200, maximum injection 
time of 86 ms, and AGC target value of 1 x 105. Repeated sequencing of already acquired 
precursors was limited by setting a dynamic exclusion of 60 sec and 7 ppm and advanced 
peak determination was deactivated. 
 
3.2.21. Processing of raw LC-MS files and data analysis 
Raw files were analyzed using Proteome Discoverer (PD) 2.4 software (Thermo Fisher 
Scientific). Files were recalibrated using the Homo sapiens SwissProt database (TaxID:9606, 
version 2017-09-11). Fixed modifications for proteome analyses were carbamidomethyl 
(C,+57.021) and TMT6 (N-terminal, +229.1629) and dynamic modification was methionine 
oxidation (M, +15.995). For phosphoproteomics fixed modifications were phosphorylation 
(S, T, Y, +79.966), carbamidomethyl (C,+57.021) and TMT6 (N-terminal, +229.1629). 
Spectra were selected using default settings and database searches performed using 
SequestHT node in PD. Database searches were performed against trypsin digested Homo 
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sapiens SwissProt database and FASTA files of common contaminants (‘contaminants.fasta‘ 
provided with MaxQuant) for quality control. Fixed modifications were set as TMT6 (N-
terminal, +229.1629 and K, +229.1629) and carbamidomethyl (C,+57.021). Dynamic 
modifications for proteome analysis were oxidation (M, +15.995) and acetylation (N-
terminal, +42.011) and for phosphoproteomics dynamic modifications were oxidation (M, 
+15.995), acetylation (N-terminal, +42.011) and phosphorylation (S, T, Y, +79.966).  
After the search, posterior error probabilities were calculated, and PSMs filtered using 
Percolator with default settings. The consensus workflow for reporter ion quantification was 
performed with default settings. Results were then exported to Excel files for further 
processing. 
The mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium (Vizcaino et al., 2014) via the PRIDE partner repository (Vizcaino et al., 2016) 
with the dataset identifier PXD020489 (Reviewer account details: Username: 
reviewer58550@ebi.ac.uk; Password: oWwUa3dj). 
Log2 fold changes were calculated by Log2 transformation of the ratio between the treated 
sample versus the control sample. Hierarchical clustering analysis was performed using the 
Perseus software package (version 1.6.10.45) with Euclidean distance and default settings 
after centering and scaling of data (Z scores). 
 
3.2.22. Data analysis 
Experimental data are presented as mean ± standard deviation (SD). At least three 
independent experiments were performed. A two-sided unpaired Student’s t-test was 
performed using Microsoft Excel software to test statistical significance. Results were 
considered statistically significant when a p-value of less than 0.05 (*) was reached, more 
significant with p < 0.01 (**), and highly significant with p < 0.001 (***), respectively. 
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4. Results 
 
4.1. Initial findings on the involvement of Survivin BIR domain in radiation survival 
and DNA damage repair 
Initial experimental studies of our group have analyzed the effect of Survivin domain deletion 
mutants on DNA damage repair, and radiation response in 3D clonogenic assays that may 
reflect a physiological environment more closely than conventional 2D cultures (Eke et al., 
2013; Storch et al., 2010). Under these conditions, cells stably expressing recombinant 
Survivin with a deletion of the BIR domain (∆BIR) were significantly radiosensitized while the 
expression of Survivin mutants lacking the microtubule binding domain (∆MicTub) fully 
rescued radiation survival following siRNA-mediated knockdown of endogenous Survivin 
(Petraki, 2014) (Figure 10a). 
Our group and others have recently shown that nuclear accumulation of Survivin contributes 
to the repair of radiation-induced DNA DSBs (Chakravarti et al., 2004; Iwasa et al., 2008; 
Rodel et al., 2005) probably via interaction with members of the NHEJ apparatus such as 
DNA-PKcs (Capalbo et al., 2010; Reichert et al., 2011; Wang et al., 2018c). The molecular 
basis for this interrelationship, however, remains elusive. Thus, we analyzed the impact of 
Survivin deletion mutants on DNA DSB repair. Residual DNA damage in 3D cell cultures was 
significantly increased upon knockdown of endogenous Survivin in EGFP and ∆BIR expressing 
cells, as evaluated by the assessment of ′γH2AX foci at 24 h after irradiation with 2 Gy. On the 
contrary, overexpression of Survivin wild type (Surv. wt) and ∆MicTub constructs rescued 
DNA repair following the knockdown of endogenous Survivin (Petraki, 2014) (Figure 10b). 
This suggested a potential role of the BIR domain of Survivin in response to DNA damage. In 
the lights of these findings, investigations were further focused on in silico molecular 
interaction potential of Survivin-DNA-PKcs interaction in Section 4.2 to elucidate the 
functional and molecular relevance of these preliminary findings. 
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Figure 10. The Survivin BIR domain is essential for 3D clonogenic radiation survival and DNA 
damage repair. (a) Clonogenic radiation survival of the indicated 3D cell cultures was analyzed after 
irradiation with 0, 2, 4 or 6 Gy (single dose). Results represent means ± SD (n = 4; * p < 0.05; ** p < 
0.01; t-test). (b) SW480 cells, stably expressing indicated Survivin mutants were subjected to siRNA 
transfection (siCtrl, non-specific control siRNA; siSurv, Survivin siRNA) and subsequently irradiated 
with 2 Gy. At 24 h after irradiation, cells were fixed and stained for γH2AX/53BP1 while nuclei were 
counterstained with DAPI. Nuclear γH2AX foci were microscopically counted (50 nuclei per 
experiment). Results represent mean foci per cell ± SD (n = 3; * p < 0.05; t-test). Figure provided by 
Dr. Chrysi Petraki (PhD thesis) (Petraki, 2014). 
 
4.2. Molecular docking analysis of Survivin and DNA-PKcs interaction 
Molecular crystallographic structures of proteins can be determined from protein crystals 
using a variety of methods, including nuclear magnetic resonance spectroscopy (NMR), X-ray 
crystallography, SAXS, cryogenic electron microscopy (Cryo-EM), neutron diffraction, electron 
crystallography and microcrystal electron diffraction (Wang and Wang, 2017). Even with 
these cutting-edge technological advances, still, many of the generated structures have a 
variety of structural defects, including missing atoms, missing/incomplete side chains, 
residues or loops, incorrect bond orders, and missing bonds, which can negatively affect the 
molecular docking analysis and further evaluations. To overcome those potential problems, 
pre-docking protein preparations were performed by the Protein Preparation Wizard module 
of Schrödinger Release 2018-1 (Sastry et al., 2013). The X-ray crystal structure of Survivin -
PDB: 1E31- (Chantalat et al., 2000) and DNA-PKcs -PDB: 5LUQ- (Sibanda et al., 2017) were 
used as input and missing/truncated atoms, side chains, loops (Prime module of Schrödinger 
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Release 2018-1, (Jacobson et al., 2002; Jacobson et al., 2004)) were filled, cap-termini, 
disulfide bonds were re-created, all non-complexed ions and solvents were deleted and 
selenomethionines converted to methionines. The hydrogen-bonding network was optimized, 
and protonation states assigned at pH 7.0. Finally, protein preparations were completed by 
performing a restrained minimization using the OPLS3 force field (Harder et al., 2016) 
(Figure 11). 
 
Figure 11. Protein preparation fixes crucial crystallographic errors. Survivin (PDB: 1E31), (a) 
before preparation, and (b) after preparation. DNA-PKcs (PDB: 5LUQ), (c) before preparation, and (d) 
after preparation. 
 
Next, optimized proteins were molecularly docked by employing the PIPER module of 
Schrödinger Release 2018-1 (Chuang et al., 2008; Kozakov et al., 2006) and PatchDock 
webserver analyses (Schneidman-Duhovny et al., 2005) and top-ranked 150 poses were 
further refined with FireDock (Mashiach et al., 2008). Qualification of hot-spot potential 
interaction residues were based on the binding free energy and distances: Interaction pairs 
that have lower binding free energy values compared to pre-docking conditions and distances 
between backbone/side chains atoms lower than 5Å were qualified as potential interactors. 
Post-docking binding free energy and potential bond-forming proximity analyses revealed that 
some specific residues such as S20, F27, C31, D53 and W67 located in the BIR domain (18-88 
amino acids (aa)) of Survivin showed low binding free energy compared to pre-docking 
conditions and showed high affinity to the catalytic PI3K domain (3747-4015 aa) of DNA-
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PKcs (Figure 12a). By contrast, phospho-mimicking form of S20 (S20D) and alanine 
substitution form of W67 (W67A) residues in silico generated by Rotamer tool of Chimera 
1.13.1 (Pettersen et al., 2004) using the Dunbrack Rotamer Library (Shapovalov and 
Dunbrack, 2011) showed greater side-chain distances and a potential decrease was observed 
in the attraction/bond formation compared to wild-type conditions by two representative 
molecular interaction poses (Figure 12b). 
 
Figure 12. Molecular in silico docking and energy analyses of the interaction of Survivin and 
DNA-PKcs. (a) Pair-wise binding free energies and distances of Survivin and DNA-PKcs’ amino acids. 
(b) Two representative docking poses indicating potential interactions between wild type or phospho-
mimicking form of S20 (S20D) and wild type or alanine substitution form of W67 (W67A) residues of 
Survivin (cyan) with Y3828 and E3838 residues of DNA-PKcs (red) respectively. 
 
4.3. BIR domain of Survivin is essential for the interaction with the PI3K domain of 
DNA-PKcs 
In the light of all findings mentioned before, the interaction potential between Survivin and 
DNA-PKcs has been verified by testing different domains/regions of DNA-PKcs by FACS-FRET 
to unravel which domains/regions are responsible for this interaction. Survivin wt or BIR 
domain deletion mutants and domains/regions of DNA-PKcs (HEAT-1, FATC, PI3K) were sub-
cloned into FRET vectors and co-transfected into SW480 colorectal cancer cells (Figure 13a). 
Analyses by cytofluorometry revealed a significant interaction of Survivin with the PI3K 
domain of DNA-PKcs, and deletion of the BIR domain of Survivin significantly diminished the 
interaction between Survivin and DNA-PKcs. Moreover, the interaction potentials between 
Survivin and the HEAT-1 and FATC domains of DNA-PKcs and as well as PI3K domain of ATM 
resulted in low interaction potentials compared to PI3K domain of DNA-PKcs. These results 
suggest that the BIR domain of Survivin is indispensably involved in the interaction with the 
PI3K domain of DNA-PKcs (Figure 13b). 
  
Results 51 
 
Figure 13. Domain-based FACS-FRET analysis for DNA-PKcs. (a) Schematic representation of the 
domains of Survivin, DNA-PKcs and ATM which subjected to FACS-FRET analyses. Vectors expressing 
enhanced yellow fluorescent protein (EYFP), Surv. wt, Survivin wild type-EYFP; ∆BIR, Survivin 
baculovirus inhibitor of apoptosis protein repeat (BIR) domain deletion mutant-EYFP. Vectors 
expressing enhanced cyan fluorescent protein (ECFP), Surv. wt, Survivin wild type-ECFP; PI3K, DNA-
PKcs phosphatidylinositol-3-kinase (PI3K) domain-ECFP; HEAT1, DNA-PKcs Huntingtin-Elongation 
Factor 3-PP2A-TOR1 (HEAT1) domain-EYFP; FATC, FRAP-ATM-TRRAP C-terminal (FATC) domain-
ECFP; PI3K-ATM, ATM phosphatidylinositol-3-kinase (PI3K) domain-ECFP. Numbering of residues 
correspond to the original positions in the complete protein sequence. (b) Analyses were performed to 
measure the interaction potentials between Survivin and the HEAT1-repeat, PI3K, and FATC domains 
of DNA-PKcs and as a negative control PI3K domain of ATM. Proteins were fused with ECFP and/or 
EYFP fluorescence tags and SW480 cells were co-transfected with the corresponding constructs. The 
interaction potentials depending on the proximity-based energy transfer from ECFP to EYFP 
fluorescence tag resulting in the EYFP emission fluorescence signal were measured by flow cytometry. 
Results represent means ± SD (n = 3; * p < 0.05; ** p < 0.01; *** p < 0.001; t-test). 
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To further confirm the importance of the BIR domain for the interaction with DNA-PKcs, co-IP 
assay were performed. Recombinant Survivin wild type/BIR domain deletion mutant 
expressing SW480 colorectal cancer cells were irradiated with 4 Gy, lysates were harvested 1 
hour after irradiation. co-IP was performed for both DNA-PKcs and Survivin. As indicated in 
Figure 14, Surv. wt co-immunoprecipitated with DNA-PKcs while deletion of BIR domain 
(∆BIR) or EGFP control did not display an interaction. Vice versa, DNA-PKcs co-
immunoprecipitated with Surv. wt while deletion of the BIR domain (∆BIR) or EGFP control 
lack an interaction. In summary, these findings revealed that the BIR domain is essential for 
this interaction (Figure 14). 
 
 
Figure 14. BIR domain is essential for the interaction between Survivin and DNA-PKcs. Whole cell 
lysates of SW480 cells, transiently transfected with EYFP, Surv. wt or ′∆BIR expression constructs, were 
isolated one hour after irradiation with 4 Gy. EYFP fusion proteins were immunoprecipitated (IP) using 
an anti-GFP antibody, and DNA-PKcs was immunoprecipitated with an anti-DNA-PK antibody.  Mouse 
and rabbit mAb isotype controls (IgG) served as controls. Subsequently, EYFP constructs and DNA-PKcs 
were detected by immunoblotting. 
 
4.4. Specific amino acids located in the BIR domain of Survivin are important for the 
interaction with the PI3K domain of DNA-PKcs 
Single mutation vectors of qualified potential interactor residues (S20, F27, C31, D53 and 
W67) (Figure 12a), negative control residues (W25, L28, E29, E76 and K79), and known 
post-translational phosphorylation sites (T34 and T117) of Survivin, also combined 
double/triple alanine and/or phosphomimetic mutation vectors were prepared by employing 
site-directed mutagenesis techniques. Correct mutation vectors were validated by sequencing 
and appropriate constructs were introduced into SW480 colorectal cancer cells and 
appropriate protein construct expression and stability were confirmed by immunoblotting 
(Figure 15). 
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Figure 15. Protein expression levels of single/multiple amino acid mutations of Survivin. The 
scope of mutations comprises high/low potential molecular docking candidates, known post-
translational phosphorylation sites and double/triple combinations of mutations. (β-actin served as a 
loading control). 
 
Alanine substitution forms of hot-spot residues of Survivin predicted by molecular docking 
analysis and PI3K domain coding sequences were cloned into acceptor and donor EYFP/ECFP 
vectors, respectively, and co-transfected into SW480 cells to test the interaction potential by 
residue-level mutations. Predicted S20, F27, C31, D53, and W67 residues of Survivin were 
highly involved in this interaction, while alanine substitutions (exceptionally aspartic acid for 
S20) highly diminished the interaction of Survivin with PI3K domain of DNA-PKcs (Figure 
16a). To further investigate the potentially involved residues, the known post-translational 
phosphorylation sites of Survivin (S20, T34, and T117) were tested in both alanine 
substitution and phospho-mimicking conditions while S20 was already predicted by molecular 
docking analysis. Phospho-mimicking aspartic acid mutations of S20, T34 and T117 and 
alanine substitution of T34 significantly decreased the interaction potential by more than 30% 
(Figure 16b). Further combined double/triple mutations cumulatively decreased the 
potential, and the S20D-W67A double mutant was found the most promising, displaying 
around 70% decrease in the interaction between Survivin and PI3K domain of DNA-PKcs 
(Figure 16c). The importance of the S20D-W67A double mutant was further verified by using 
additional colorectal cancer cell lines DLD-1 and HCT-15 (Figure 16d,e). 
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Figure 16. Specific amino acids located in the BIR domain of Survivin are essential for the 
interaction with the PI3K domain of DNA-PKcs. (a) Fluorescence-based FACS-FRET analysis of the 
interaction potentials of alanine substitution forms of various Survivin sites in the interaction with PI3K 
domain of DNA-PKcs in SW480 cells. Substitutions were generated by site-directed mutagenesis and 
SW480 cells were transfected with corresponding constructs (Surv, Survivin-EYFP; PI3K, PI3K domain 
of DNA-PKcs-ECFP; W25A, Tryptophan 25 Alanine-EYFP; F27A, Phenylalanine 27 Alanine-EYFP; L28A, 
Leucine 28 Alanine-EYFP; E29A, Glutamic acid 29 Alanine-EYFP; C31A, Cysteine 31 Alanine-EYFP; 
D53A, Aspartic acid 53 Alanine-EYFP; W67A, Tryptophan 67 Alanine-EYFP; E76A, Glutamic acid 76 
Alanine-EYFP; K79A, Lysine 79 Alanine-EYFP;). Results represent means ± SD (n = 3; * p < 0.05; ** p 
< 0.01; *** p < 0.001; t-test). (b) FACS-FRET analysis of the interaction potentials of alanine and 
phospho-mimicking substitution forms of known Survivin post-translational phosphorylation sites with 
PI3K domain of DNA-PKcs in SW480 cells (S20A, Serine 20 Alanine-EYFP; S20D, Serine 20 Aspartic 
acid-EYFP; T34A, Threonine 34 Alanine-EYFP; T34D, Threonine 34 Aspartic acid-EYFP; T117A, 
Threonine 117 Alanine-EYFP; T117A, Threonine 117 Aspartic acid-EYFP). Results represent means ± 
SD (n = 3; * p < 0.05; ** p < 0.01; *** p < 0.001; t-test). (c) Fluorescence-based FACS-FRET analysis 
of the interaction potentials of BIR domain deletion (∆BIR, Survivin-∆BIR-EYFP) and double/triple 
mutations of the Survivin candidate sites which generated according to relative decrease on the 
interaction with PI3K domain of DNA-PKcs in SW480 cells. Results represent means ± SD (n = 3; * p 
< 0.05; ** p < 0.01; *** p < 0.001; t-test). (d) FACS-FRET analysis results of the interaction potentials 
of candidate mutants (ECFP/EYFP, Surv-wt, ∆BIR, S20D, W67A, S20D-W67A) in DLD-1, and (e) HCT-
15 cells. Results represent means ± SD (n = 3; * p < 0.05; ** p < 0.01; *** p < 0.001; t-test). 
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Finally, the interaction between Survivin S20D, W67A single; S20D-W67A double mutant 
constructs, and PI3K domain was tested by performing immunoprecipitation experiments and 
it was found that single mutants showed significant decrease while double mutant diminished 
further the interaction with PI3K domain. PI3K domain co-immunoprecipitated with 
recombinant Surv. wt (and vice versa) but not with the ′∆BIR Survivin mutant which verified 
the direct involvement of the BIR domain in the interaction between Survivin and DNA-PKcs 
via its catalytic PI3K domain (Figure 17a,b). 
 
 
Figure 17. S20D-W67A double mutant hampers the interaction between Survivin and the PI3K 
domain of DNA-PKcs. Whole cell lysates of SW480 cells, transiently transfected with Mock 
(Transfection reagent-treated cells), PI3K-Flag, EYFP, Surv, ′∆BIR, S20D, W67A and S20D-W67A 
expression constructs as depicted in the figure, were isolated one hour after irradiation with 4 Gy. (a) 
The PI3K domain of DNA-PKcs was immunoprecipitated with an anti-Flag antibody and (b) EYFP 
fusion proteins were immunoprecipitated (IP) using an anti-GFP antibody.  Mouse and rabbit mAb 
Isotype controls (IgG) served as controls. Subsequently, EYFP constructs and PI3K domain of DNA-PKcs 
were detected by immunoblotting. β-actin served as a loading control. 
 
4.5. S20 and W67 residues located in the Survivin BIR domain are essential for 3D 
clonogenic radiation survival and DNA repair of SW480 and DLD-1 colorectal 
cancer cells  
In order to investigate a functional involvement of Survivin S20 and W67 residues in the DNA 
damage response, SW480 and DLD-1 colorectal cancer cells were stably transfected with the 
EGFP-fused Survivin mutants. Recombinant protein expression and efficient knockdown of 
endogenous Survivin were confirmed by immunoblotting (Figure 18). Then, 3D colony 
formation assays were performed by using SW480 and DLD-1 cells stably expressing Surv.wt 
or Survivin mutant constructs which were subjected to siRNA-mediated knockdown of 
endogenous Survivin. SW480 colorectal cancer cells expressing W67A, S20D-W67A, and ∆BIR 
mutant Survivin failed to rescue 3D clonogenic radiation survival while compared to the other 
mutants S20D displayed a weak but significant effect (Figure 19a). However, for the DLD-1 
colorectal cancer cells all the mutations (S20D, W67A, S20D-W67A, and ∆BIR) resulted in 
significant radiosensitization (Figure 20a). These findings identify the S20 and W67 residues 
located in the BIR domain as important mediators of Survivin-dependent radiation survival. 
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Representative pictures of 3D colonies showing the radiosensitization effect are depicted in 
Figure 19b and 20b.  
 
 
Figure 18. Recombinant protein expression of Survivin wt/mutant fusion proteins in SW480 and 
DLD-1 colorectal cancer cells. SW480 and DLD-1 cells, stably transfected with EGFP, Surv.wt, ′∆BIR, 
S20D, W67A and S20D-W67A expression constructs in both control siRNA (siCtrl) and Survivin siRNA 
(siSurv) conditions were immunoblotted. Detection was performed by anti-GFP antibody (first blots for 
both cell lines) and anti-Survivin antibody (second blots for both cell lines). β-actin served as a loading 
control. 
 
Next, the impact of Survivin ∆BIR, S20D, W67A and S20D-W67A mutants on DNA DSB repair 
capacity was analyzed. Residual DNA damage in SW480 and DLD-1 3D cell cultures was 
significantly increased upon knockdown of endogenous Survivin in EGFP, ′∆BIR, W67A, and 
S20D-W67A expressing cells while S20D expressing cells exhibited a non-significant increase, 
as evaluated by the assessment of ′γH2AX/53BP1 foci at 24 h after irradiation with 2 Gy. In 
contrast, overexpression of Surv. wt rescued DNA repair following the knockdown of 
endogenous Survivin (Figure 21a and 22a). Representative pictures of SW480 3D colorectal 
cancer cells show the DNA repair effect of experimental conditions (Figure 21b). 
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Figure 19. Mutation of W67A, S20D-W67A and ∆BIR deletion radiosensitize  3D-cultured SW480 
colorectal cancer cells. (a) Clonogenic radiation survival of EGFP, Surv. wt, ′BIR, S20D, W67A, and 
S20D-W67A mutant-expressing SW480 3D cells after knockdown of endogenous Survivin (siSurv) or 
control siRNA (siCtrl) transfected cells were measured after irradiation with 0, 2, 4 or 6 Gy (single 
dose) using a 3D colony forming assay. Results represent means ± SD (n ≥ 3; * p < 0.05; ** p < 0.01; 
*** p < 0.001; t-test). (b) Representative pictures of 3D SW480 cell colonies (Axio Observer Z1; 10x 
objective). Scale bar: 100 µm. 
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Figure 20. S20D, W67A, S20D-W67A and ∆BIR deletion mutant radiosensitize 3D-cultured DLD-1 
colorectal cancer cells. (a) Clonogenic radiation survival of the EGFP, Surv. wt, ′BIR, S20D, W67A 
and S20D-W67A mutant-expressing DLD-1 3D cells after knockdown of endogenous Survivin (siSurv) 
or control siRNA (siCtrl) transfected cells were measured after irradiation with 0, 2, 4 or 6 Gy (single 
dose) using a 3D colony-forming assay. Results represent means ± SD (n ≥ 3; * p < 0.05; ** p < 0.01; 
*** p < 0.001; t-test). (b) Representative pictures of 3D DLD-1 cell colonies (Axio Observer Z1; 10x 
objective). Scale bar: 100 µm. 
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Figure 21. W67A, S20D-W67A mutation and ∆BIR deletion hamper the radiation-induced DNA 
repair in 3D-cultured SW480 colorectal cancer cells. (a) SW480 cells, stably expressing indicated 
Survivin mutants were subjected to siRNA transfection (siCtrl, non-specific control siRNA; siSurv, 
Survivin siRNA) and subsequently irradiated with 2 Gy. At 24 h after irradiation, cells were fixed and 
stained for γH2AX/53BP1 while nuclei were counterstained with DAPI. Nuclear γH2AX/53BP1 foci 
were microscopically counted (50 nuclei per experiment). Results represent mean foci per cell ± SD (n 
≥ 3; *** p < 0.001; t-test). (b) Representative microscopic pictures of foci detection 24 h after 2 Gy 
irradiation of 3D SW480 cells under indicated conditions (Zeiss Axio Imager A1; 63x objective). Scale 
bar: 5 µm. 
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Figure 22. W67A single, S20D-W67A double mutation and ∆BIR deletion hamper the radiation-
induced DNA repair in 3D-cultured DLD-1 colorectal cancer cells. DLD-1 colorectal cancer cells, 
stably expressing indicated Survivin mutants were subjected to siRNA transfection (siCtrl, non-specific 
control siRNA; siSurv, Survivin siRNA) and subsequently irradiated with 2 Gy. At 24 h after irradiation, 
cells were fixed and stained for γH2AX/53BP1 while nuclei were counterstained with DAPI. Nuclear 
γH2AX/53BP1 foci were microscopically counted (50 nuclei per experiment). Results represent mean 
foci per cell ± SD (n ≥ 3; *** p < 0.001; t-test). 
 
4.6. Molecular docking and molecular dynamics simulations suggest a 
heterotetramer complex of Survivin-DNA-PKcs interaction 
Given that the previous docking approach (~150 poses, Figure 12) indicate two prominent 
poses, placing S20 and W67 in close proximity to the PI3K region of DNA-PKcs, next an 
extended interaction analysis in a broader scale docking (~100k poses) was performed. By 
this, the minimum distance 6789 = *+: | − | :   ∈ B=8>? ,  ∈ BCDB@	between any docked 
Survivin BIR domain and the entire PI3K region atoms was calculated. Here B=8>? is the 
collection of atom coordinates from the PI3K site and BCDB is the collection of atom 
coordinates from the docked Survivin BIR domain. The minimum distance between any of 
these atoms covers a sensible distance measure for examining if and what extent these 
domains touch. 
The two-dimensional histograms indicate the distribution of the molecular distances and 
interface scores of large-scale molecular docking data between the Survivin BIR domain and 
PI3K domain of DNA-PKcs (Figure 23a, 23b). Histograms revealed the existence of two 
clusters concentrated on 20 to 40 Å (Figure 23a), and 1 to 2 Å (Figure 23b) distances. The 
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second cluster (Figure 23b) suggests the potential binding between the BIR and the PI3K 
domains. According to the preliminary molecular in silico approach and experimental findings 
in Figure 12, 16 and 17, respectively, large-scale global docking results were filtered for 
spatial proximity of S20 and W67 residues of Survivin to the PI3K domain of DNA-PKcs. Two 
differing states were found for S20 and W67, showing different configurations and 
orientations towards the PI3K domain (between 3747-4015 residues), while for geometrical 
constraints, it is not possible to fulfil both poses at the same time. Thus, a heterotetramer 
hypothesis was generated covering a structure requiring Survivin monomers within the dimer 
to interact with two head domains of DNA-PKcs by the help of S20 and W67 residues, which 
fulfils the spatial constraints (Figure 23c). The generated heterotetramer structure also 
incorporates an interface between the FKBP-rapamycin-binding (FRB) (between 3540-3746 
residues, located between FAT and PI3K domains) and FAT (between 2906-3539 residues) 
domains of two head domains independent of Survivin binding (head-dimer). To 
experimentally confirm the live-cell occurrence of the predicted heterotetramer complex 
interaction, a FACS-FRET assay was employed. Briefly, SW480 cells were co-transfected with 
ECFP and EYFP fusion constructs of recombinant PI3K domain under different conditions, 
additional transfection of mock, control siRNA, Survivin siRNA or Survivin-Flag construct 
respectively. The PI3K domain indicates a clear dimerization in mock as well as control siRNA 
transfected conditions while the condition with Survivin siRNA did not show changes. Most 
importantly, Survivin overexpression (Survivin-Flag construct transfected) revealed a 
significant enhancement of ~40% on the dimerization of the PI3K domain of DNA-PKcs 
(Figure 23d). Furthermore, as mentioned before, it was observed by the in silico approach 
that dimerization of the PI3K domain without Survivin (head-dimer) was well-fitting to the 
FRB – FAT interface. These findings suggested that the heterotetramer can be produced by 
Survivin binding to a pre-existing DNA-PKcs dimer. 
To confirm the energetic suitability of the heterotetramer structure, three individual 
molecular dynamics simulations were performed on heterotetramer, head-dimer and a 
reference model. All simulations are illustrated as animations in the weblinks given at Section 
3.2.8. The head-dimer produced by deletion of Survivin from the heterotetramer structure 
consisted of two head domains interacting via the FRB and FAT regions. The reference model 
covers the result of an in-silico docking of two identical sites within DNA-PKcs, known as the 
FRB Domain. Since the FRB domain is a small sub-domain not located within the PI3K region, 
which was concluded that potential structural changes due to kinase dimerization cannot be 
observed in this model. The heterotetramer convergence in RMSD was observed for both head 
domains (Chain A and D) after ~50ns, although Chain A stabilized much faster (Figure 24a). 
The reference model showed a different behaviour compared to the other two models in both, 
RMSD and radius of gyration in the case of chain D (Figure 24a, 24b). The RMSD was stable 
for Survivin Chain B where S20 was in proximity to the PI3K domain (Figure 24c). In 
particular, Survivin Chain C, where W67 was in proximity to the PI3K domain, shows 
deviations between 30ns – 80ns for both RMSD and radius of gyration, suggesting potential 
structural changes (Figure 24c, 24d). The RMSD and radius of gyration results of the head-
dimer were essentially identical to the heterotetramer for both head domains (Chain A and 
D).  
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Figure 23. In silico molecular docking results in a DNA-PKcs – Survivin – DNA-PKcs 
heterotetramer complex. (a) Two-dimensional distribution for distance to active site 6FG [Å] for any 
BIR atom in poses, versus interface score G&$, quantifying the quality of docking poses. (b) Next to the 
region where BIR domain atoms are at least within 20 Å of the PI3K domain (6FG	≤ 20), is shown to 
emphasize the BIR – PI3K interaction. (c) Filtering the large-scale docking results unravelled two 
docking poses. Aligning these poses on Survivin minimizes the distance between residues W67, S20 
and the PI3K domain in DNA-PKcs. This results in the constitution of a heterotetramer complex whose 
constituents are Chain A head domain (green), Chain B Survivin (cyan), Chain C Survivin (purple), 
Chain D head domain (yellow), PI3K domains of both head domains (white), and active sites (red) 
depicted in relevant colors. (d) Experimental confirmation of the heterotetramer complex interaction 
assayed by FACS-FRET methodology. Briefly, SW480 cells were co-transfected with ECFP and EYFP 
fusion constructs of recombinant PI3K domain under different conditions by additional transfection of 
mock, control siRNA, Survivin siRNA, or Survivin-Flag construct respectively. Survivin overexpression 
was significantly enhanced, while knockdown of endogenous Survivin was not hampering the 
dimerization of PI3K domain. Results represent mean ± SD (n = 4; * p < 0.05; ** p < 0.01; *** p < 
0.001; t-test)  
 
The particle density for Chain A of the reference model was almost constant, while Chain D 
exhibited a downward trend after 50ns suggesting a partial opening of active site cavity. The 
head dimer showed a downward trend till ~150ns and shows a favourable opening of the 
active site for both chains. The heterotetramer exhibited far greater surface accessibility for 
chain D, while density for chain A was almost constant (Figure 25a). Particularly active site 
region of heterotetramer structure Chain D (green line) was clearly diverging (Figure 25a) 
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and resulted in a more accessible active site region (red in Figure 25b and 25c) at the 
simulation end (Figure 25c) compared to the beginning (Figure 25b).  
 
 
Figure 24. RMSD and radius of gyration of heterotetramer complex are predominantly stable 
over the molecular dynamics simulation. (a) RMSD atomic position and (b) radius of gyration 
analyses during the MD simulations of heterotetramer (red), head dimer (blue), and reference model 
(orange) structures over the course of 200 ns simulation time. (c) RMSD atomic position and (d) radius 
of gyration analyses during the MD simulations of Survivin chain B (red) and chain C (blue) structures 
over the course of 200 ns simulation time.   
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Figure 25. Particle density analysis revealed a heterotetramer complex with increased 
accessibility for the active site of the PI3K domain. (a) Particle density analysis of the atoms located 
above the active site region of PI3K domain for both chains A (orange) and D (green). (b) Visualization 
of the energy minimized and equilibrated heterotetramer at the start of MD simulation revealed 
relatively closed active site cavity, (c) while it became more accessible at the end of the simulation, 
(Colors: Chain A head domain (green), Chain B Survivin (cyan), Chain C Survivin (purple), Chain D 
head domain (yellow), PI3K domains of both head domains (white) and active sites (red)). 
 
4.7. Survivin enhances the kinase activity of DNA-PKcs 
To quantify the effect of Survivin binding on the kinase activity of DNA-PKcs, an in vitro 
methodology by modifying the SignaTECT DNA-Dependent Protein Kinase Assay System was 
designed. Stably EGFP or EGFP-tagged Survivin expressing SW480 cells were depleted for 
endogenous Survivin by siRNA-treatment. Next, immunoprecipitations were performed by 
using GFP antibody and densitometrically equal amounts of proteins were added into the 
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kinase reactions. Radioactive phosphor-quantification results indicate that the presence of 
Surv.wt significantly increased the kinase activity ~45% (Figure 26). 
 
Figure 26. Survivin enhances the kinase activity of DNA-PKcs. Effect of Survivin on the kinase 
activity of DNA-PKcs was assayed by using the SignaTECT DNA-Dependent Protein Kinase Assay System 
and purified DNA-PK. SW480 cells stably expressing EGFP or Surv-EGFP were subjected to Survivin 
siRNA transfection and subsequently irradiated with 4 Gy. At 1 h after irradiation, cells were lysed and 
immunoprecipitation was performed with an EGFP antibody or IgG rabbit antibody. Densitometrically 
equal amounts of immunoprecipitated proteins were added to in vitro DNA-PKcs kinase reaction tubes 
and after kinase reaction probed to the membrane (provided by the kit) and exposition quantified with 
a Phosphoimager. Results represent means ± SD (n≥4; * p < 0.05; ** p < 0.01; *** p < 0.001; t-test 
vs. EGFP), (Abbreviations: Pos. control, DNA-PK + substrate peptide; IgG control, DNA-PK + substrate 
peptide + IgG pull-down; EGFP, DNA-PK + substrate peptide + EGFP pull-down; Surv. wt, DNA-PK + 
substrate peptide + Surv. wt pull-down; DNA-PK Inh., DNA-PK + substrate peptide + DNA-PK inhibitor 
(1µM); Neg. control, DNA-PK). 
 
4.8. Phosphoproteomics and proteomics approaches revealed post-translational 
phospho-regulatory and translational expression-regulatory functions of 
Survivin-DNA-PKcs interaction 
Due to the enhanced kinase activity of DNA-PKcs in the presence of Survivin in the in vitro 
kinase reaction, next a putative regulatory function of Survivin on the phosphorylation status 
of the substrates of DNA-PKcs was addressed by performing LC-MS2 and LC-MS3 
phosphoproteomics and proteomics analyses, respectively. The experimental setup consists of 
five conditions such as DNA-PK inhibitor treatment (DNA-PK inh.), mock (siCtrl), endogenous 
Survivin knockdown (siSurv), EGFP overexpression (EGFP), and Survivin-EGFP 
overexpression (Surv-EGFP), accompanied by control siRNA or Survivin siRNA treatments. For 
the evaluation of experimental setup conditions, we have defined three comparison 
conditions, DNA-PK inh. vs. siCtrl, siSurv vs. siCtrl, and Surv-EGFP vs. EGFP (Figure 27). To 
classify the regulatory effect, we have defined two hypotheses by applying certain Log2 fold 
change thresholds, naming as direct or inverse (inverse is for proteomics) effect. In the direct 
effect hypothesis, an increased phosphorylation/expression of phosphosites/proteins upon 
overexpression of Survivin and decreased phosphorylation/expression upon endogenous 
Survivin knockdown and DNA-PK inhibitor treatment was expected. In contrast, for the 
inverse effect hypothesis, a decreased expression of proteins upon overexpression of Survivin 
and increased expression upon endogenous Survivin knockdown and DNA-PK inhibitor 
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treatment was expected. For the direct effect mechanism, Log2 fold change thresholds were 
set as [≤ -0.25], [≤ -0.25], and [≥ 0.25] for DNA-PK inh. vs. siCtrl, siSurv vs. siCtrl, and Surv-
EGFP vs. EGFP evaluation conditions, respectively. For the inverse mechanism, Log2 fold 
change thresholds were defined as [≥ 0.25], [≥ 0.25], and [≤ -0.25] for DNA-PK inh. vs. siCtrl, 
siSurv vs. siCtrl, and Surv-EGFP vs. EGFP evaluation conditions, respectively. 
 
 
Figure 27. Schematic representation of the experimental setup and workflow of 
phosphoproteomics and proteomics analyses. Briefly, SW480 colorectal cancer cells, including EGFP 
and Surv-EGFP stably expressing cells, were transfected with control siRNA or Survivin siRNA. For 
DNA-PK inhibitor conditions, cells were further treated with DNA-PK inhibitor (1 h before irradiation). 
All cultures were irradiated with 4 Gy. At 1 h after irradiation, cells were harvested, lyzed, and samples 
were prepared for MS analyses. Subsequently, phosphoproteomics –LC-MS2– and proteomics –LC-
MS3– analyses were performed and evaluations were carried out considering three comparisons: DNA-
PK inh. vs. Ctrl, siSurv vs. Ctrl, Surv-EGFP vs. EGFP. Two independent experiments have been 
performed.  
 
4.8.1.  Phosphoproteomics analysis 
Evaluation conditions yielded over 16 thousand phosphosites, which clustered by hierarchical 
clustering method with default Euclidean distance. The analysis revealed a similar clustering 
of the evaluation conditions of both separate experiments (Figure 28).   
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Figure 28. Hierarchical clustering of phosphoproteomics conditions. LC-MS2 quantification of 
TMT-labeled, phospho-enriched, and fractionated phospho-peptides revealed a similarly clustered 
differential phosphorylation profile of phosphosites. Computation of Z scores are derived from the 
centered data by dividing by the standard deviations.  
 
All phosphosites were next displayed in a volcano plot by setting Log2 fold change thresholds 
of effect mechanisms of siSurv vs. siCtrl and Surv-EGFP vs. EGFP evaluation conditions 
(Figure 29a). The qualified portion of regulated phosphosites (orange-colored in Figure 29a) 
were used as input for another volcano plot distribution to also consider the effect of DNA-PK 
inhibitor by setting Log2 fold change thresholds of effect mechanism of DNA-PK inh. vs. siCtrl 
evaluation condition (Figure 29b). 
The second-step qualified portion of regulated phosphosites (orange-colored in Figure 29b) 
were normalized with the related proteome data, then fold changes were represented in a 
heatmap graph (Figure 30a). Pathway analysis of regulated phosphosites revealed 
predominant involvement in DNA damage/repair, as well as in chromosome organization, cell 
cycle, (post)-transcriptional regulation, apoptosis, adhesion and ion transport (Figure 30b). 
Particularly, FOXO3 is one of the notable candidates which has both direct (Shiga et al., 
2020) and indirect (Barragan et al., 2006; Carew et al., 2011; Chen et al., 2007b; Haque et 
al., 2015; Niedan et al., 2014; Singh et al., 2010; Zheng et al., 2000) relationships with DNA 
damage/repair and DNA-PKcs. For validation purposes, the phosphorylation status of FOXO3 
S253 residue was analysed by western immunoblot. Data given in Figure 31 indicate that in 
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response to Survivin overexpression, the phosphorylation status of FOXO3 S253 was 
increased by 64% compared to EGFP control while in response to DNA-PK inhibitor treatment, 
the phosphorylation was decreased by 55% compared to siCtrl conditions in SW480 cells. 
These findings suggested that particularly an increase in the phosphorylation status of FOXO3 
S253 residue was both Survivin and DNA-PK activity-dependent while a decrease was 
Survivin-independent. 
 
 
 
 Figure 29. Qualification of phosphoproteomics candidates. (a) Analysis of directly (orange) 
regulated hits by setting Log2 fold change cut-offs as follows: [≥ 0.25] for Surv-EGFP vs. EGFP, [≤ -
0.25] for DNA-PK inh. vs. siCtrl and siSurv vs. siCtrl conditions by comparative distribution 
representations of the status of phosphosites as Volcano plot graphics. (b) Qualified phosphosites 
(orange-colored in Figure 29a) were used as input for further analysis to consider also the effect of 
DNA-PK inhibitor. Results represent mean Log2 fold change value (n=2). 
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Figure 30. Regulated final candidate phosphosites. (a) The final set of regulated phosphosites 
(orange-colored in Figure 29b) were normalized with proteome data then presented by two heatmap 
graphs; first with high Log2 fold change cut-offs [≤ -0.5], [≤ -0.5] and [≥ 0.5], second with low Log2 
fold change cut-offs [≤ -0.25], [≤ -0.25] and [≥ 0.25] for DNA-PK inh. vs. siCtrl, siSurv vs. siCtrl and 
Surv-EGFP vs. EGFP, respectively. (b) Pathway analysis by considering Pathway Commons 
(https://www.pathwaycommons.org) terms and related individual studies from literature. 
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Figure 31. Western immunoblotting verification of FOXO3 S253 residue phosphorylation. Western 
immunoblotting revealed decreased phosphorylation of FOXO3 S253 residue in response to DNA-PK 
inhibitor and increased phosphorylation in response to Survivin overexpression in SW480 cells. 
(Abbreviations: DNA-PK inh, control siRNA + DNA-PK inhibitor treated (1µM). siCtrl, control siRNA 
treated. siSurv, Survivin siRNA treated. EGFP, Survivin siRNA + EGFP overexpression treated. Surv-
EGFP, Survivin siRNA + Survivin-EGFP overexpression treated). Densitometric analysis performed by 
Analysis module of LI-COR Image StudioTM Software ver. 5.2.5. 
Next, regulated phosphosites (Figure 30a) were further analyzed for a potential consensus 
phosphorylation motif and for this purpose, amino acid sequence profile alignment and 
weighted logo generator Seq2Logo 2.0 Server (http://www.cbs.dtu.dk/biotools/Seq2Logo/) 
was employed. Consensus motif analysis of phosphosites revealed high conservation of S/T-
Hydr motifs (hydrophobic residues: G, A, V, L, I, P, F, M, W) with 60.5%, particularly high 
conservation on S/T-P motif with 33.3% including FOXO3 S253, flna/Filamin-A T2336. 
Interestingly, the well-known DNA-PKcs phosphorylation motif S/T-Q was conserved only in 
1.2% (Figure 32). Besides, in addition to the well-known consensus phosphorylation motif 
(S/T-Q), the enrichment of S/T-P motif was also previously found in response to DNA damage 
(Bennetzen et al., 2010).  
 
Figure 32. Consensus motif analysis of final candidate phosphosites revealed a highly conserved 
S/T-P motif. Bits states the information content units as the weighted prevalence frequency of 
indicated motif generated by Seq2Logo. The input motifs were used from the hits in Figure 30a. 
Generation of logo based on ‚Probability Weighted Kullback-Leibler´ logo type and Hobohm algorithm 
for sequence weighting type). 
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4.8.2.  Proteomics analysis 
Proteomics analyses performed in parallel to the phosphoproteomics assessment as reported 
before revealed differential expression of proteins in response to Survivin overexpression as 
well as Survivin knockdown and DNA-PK inhibitor treatment. Evaluation conditions yielded 
over 7 thousand peptides/proteins which clustered by the hierarchical clustering method with 
default Euclidean distance. The analysis revealed a similar clustering of the evaluation 
conditions of both experiments (Figure 33). 
 
Figure 33. Hierarchical clustering of proteomics conditions. LC-MS3 quantification of TMT-labeled 
and fractionated peptides revealed a similarly clustered differential expression profile of proteins. 
 
All proteins were distributed in a volcano plot, and sorted by setting Log2 fold change 
thresholds of directly and inversely regulated proteins of siSurv vs. siCtrl and Surv-EGFP vs. 
EGFP conditions (Figure 34a). The qualified portion of directly (orange-colored in Figure 
34a), and inversely (purple-colored in Figure 34a) regulated proteins were used as input for a 
volcano plot distribution to consider the effect of DNA-PK inhibitor by setting Log2 fold 
change thresholds of DNA-PK inh. vs. siCtrl evaluation condition (Figure 34b). 
Next, the fold changes of the second-step qualified portion of regulated proteins were 
represented in two separate heatmap graphs as directly (Figure 35a) and inversely (Figure 
35b) regulated final candidate proteins. Notably, both directly and inversely regulated 
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candidate proteins are predominantly involved in DNA damage/repair (labeled with asterisk 
(*), Figure 35). 
It was previously shown that DNA-PKcs has a remarkable modulatory function on gene 
expression of proteins via regulating transcription (Goodwin et al., 2015; Woodard et al., 
1999). However, there was no clear statement about the role of the activity of DNA-PKcs on 
transcriptional regulation except a study which suggested a potential limited gene-specific 
transcriptional regulatory function may depend on the activity of DNA-PKcs (Bryntesson et al., 
2001). According to our findings, the activity of DNA-PKcs seems to have an expressional 
regulatory role on a variety of proteins. The directly regulated proteins (Figure 35a) mainly 
involved in DNA damage/repair including proteins like cell division cycle associated 2 
(cdca2/Repo-Man) (Peng et al., 2010), regulator of sister chromatid separation 
(pttg1/Securin) (Mjelle et al., 2015), sumo specific peptidase 5 (SENP5) (Jin et al., 2016), 
stimulated by retinoic acid gene 13 protein (STRA13) (Thin et al., 2007), and DNA 
topoisomerase II alpha (TOP2A) (de Campos-Nebel et al., 2010; Morimoto et al., 2019). 
Particularly, cdca2/Repo-Man plays a role in ATM activation (Peng et al., 2010), while SENP5 
is involved in ATRIP inhibition (Jin et al., 2016) that suggest potential inhibitory roles of 
Survivin and DNA-PKcs on ATM and ATR-dependent pathways via regulating the expressions 
of cdca2/Repo-Man and SENP5. 
 
Figure 34. Qualification of proteomics candidates. (a) Analysis of directly (orange) and inversely 
(purple) regulated hits by setting Log2 fold change cut-offs as followed: Directly regulated hits, [≥ 0.25] 
for Surv-EGFP vs. EGFP, [≤ -0.25] for DNA-PK inh. vs. siCtrl and siSurv vs. siCtrl; inversely regulated 
hits, [≤ -0.25] for Surv-EGFP vs. EGFP, [≥ 0.25] for DNA-PK inh. vs. siCtrl and siSurv vs. siCtrl 
conditions by comparative distribution representations of the status of expression as Volcano plot 
graphics. (b) Qualified proteins (orange and purple colored in Figure 34a) used as input for further 
qualification to consider also the effect of DNA-PK inhibitor. Results represent mean Log2 fold change 
value (n = 2). 
 
Interestingly, the inversely regulated proteins (Figure 35b) such as HIRA interacting protein 3 
(HIRIP3), retinoblastoma binding protein 8 (rbbp8/CtIP), high mobility group at-hook 
(HMGA) and high mobility group nucleosome binding domain (HMGN) family members 
(HMGA1, HMGA2, HMGN1, HMGN2 and HMGN5) are reported to be involved in DNA 
damage/repair. Studies revealed their particular involvement in HR and ATM/ATR dependent 
pathways (Adamson et al., 2012; Hoa et al., 2015; Kim et al., 2009; Makharashvili et al., 
2014; Natarajan et al., 2013; Palmieri et al., 2011; Quennet et al., 2011; Singh et al., 2015; 
  
Results 73 
Wang et al., 2018b) that suggest a potential inhibitory regulation role of Survivin and DNA-
PKcs on HR and ATM/ATR dependent pathways. 
 
Figure 35. Directly and inversely regulated candidate proteins. (a) Final set of directly regulated 
proteins (orange-colored in Figure 34b) qualified by Log2 fold change cut-offs [≤ -0.25], [≤ -0.25] and 
[≥ 0.25] for DNA-PK inh. vs. siCtrl, siSurv vs. siCtrl and Surv-EGFP vs. EGFP, respectively, are 
presented as heatmap graph. (b) The final set of inversely regulated proteins (purple colored in Figure 
34b) qualified by Log2 fold change cut-offs [≥ 0.25], [≥ 0.25], and [≤ -0.25] for DNA-PK inh. vs. siCtrl, 
siSurv vs. siCtrl, and Surv-EGFP vs. EGFP, respectively, are presented as heatmap graph. (asterisk (*) 
indicates the involvement in DNA damage/repair). 
 
To specifically focus on the effect of Survivin overexpression and knockdown, we classified 
the qualified proteins by employing a pairwise intersection matrix representation considering 
different cut-off Log2 values. For the directly (orange-colored in Figure 34a) and inversely 
(purple colored in Figure 34a) regulated proteins, Log2 fold changes were determined as low 
[± 0.25], high [± 0.5] and highest [± 1.0] differentially regulated candidate proteins in 
response to Survivin overexpression and Survivin knockdown by representing the Log2 fold 
change levels as heatmap graphs (Figure 36). The proteins directly (Figure 36a) or inversely 
(Figure 36b) regulated by only Survivin are involved in a variety of pathways: Directly 
regulated proteins are predominantly involved in the regulation of apoptosis, cell cycle, and 
DNA damage/repair while inversely regulated proteins participate in transcriptional 
repression, nucleolar reorganization, immune response, motility/invasiveness, and general 
cellular metabolism. 
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Figure 36. Directly and inversely Survivin-dependent regulated final candidate proteins. (a) 
Pairwise intersection matrix classifies directly regulated proteins (orange-colored in Figure 34a) by 
Log2 fold changes as low [± 0.25], high [± 0.5] and highest [± 0.5] differentially expressed proteins in 
response to Survivin overexpression and Survivin knockdown by presenting the differential expression 
levels as heatmap graphs. (b) Pairwise intersection matrix classifies inversely regulated proteins (purple 
colored in Figure 34a) by Log2 fold changes as low [± 0.25], high [± 0.5] and highest [± 0.5] 
differentially expressed proteins in response to Survivin overexpression and Survivin knockdown by 
presenting the differential expression levels as heatmap graphs. 
  
Results 75 
4.9. Virtual screening approach to design an inhibitor aiming to prevent the 
interaction between Survivin and DNA-PKcs 
Finally, analyses were performed to address the question whether Survivin-DNA-PKcs 
interaction is druggable. For that, a global virtual screening approach was performed by 
employing ~8 x 106 drug/drug-like ligands. Evaluation of candidates was based on four 
conditions: Attraction/interaction of ligand directly with S20 or W67 residue (via H-bond, Pi-
Pi stacking, Pi-cation or Salt bridge), Virtual docking score (Extra Precision Glide docking 
score – XP Gscore), KDEEP pKd value –predicted dissociation constant– (ligand binding affinity), 
and ∆G binding free energy. The evaluation revealed a variety of candidate ligands for both 
S20 and W67 residues (Table 11 and 12). The top candidates for both S20 and W67 were 
used as representative figures (Figure 37 and 38). The surface of S20 and neighbouring 
residues is topologically less compatible for docking than the surface of W67 and 
neighbouring residues. This major restriction caused a limitation on the number of potential 
candidates and increased the XP Gscore for S20 targeting ligands. For this reason, the XP 
Gscore thresholds were set to ≤ -5.000 for S20, and ≤ -9.000 for W67. For S20 residue, M-
000-631-284 labeled ligand was exhibiting the best XP GScore/pKd/∆G relative performance 
and hydrogen bonding directly with S20 residue (Figure 37). And for W67 residue, M-005-
139-808 labeled ligand was displayed the best XP GScore/pKd/∆G relative performance and 
generated a direct Pi-cation attraction with W67 residue (Figure 38). Evaluation values 
suggest both candidates (Molport repository - M-000-631-284 and M-005-139-808 ligands) 
promise the potentials to target the related regions on Survivin efficiently. 
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Figure 37. Docking of M-000-631-284 ligand into the S20 structural cavity. (a) Docking pose of 
Survivin and M-000-631-284 ligand as surface representation. The image was taken by Chimera version 
1.14rc (Pettersen et al., 2004). (b) Direct hydrogen bonding between Survivin residues S20, K23 and 
M-000-631-284 ligand. The image was taken by Ligand Interaction Diagram - Maestro version 11.5 of 
Schrödinger Release 2018-1. 
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Figure 38. Docking of M-005-139-808 ligand into the W67 structural cavity. (a) Docking pose of 
Survivin and M-005-139-808 ligand as surface representation. The image was taken by Chimera version 
1.14rc (Pettersen et al., 2004). (b) Multiple attraction and direct interactions (Hydrogen bonds, Pi-
cation attractions, and Salt bridges) between Survivin residues E51, E63, E65, W67, D71, E76 and M-
005-139-808 ligand. The image was taken by Ligand Interaction Diagram - Maestro version 11.5 of 
Schrödinger Release 2018-1. 
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5. Discussion 
 
5.1. Radiation resistance role of Survivin BIR domain 
The IAP family consists of eight members which all contain BIR domains mainly located in the 
N-terminal region (Oberoi-Khanuja et al., 2013; Srinivasula and Ashwell, 2008). Previously it 
was found that some of the members of IAP directly or indirectly play a role in the DDR and 
genetic instability (Ge et al., 2015; Hinz et al., 2010).  
 The activation of signal transduction pathways by ionizing radiation to induce DNA damage 
repair and regulate cell cycle progression/arrest and cell death is the main feature of the 
cellular radiation response (Dent et al., 2003). As there is substantial evidence for the 
involvement of Survivin in all of these pathways in line with a pronounced overexpression in 
tumor cells, Survivin is reported to be associated with a radiation-resistant phenotype. 
Moreover, Survivin has been recognized as a radiation-inducible factor (Badura et al., 2012; 
Rodel et al., 2003) clinically associated with an unfavorable prognosis, metastasis and 
resistance to conventional radiation or chemoradiation therapy in a multitude of tumors 
(Rodel et al., 2012; Sprenger et al., 2011). The complexity and molecular basis of Survivin’s 
impact on radiation response, however, remains to be elucidated as it includes caspase-
dependent as well as caspase-independent mechanisms (Chakravarti et al., 2004; Rodel et al., 
2005; Rodel et al., 2011). 
 A radiosensitization of tumor cells analyzed by conventional 2D culture assays has been 
reported following attenuation of Survivin (Chakravarti et al., 2004; Iwasa et al., 2008; Rodel 
et al., 2005). There is, however, compelling evidence that tumor cell growth in extracellular 
matrix most pronounced under 3D cell culture conditions has an impact on radiation response 
due to altered gene expression, proliferation and survival (Hehlgans et al., 2008; Roskelley et 
al., 1994; Zschenker et al., 2012). 
Survivin contains a single BIR domain which has been reported to be a protein interaction 
hub and mediates protein-protein interactions with multiple proteins including caspases, 
kinases, histones and chaperones. Besides, the extended amphipathic α-helical coiled-coil 
domain at the C-terminus predominantly mediates the interactions with microtubule-
associated proteins (LaCasse et al., 1998; Verdecia et al., 2000). Our initial studies have 
analyzed the effect of Survivin domain deletion mutants on radiation response in 3D 
clonogenic assays that may reflect a physiological environment more closely than 
conventional 2D cultures (Eke et al., 2013; Storch et al., 2010). Under these conditions, cells 
stably expressing recombinant Survivin with a deletion of the BIR domain were significantly 
radiosensitized while the expression of Survivin mutants lacking the microtubules domain 
fully rescued radiation survival following siRNA-mediated knockdown of endogenous Survivin 
(Petraki, 2014). That suggested that the presence of the BIR domain (residues 18-88) is of 
pivotal importance for long term clonogenic radiation survival, whereas the microtubules 
domain does not seem to be involved. 
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5.2. Is the Survivin BIR domain a kinase/kinase-domain binding region? 
The corroborative findings by initial global blind molecular docking analysis of Survivin and 
DNA-PKcs revealed predominant involvement of the BIR domain in the interaction with the 
PI3K domain of DNA-PKcs (Figure 12). In line with the potential interaction with the PI3K 
domain of DNA-PKcs, Survivin was previously found to directly interact with a variety of 
kinases/kinase domains such as Aurora kinase C, polo like kinase 1 (PLK1), cell division cycle 
2 (CDC2), cyclin-dependent kinase 4 (CDK4) and Aurora kinase B (Chen et al., 2003; 
Colnaghi and Wheatley, 2010; O'Connor et al., 2000; Sasai et al., 2016; Suzuki et al., 2000). 
Particularly, the N-terminal region of Survivin, 1-90 residues –containing the BIR domain-, 
was found to more strongly co-immunoprecipitate with PLK1 compared to full-length 
Survivin, while N-terminal truncated Survivin, 98-142 residues –containing the Microtubules 
domain- was comparable with glutathione S-transferase (GST) negative control (Colnaghi and 
Wheatley, 2010). Additionally, Survivin was found to co-immunoprecipitate with the kinase 
domain of Aurora kinase B. Notably, the presence of Survivin in an in vitro Aurora kinase B 
kinase assay enhanced the kinase activity and increased the phosphorylation of Histone H3. 
Furthermore, siRNA-mediated knockdown of Survivin suppressed the phosphorylation of 
Histone H3 (Chen et al., 2003). In the light of these findings and our previous studies 
revealing a direct and kinase regulatory interaction of Survivin with DNA-PKcs (Capalbo et al., 
2010; Reichert et al., 2011), we investigated the sequence specific interaction of Survivin with 
the different domain/regions of DNA-PKcs by employing FACS-FRET methodology. Our 
findings confirmed that the BIR domain of Survivin directly interacts with the PI3K domain of 
DNA-PKcs (Figure 13 and 14). Likewise, via immunoprecipitation analysis we observed that 
Survivin lacking the BIR domain does not co-immunoprecipitate with DNA-PKcs (and vice 
versa) in contrast to Surv. wt (Figure 14). Nevertheless, further investigations are needed to 
decipher the molecular and functional relationships of Survivin with the PI3K domain of DNA-
PKcs and downstream kinases. However, considering all findings, it is conceivable that the 
BIR domain functions predominantly as kinase/kinase domain binding region of Survivin.  
 
5.3. Involvement of the S20 and W67 residues of BIR domain in clonogenic radiation 
survival and DNA repair 
Recent data demonstrate that nuclear accumulation of Survivin following irradiation and 
interaction with components of the DNA repair machinery like DNA-PKcs, KU70 and 53BP1 
may comprise a further mechanism of Survivin-mediated radiation resistance mediated by 
regulation of DNA-PKcs kinase activity (Capalbo et al., 2010; Reichert et al., 2011; Wang et 
al., 2018c). In that context, knockdown of Survivin resulted in elevated numbers of DNA DSBs 
as measured by single cell gel electrophoresis (comet assay) (Chakravarti et al., 2004; 
Reichert et al., 2011) and increased phospho-histone-γH2AX foci detection in irradiated cells 
(Capalbo et al., 2010; Iwasa et al., 2008; Rodel et al., 2005; Wang et al., 2018c). Initial 
studies of our group demonstrated that SW480 cancer cells stably expressing the Survivin 
∆BIR mutant were significantly radiosensitized upon knockdown of endogenous Survivin and 
also exhibited an increased number of residual γH2AX foci as compared to overexpression of 
Surv. wt and ∆MicTub constructs after irradiation with 2 Gy (Petraki, 2014). 
 A variety of different Survivin amino acids, which were determined as potential interaction 
sites by our initial global blind molecular docking analysis, and the known phosphorylation 
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sites were subjected to FACS-FRET analysis to investigate the interaction potential of Survivin 
and PI3K domain of DNA-PKcs on amino acids level. S20D, F27A, C31A, D53A and W67A 
from predicted sites and T34A and T34D from phosphorylation sites showed significant 
decrease in the interaction (Figure 16a and 16b). By further performing a variety of different 
double/triple mutant combinations, the S20D-W67A double mutant revealed the most 
significant decrease with about 70% diminution of binding (Figure 16c). Moreover, the 
importance of S20 and W67 on the interaction of Survivin with the PI3K domain of DNA-PKcs 
was verified additionally in DLD-1 and HCT-15 colorectal cancer cells (Figure 16d and 16e). 
In line with that, S20 and W67 amino acids of Survivin were among the top candidates 
according to ∆G binding free energy ranking in molecular docking analyses further suggesting 
a potential involvement in the interaction (Figure 12a). Moreover, in silico S20D and W67A 
mutagenesis resulted in a greater distance between interaction amino acid backbones/side 
chains and decreased the hydrogen bonding potential, which can be interpreted as a potential 
decrease in the interaction (Figure 12b). Further, co-immunoprecipitation validation of the 
most promising amino acid findings in FACS-FRET analysis clearly indicated that deletion of 
BIR domain completely disrupted the interaction while S20D, W67A, and S20D-W67A double 
mutant also showed a marked decrease in the interaction (Figure 17a and 17b). These data 
confirm the previous findings and support the contribution of specific amino acids located in 
the BIR domain of Survivin to the interaction with the PI3K domain of DNA-PKcs.     
 Furthermore, we focused on S20 and W67 amino acids of Survivin with respect to clonogenic 
radiation survival and DNA repair in 3D grown colorectal cancer cells. SW480 and DLD-1 
colorectal cancer cells overexpressing the phospho-mimicking form of S20D were showing less 
radiosensitization while alanine substitution of W67A, S20D-W67A double mutant and BIR 
deletion displayed a significant radiosensitizing effect upon endogenous Survivin knockdown. 
By contrast, Surv.wt rescued the radiation survival of SW480 and DLD-1 colorectal cancer 
cells following attenuation of endogenous Survivin (Figure 19 and 20). These results 
strengthen the notion that mutations of these amino acids are important for the interaction 
with PI3K domain of DNA-PKcs and impact on clonogenic radiation survival of SW480 and 
DLD-1 colorectal cancer cells. In line with an increased radiation response, SW480 and DLD-1 
colorectal cancer cells stably overexpressing Survivin W67A, S20D-W67A double mutant and 
BIR deletion mutant showed significantly increased numbers of residual γH2AX/53BP1 foci 
after knockdown of endogenous Survivin. By contrast S20D revealed a diminished increase on 
residual γH2AX/53BP1 foci and Surv. wt completely rescued the DNA damage repair (Figure 
21 and 22). Thus, we consider that Survivin S20 and W67 amino acids are indispensable for 
DNA repair regulation, possibly via interaction with DNA-PKcs in SW480 and DLD-1 colorectal 
cancer cells. 
 
5.4. The potential importance of S20 residue of Survivin in DDR 
According to the above-mentioned findings, it is evident that Alanine substitution of S20 
residue does not affect the interaction between Survivin and PI3K domain of DNA-PKcs while 
phospho-mimetic aspartic acid substitution significantly decreased binding (Figure 16b). That 
suggests S20 phosphorylation may have an inhibitory effect on the interaction of Survivin 
with DNA-PKcs. Studies revealed that Survivin S20 is phosphorylated by PLK1, Aurora kinase 
B, Aurora kinase C, and Protein kinase A (PKA) (Colnaghi and Wheatley, 2010; Dohi et al., 
2007; Raab et al., 2015; Sasai et al., 2016). Phosphorylation of Survivin S20 by these kinases 
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appears important for both proper chromosome segregation and apoptosis inhibition. 
Overexpression of a non-phosphorylatable version, S20A, has been shown to be unable to 
correct spindle-attached chromosomes, which causes entering into anaphase with misoriented 
chromosomes and evading the spindle tension checkpoint. Moreover, the prevention of 
Survivin S20 phosphorylation by PKA in cytosol disrupts the binding interface between 
Survivin and XIAP which hampers anti-apoptotic functions of the Survivin-XIAP 
interrelationship (Colnaghi and Wheatley, 2010; Dohi et al., 2007; Raab et al., 2015; Sasai et 
al., 2016). Resembling the functional interaction of Survivin with DNA-PKcs, Survivin was 
previously found to interact with the kinase domain of Aurora kinase B and resulting in 
enhanced kinase activity (Chen et al., 2003). Furthermore, another study revealed that S20 
phosphorylation of Survivin by PLK1 required for the centromeric activation of Aurora kinase 
B (Chu et al., 2011). These findings suggest that S20 residue of Survivin may function as a 
switch-regulator conferring different roles of Survivin in both nucleus and cytoplasm. 
  
5.5. Heterotetramer complex formation by Survivin and DNA-PKcs 
Our data suggested two distinct spatial binding conformations (Chain B of Survivin in close 
proximity via S20 to Chain A of the head-domain of DNA-PKcs, and Chain C of Survivin in 
close proximity via W67 to Chain A of the head-domain of DNA-PKcs) which resulted in a 
heterotetramer hypothesis where Survivin is bound to the surface of PI3K domains of a pre-
existing DNA-PKcs dimer. The conformational opening of the surface of the active site region 
for the heterotetramer (particularly in Chain D) and partly in a head-dimer can be concluded 
as potentially increased accessibility by ATP and the substrates of DNA-PKcs, which might 
lead to enhanced kinase activity and could eventually result in increased phosphorylation. 
Indeed, in vitro kinase assays confirmed the in silico predicted increased catalytic activity 
potentials of the heterotetramer and head-dimer structures. DNA-PKcs already showed a basal 
level of phosphorylation in the absence of Survivin, while the addition of Survivin to the assay 
significantly enhanced the kinase activity approximately 45% (Figure 26). Consequently, the 
combination of findings from both in silico docking studies and experimental approaches 
showed a clear interaction between the BIR domain of Survivin and the PI3K domain of DNA-
PKcs by generating a heterotetramer complex resulting in an increased kinase activity. 
DNA-PKcs acts as a locomotive in DNA damage/repair by its catalytic enzyme function, which 
is activated by the DNA-PKcs-KU70/80-DNA holoenzyme complex formation. DNA 
accommodates into the tunnel formed by a KU70/80 heterodimer ring, which subsequently 
provides a binding platform for DNA-PKcs (Hill and Lee, 2010). Recent contradictory findings 
suggest that the DNA-PKcs is not important for the synapsis formation (Zhao et al., 2019), 
while many other recent findings by EM/cryoEM and SAXS studies concerning the 
symmetric/asymmetric homo/heterodimerization of DNA-PKcs showed the potential 
importance of DNA-PKcs in the synapsis process and brought novel perspectives to our current 
knowledge on NHEJ. Findings suggested either alone or as a holoenzyme with KU70/80, 
DNA-PKcs was able to generate differerent dimerization complexes by interacting with N-
terminal HEAT repeats, mid part of cradle, and particularly FATKIN domains (Baretic et al., 
2019; DeFazio et al., 2002; Hammel et al., 2010; Sibanda et al., 2017; Spagnolo et al., 2006). 
All these findings in correlation with our heterotetramer hypothesis further postulates the 
direct dimerization of the PI3K domain of DNA-PKcs and subsequent binding to two Survivin 
molecules which increases the binding potential, stability and kinase activity of DNA-PKcs. 
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Moreover, kinase activity (Figure 26) was enhanced in the presence of Survivin, while siRNA 
mediated knockdown of the IAP does not impact on complexation and basal level of 
phosphorylation. Accordingly, we do not consider Survivin binding to a preexisting DNA-PKcs 
PI3K dimer to cover an initial step in the NHEJ repair cascade, but may display a selective 
activation of the DNA-PKcs kinase activity at later stages of repair. In line with that, results 
from molecular simulations further indicate a change in kinase active site accessibility upon 
binding of Survivin that suggests enhanced accessibility of ATP and potential substrates to 
enter the active site. These results are comparable to reports, that histone H3 phosphorylated 
at threonine 3 is recognized by a binding pocket in the BIR domain of Survivin directing the 
CPC to chromosomes and resulting in an activation of its kinase subunit Aurora kinase B 
(Kelly et al., 2010). By contrast, cells depleted of Survivin display a lowered kinase activity 
and mislocalization of Aurora kinase B to its substrates including histone H3 (Chen et al., 
2003; Kelly et al., 2010). 
 
5.6. Change on phosphorylation motif of DNA-PK (S/T-Q  S/T-P) 
Consensus motif analysis of phosphosites discovered in this study revealed highly conserved 
S/T-Hydr (Hydrophobic residues: G, A, V, L, I, P, F, M, W) particularly S/T-P motifs (Figure 
32) and the enrichment of S/T-P motifs were also previously reported in response to DNA 
damage (Bennetzen et al., 2010). However, high throughput studies revealed over 900 Serine 
or Threonine, followed by Glutamine motif (S/T-Q) phosphorylation sites encompassing over 
700 proteins in response to irradiation-triggered DNA damage response (Matsuoka et al., 
2007). Like other PI3K family members, DNA-PK predominantly phosphorylates the S/T-Q 
motifs present in DNA-PKcs itself S2056/T2609, Artemis S516/S645, DNA ligase IV S672, 
H2AX S139, and KU70 S51 sequences. Nevertheless, DNA-PKcs is also capable of 
phosphorylating non-S/T-Q motifs (Lees-Miller and Anderson, 1989). Particularly, 
holoenzyme components KU70/80, DNA-PKcs itself and some other substrates covering a S/T-
Hydr motif were shown to be efficiently phosphorylated by DNA-PK (Yu et al., 2003). All 
these findings and specific confirmation of FOXO3 S253 phosphorylation site (Motif: 250-R-A-
V-S-M-D-N-256) by western immunoblotting strengthen the notion that Survivin binding 
redirects the substrate preference of DNA-PK to predominantly S/T-Hydr motifs, particularly 
S/T-P. 
 
5.7. Phosphorylation of FOXO3 S253 and its dependence on DNA-PKcs 
LC-MS analyses revealed a set of regulated phosphosites which were previously little-known 
to be related with DNA-PKcs. Pathway analysis was further revealed the predominant 
involvement of regulated phosphosites in DNA damage/repair, as well as in chromosome 
organization, cell cycle, (post)-transcriptional regulation, apoptosis, adhesion and ion 
transport (Figure 30a and 30b). One of the remarkable regulated phosphoproteins is FOXO3 
which is a member of the forkhead family transcription factors that particularly functions on 
the transcriptional regulation of apoptosis and autophagy (Fitzwalter et al., 2018). The 
importance of FOXO3 S253 phosphorylation in relation with DNA damage/repair and DNA-
PKcs is further supported by a variety of other studies: In three different studies, it was shown 
that FOXO3 S253 phosphorylation decreased upon LY294002 inhibitor treatment (Haque et 
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al., 2015; Singh et al., 2010; Zheng et al., 2000) which is a PI3K inhibitor with a known DNA-
PK inhibitory effect (Rosenzweig et al., 1997). Besides, Wortmannin a PI3K inhibitor with a 
major DNA-PKcs inhibitory effect (Hashimoto et al., 2003), completely diminished FOXO3 
S253 phosphorylation in rat granulosa and PC12 cells (Chen et al., 2007b; Zheng et al., 
2000). Further, a study showed that HK-2 cells overexpressing FOXO3 revealed increased 
phosphorylation of S253 residue upon TGF-β1 treatment (Carew et al., 2011). The bottom 
line is that TGF- β1 has a key role in DNA damage response, which enhances the NHEJ 
pathway in irradiated cells via regulating the expression of DNA ligase IV (Kim et al., 2015). 
Likewise, the treatment of B-CLL cells with 10 nM Phorbal 12-myristate 13-acetate (PMA) 
revealed a significant increase in the phosphorylation of FOXO3 S253 residue (Barragan et al., 
2006), and PMA-treated THP1 cells showed a remarkable increase in both DNA-PKcs 
expression and DNA-PKcs T2609 phosphorylation (So et al., 2013). In consideration of all 
these findings with our experimental support, it is suggested that DNA-PKcs regulates the 
phosphorylation of S253 residue of FOXO3 in a Survivin-DNA-PKcs interrelationship-
dependent manner.  
 
5.8. Additional phosphosites promise a better understanding of the relation of 
Survivin with DNA-PKcs 
Not only FOXO3 S253, but also some other phosphosites investigated in the current study 
display a relation with DNA damage/repair. Such phosphosites are DNA polymerase α 
regulatory subunit (POLA2) S141 (Beli et al., 2012; Boeing et al., 2016) POLA2 S152, 
flna/Filamin-A T2336, zinc finger protein 36 C3H1 type-like 2 (ZFP36L2) S125, E2F 
transcription factor 1 (E2F1) S375, thyroid hormone receptor associated protein 3 (THRAP3) 
S622, nucleoporin 98 and 96 precursor (NUP98) S839 (Beli et al., 2012) and treacher collins-
franceschetti syndrome 1 (TCOF1) S1407 (Boeing et al., 2016). Nucleocytoplasmic protein 
Filamin-A is a multi-complex interacting scaffold that anchors transmembrane receptors and 
actin filaments to glycoproteins. Besides, it interacts with breast cancer type 1/2 susceptibility 
proteins (BRCA1 and BRCA2), DNA-PKcs, integrins and second messengers to regulate DNA 
damage response, cell shape/size, ciliogenesis, cell-cell anchorage, and migration (Yue et al., 
2013). Previous findings suggest that flna/Filamin-A is required to stabilize the interaction 
between components of the DNA-PK holoenzyme complex, particularly in between DNA-PKcs 
and KU80 via directly interacting with DNA-PKcs in vivo. Furthermore, flna-null cells were 
found to be deficient in DNA repair (Velkova et al., 2010). This suggests, that DNA-PK 
holoenzyme is a multi-effector dynamic protein complex by the recruitment of Survivin and 
probably some other proteins such as Filamin-A to expand its functional capacity.  
POLA2 is required for the initiation of DNA replication by forming a primosome via an 
interaction with primase. Hereby, primosome synthesizes a short RNA:DNA primer which is 
used as a substrate for  high fidelity polymerases δ and ε (Dang and Morales, 2020; Nunez-
Ramirez et al., 2011). The recent study was revealed that POLA2 was directly involved in 
double strand break repair and regulation of genotoxic stress. pola2-deficient cells showed an 
increased number of 53BP1 foci and a significant decrease on the efficiency of both NHEJ and 
HR pathways. Moreover, pola2-deficient cells displayed a decreased cellular survival in 
response to IR (Dang and Morales, 2020). These findings and our phosphorylation findings 
potentially on POLA2 S141 and S152 residues suggest conceivably a DNA end polymerization 
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role for POLA2 in NHEJ pathway by the regulatory effect of Survivin-DNA-PKcs 
interrelationship.      
 
5.9. Survivin-DNA-PKcs interrelationship has not only post-translational but also 
protein expression-level regulatory functions 
Proteomics analysis revealed a vast amount of directly and inversely regulated proteins which 
function predominantly in DNA damage/repair such as cdca2/Repo-Man, SENP5, and HMGA 
family members (Figure 35). Particularly, inhibition of cdca2/Repo-Man enhances the ATM 
activation and autophosphorylation on S1981 (Peng et al., 2010). Additionally, SENP5 is 
found to interact with ATRIP and stimulated its desumoylation (Jin et al., 2016), which is 
essential for ATRIP to properly function and activate the ATR pathway (Wu et al., 2014). The 
increase in the expression of cdca2/Repo-Man and SENP5 in response to Survivin expression 
and decrease in response to Survivin knockdown and DNA-PK inhibitor treatment (Figure 
35a) suggest that DNA-PKcs may have an inhibitory effect on ATM and ATR via regulating the 
expression of cdca2/Repo-Man and SENP5.  
HMGA family proteins -HMGA1 and HMGA2- are chromatin-associated proteins that regulate 
the transcription via altering the chromatin architecture. HMGA2 particularly plays a role in 
the regulation of cell cycle, apoptosis, and chromosome condensation (Zhang et al., 2019). 
HMGA2 has an inhibitory effect on DNA-PKcs during the NHEJ process by altering the steady-
state form of DNA-PK holoenzyme and delaying the release of DNA-PKcs from the DNA DSB 
ends (Li et al., 2009). That may indicate that DNA-PKcs and Survivin inversely regulate the 
expression of HMGA2 to preserve the functions and time-dependent regulation of NHEJ. 
The studies with the synergistic effect of our proteomics findings strengthen the concept that 
the enhanced kinase activity of DNA-PKcs with the help of Survivin may change the repair 
preference to the DNA-PKcs-dependent pathway via dysregulation of HR and ATM/ATR-
dependent pathways by regulating the expression of HIRIP3, rbbp8/CtIP, HMGA and HMGN 
family members (Adamson et al., 2012; Hoa et al., 2015; Kim et al., 2009; Makharashvili et 
al., 2014; Natarajan et al., 2013; Palmieri et al., 2011; Quennet et al., 2011; Singh et al., 
2015; Wang et al., 2018b) (Figure 35b). However, a recent study suggests a dependence of 
efficient processing and resection of DNA ends on the phosphorylation of rbbp8/CtIP to DNA-
PKcs (Deshpande et al., 2020). 
Besides Survivin-DNA-PKcs interrelationship-dependent regulatory functions, Survivin has 
unique regulatory functions as well. As depicted in Figure 36a, INCENP, cdca8/Borealin and 
Aurora kinase B protein expressions were significantly increased in response to Survivin 
overexpression and decreased in response to Survivin knockdown. The cruces is that INCENP, 
cdca8/Borealin and Aurora kinase B together with Survivin are the members of the 
chromosomal passenger complex (CPC) which facilitates a vital step for mitotic cell division 
by accomplishing proper chromosome segregation (Carmena et al., 2012). It appears that, 
Survivin has a regulatory role on protein expression of the other CPC members that may 
define the fate of the cell.     
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5.10. Nucleus-directed drug targeting of Survivin – DNA-PKcs interaction 
Since the relation of Survivin with cancer progression and therapy response was investigated 
shortly after its discovery, the protein was considered a valuable and attractive target for drug 
design approaches to target cancer cells. Our current study revealed novel candidate residues 
to particularly target the DNA-PKcs interaction interface of Survivin for radiosensitization of 
cancer cells. Thus far, there is no direct inhibitory approach in the literature targeting the 
amino acids revealed by current study to radiosensitize the cancer cells. 
Recently, cytoplasmic/mitochondrial SMAC-Survivin interaction took attention of drug 
designers to stimulate apoptosis in cancer cells. The W67 residue is located in between the 
SMAC binding amino acids of Survivin (L64, D71 and L87) (Song et al., 2003) which partially 
provides some hydrophobic, π – π or π – cation attractions to the designed drugs (Park et al., 
2019; Wang et al., 2018a; Xiao et al., 2015). But it is clearly observed that while L64A 
mutation conferred reduced binding, W67A nearly had no effect on the binding efficiency of 
inhibitors designed to target the same region (Park et al., 2019). In addition to this, Alanine 
and Arginine mutagenesis screening of Survivin have reported that R18A, W25A, C33R, 
C57A, and W67A mutations prevented the interaction with Histone H3 protein (Yamagishi et 
al., 2010). However, a more recent study generated the crystal structure of this interaction 
and findings revealed that only K62, E65, D71 and H80 residues but not W67 are responsible 
for the Survivin-Histone H3 interaction (Niedzialkowska et al., 2012). All these studies 
strengthen the hypothesis that W67 could be one of the unique amino acids for binding to 
DNA-PKcs in the nucleus. 
Accumulation of drug molecules in the nucleus of cancer cells is of vital importance for 
specific targeting of Survivin-DNA-PKcs interaction and drug efficiency in our investigation. 
Recently, a polymeric drug delivery system was generated, which penetrates efficiently to cell 
nucleus. For selective delivery to the tumor cells, researchers designed self-assembled poly-
(ethylene glycol)-block-poly(ε-caprolactone) nanocarriers fused with folic acid (FA-PECL). For 
the nucleus delivery, cell penetration peptide (CPP) fused with doxorubicin (DOX) resulted in 
a conjugate (CPP-DOX). The resulting drug-loaded delivery system is based on the the 
combination of both cell and nucleus delivery systems (FA-PECL/CPP-DOX). It is reported that 
it decreased a five times decreased tumor size in comparison to non-targeted therapies and is 
easy to implement to the other drugs instead of DOX (Hua et al., 2019). Besides to that, there 
are a variety of different nuclear delivery methods which can be implemented in our approach 
such as TAT-peptide conjugated mesoporous silica nanoparticles (MSNs-TAT) (Pan et al., 
2012), targeted charge‐reversal nanoparticles (TCRNs) comprised of poly(ε‐caprolactone)‐
block‐polyethyleneimine (PCL‐PEI) (Xu et al., 2007), and biodegradable cross-linked N-(2-
hydroxypropyl) methacrylamide (HPMA) copolymer micelles (Zhou et al., 2017b). 
 
5.11. Future perspectives 
Even under BIR domain deletion condition, we measured a small interaction potential 
(~15%) between Survivin and PI3K domain of DNA-PKcs by sensitive FACS-FRET approach 
(Figure 13 and 16). For that, alanine and phosphomimetic (for S/T/Y residues) screening of 
not only the rest of BIR domain, but also MicTub domain residues will provide a better 
understanding about the involvement of potential other residues, post-translational phospho-
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regulatory functions, and exact spatial/structural interaction within the heterotetramer 
complex. Further, with the latest technological advancements in Cryo-EM and X-ray laser 
crystallography systems, the generation of the crystal structures of large multi-
macromolecular complexes is feasible (Helliwell, 2017). Therefore, the generation of the 
condition-dependent dynamic crystal structure of Survivin – DNA-PKcs interaction will 
definitely provide a better understanding of the basis of molecular and functional roles. 
Investigation of the intracellular interaction dynamics can be further supplemented by the 
analyses with multiplexed super-resolution live-cell imaging and single-particle tracking 
microscopy studies. 
The findings and/or hypotheses on the change of substrate recognition/phosphorylation motif 
(S/T-Hydr. and S/T-P) and potential inhibitory roles on HR and ATM/ATR-dependent 
pathways need be to further investigated to more closely unravel the translational and post-
translational phospho-regulatory roles of the interaction of Survivin and DNA-PKcs. 
Particularly, FOXO3, flna/Filamin-A, POLA2, cdca2/Repo-Man, SENP5, HIRIP3, rbbp8/CtIP, 
and HMGA and HMGN family members seem to be of high importance. 
To extend the knowledge on the dynamic interactome and interaction interfaces of Survivin – 
DNA-PKcs interrelationship, Proximity-dependent Biotin identification 
(BioID/BioID2/TurboID) technology may be implemented to capture both strong (stable 
interactors) and weak (transient interactors and substrates) interactors of the Survivin-DNA-
PKcs interrelationship. Briefly, the plasmid construct including the bait protein (Survivin and 
DNA-PKcs) fused with either ascorbate peroxidase (APEX) or biotin ligase (BirA) enzymes 
should be recombinantly expressed in the cells. Afterwards, both APEX and BirA will be able 
to biotinylate the proteins in 10-15 nm proximity to the bait protein. This step is followed by a 
pull-down process by streptavidin beads to capture biotinylated protein which then can be 
subjected to LC-MS (Branon et al., 2018; Kim et al., 2016; Lam et al., 2015; Roux et al., 
2012). After the pull-down step, samples can be further treated with protein-protein 
crosslinkers such as disuccinimidyl suberate (DSS) and bis(sulfosuccinimidyl)suberate (BS3) 
which covalently stabilize the protein-protein interactions and subsequent subjection to LC-
MS analysis would provide essential data on protein interaction regions (Leitner et al., 2016; 
Rappsilber, 2011). 
The in vitro cell-based testing of novel ligands that have in silico potential to target the S20 
and W67 residues should give insight, whether a prevention of Survivin-DNA-PKcs interaction 
is a promising strategy for radiosensitization of cancer cells. In dependence on these 
preceding in vitro and in vivo experiments, our approach may open a new possibility within 
current radiosensitization strategies by targeting Survivin-DNA-PKcs interaction with 
hopefully fewer side effects. 
 
Summary 
In summary, our results confirm Survivin to act as a radiation resistance factor modulating 
cellular radiation responses by multiple mechanisms, including radiation survival and DNA 
DSB repair. For the first time, we indicate in a 3D cell culture system that S20 and W67 amino 
acids located in the BIR domain are essential for radiation survival and regulation of DNA 
damage repair, at least in part by disturbing protein interaction with the PI3K kinase domain 
of DNAPKcs. The involvement of Survivin in the enhancement of the kinase activity of DNA-
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PKcs was further confirmed by a heterotetramer hypothesis employing both in silico and 
experimental approaches. Of particular importance, this novel hypothesis suggests the binding 
of Survivin to a pre-existing DNA-PKcs dimer which leads to a conformational change in the 
PI3K domain and results in the modulation of kinase activity and a differential change in 
DNA-PKcs’ substrate specificity (Figure 39). 
 
 
Figure 39. Functional overview of Survivin-DNA-PKcs interrelationship. Upon irradiation, Survivin 
accumulates in the nucleus and generates a heterotetramer via binding to a pre-existing DNA-PKcs 
dimer. This particular interaction is mediated mainly by S20, W67 and some other potential residues 
such as F27, C31, T34 and D53 of Survivin. Formation of the heterotetramer complex drives 
predominantly the phosphorylation of S/T-Hydr motifs (hydrophobic residues: G, A, V, L, I, P, F, M, 
W). Besides the regulatory functions on the phosphorylation pattern of substrates, the Survivin-DNA-
PKcs interrelationship has essential functions on DNA damage/repair via modulating the expression 
levels of proteins. 
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7. Appendix 
 
7.1. Virtual Screening Hits 
 
Table 11. Virtual screening final candidate ligands for S20 residue of Survivin. (A, Asinex repository. C, 
ChemBridge repository. M, MolPort repository.)  
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Table 12. Virtual screening final candidate ligands for W67 residue of Survivin. (C, ChemBridge 
repository. M, MolPort repository. S, Specs repository.) 
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7.2. DNA sequences 
 
Survivin wt 
GGTGCCCCGACGTTGCCCCCTGCCTGGCAGCCCTTTCTCAAGGACCACCGCATCTCTACATTCA
AGAACTGGCCCTTCTTGGAGGGCTGCGCCTGCACCCCGGAGCGGATGGCCGAGGCTGGCTTCA
TCCACTGCCCCACTGAGAACGAGCCAGACTTGGCCCAGTGTTTCTTCTGCTTCAAGGAGCTGGA
AGGCTGGGAGCCAGATGACGACCCCATAGAGGAACATAAAAAGCATTCGTCCGGTTGCGCTTT
CCTTTCTGTCAAGAAGCAGTTTGAAGAATTAACCCTTGGTGAATTTTTGAAACTGGACAGAGAA
AGAGCCAAGAACAAAATTGCAAAGGAAACCAACAATAAGAAGAAAGAATTTGAGGAAACTGCG
GAGAAAGTGCGCCGTGCCATCGAGCAGCTGGCTGCCATGGAT 
 
PI3K-DNA-PKcs 
ATGGAACACCCTTTCCTGGTGAAGGGTGGCGAGGACCTGCGGCAGGACCAGCGCGTGGAGCAG
CTCTTCCAGGTCATGAATGGGATCCTGGCCCAAGACTCCGCCTGCAGCCAGAGGGCCCTGCAG
CTGAGGACCTATAGCGTTGTGCCCATGACCTCCAGGTTAGGATTAATTGAGTGGCTTGAAAATA
CTGTTACCTTGAAGGACCTTCTTTTGAACACCATGTCCCAAGAGGAGAAGGCGGCTTACCTGAG
TGATCCCAGGGCACCGCCGTGTGAATATAAAGATTGGCTGACAAAAATGTCAGGAAAACATGAT
GTTGGAGCTTACATGCTAATGTATAAGGGCGCTAATCGTACTGAAACAGTCACGTCTTTTAGAA
AACGAGAAAGTAAAGTGCCTGCTGATCTCTTAAAGCGGGCCTTCGTGAGGATGAGTACAAGCC
CTGAGGCTTTCCTGGCGCTCCGCTCCCACTTCGCCAGCTCTCACGCTCTGATATGCATCAGCCA
CTGGATCCTCGGGATTGGAGACAGACATCTGAACAACTTTATGGTGGCCATGGAGACTGGCGG
CGTGATCGGGATCGACTTTGGGCATGCGTTTGGATCCGCTACACAGTTTCTGCCAGTCCCTGAG
TTGATGCCTTTTCGGCTAACTCGCCAGTTTATCAATCTGATGTTACCAATGAAAGAAACGGGCC
TTATGTACAGCATCATGGTACACGCACTCCGGGCCTTCCGCTCAGACCCTGGCCTGCTCACCAA
CACCATGGATGTGTTTGTCAAGGAGCCCTCCTTTGATTGGAAAAAT 
 
HEAT1-DNA-PKcs 
ATGGCGGGCTCCGGAGCCGGTGTGCGTTGCTCCCTGCTGCGGCTGCAGGAGACCTTGTCCGCT
GCGGACCGCTGCGGTGCTGCCCTGGCCGGTCATCAACTGATCCGCGGCCTGGGGCAGGAATGC
GTCCTGAGCAGCAGCCCCGCGGTGCTGGCATTACAGACATCTTTAGTTTTTTCCAGAGATTTCG
GTTTGCTTGTATTTGTCCGGAAGTCACTCAACAGTATTGAATTTCGTGAATGTAGAGAAGAAAT
CCTAAAGTTTTTATGTATTTTCTTAGAAAAAATGGGCCAGAAGATCGCACCTTACTCTGTTGAAA
TTAAGAACACTTGTACCAGTGTTTATACAAAAGATAGAGCTGCTAAATGTAAAATTCCAGCCCT
GGACCTTCTTATTAAGTTACTTCAGACTTTTAGAAGTTCTAGACTCATGGATGAATTTAAAATTG
GAGAATTATTTAGTAAATTCTATGGAGAACTTGCATTGAAAAAAAAAATACCAGATACAGTTTTA
GAAAAAGTATATGAGCTCCTAGGATTATTGGGTGAAGTTCATCCTAGTGAGATGATAAATAATG
CAGAAAACCTGTTCCGCGCTTTTCTGGGTGAACTTAAGACCCAGATGACATCAGCAGTAAGAGA
GCCCAAACTACCTGTTCTGGCAGGATGTCTGAAGGGGTTGTCCTCACTTCTGTGCAACTTCACT
AAGTCCATGGAAGAAGATCCCCAGACTTCAAGGGAGATTTTTAATTTTGTACTAAAGGCAATTC
GTCCTCAGATTGATCTGAAGAGATATGCTGTGCCCTCAGCTGGCTTGCGCCTATTTGCCCTGCA
TGCATCTCAGTTTAGCACCTGCCTTCTGGACAACTACGTGTCTCTATTTGAAGTCTTGTTAAAGT
GGTGTGCCCACACAAATGTAGAATTGAAAAAAGCTGCACTTTCAGCCCTGGAATCCTTTCTGAA
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ACAGGTTTCTAATATGGTGGCGAAAAATGCAGAAATGCATAAAAATAAACTGCAGTACTTTATG
GAGCAGTTTTATGGAATCATCAGAAATGTGGATTCGAACAACAAGGAGTTATCTATTGCTATCC
GTGGATATGGACTTTTTGCAGGACCGTGCAAGGTTATAAAC 
 
FATC-DNA-PKcs 
ATGCTGAAAAAAGGAGGGTCATGGATTCAAGAAATAAATGTTGCTGAAAAAAATTGGTACCCCC
GACAGAAAATATGTTACGCTAAGAGAAAGTTAGCAGGTGCCAATCCAGCAGTCATTACTTGTGA
TGAGCTACTCCTGGGTCATGAGAAGGCCCCTGCCTTCAGAGACTATGTGGCTGTGGCACGAGG
AAGCAAAGATCACAACATTCGTGCCCAAGAACCAGAGAGTGGGCTTTCAGAAGAGACTCAAGT
GAAGTGCCTGATGGACCAGGCAACAGACCCCAACATCCTTGGCAGAACCTGGGAAGGATGGGA
GCCCTG 
 
PI3K-ATM 
ATGGTGGACCACACAGGAGAATATGGAAATCTGGTGACTATACAGTCATTTAAAGCAGAATTTC
GCTTAGCAGGAGGTGTAAATTTACCAAAAATAATAGATTGTGTAGGTTCCGATGGCAAGGAGAG
GAGACAGCTTGTTAAGGGCCGTGATGACCTGAGACAAGATGCTGTCATGCAACAGGTCTTCCA
GATGTGTAATACATTACTGCAGAGAAACACGGAAACTAGGAAGAGGAAATTAACTATCTGTACT
TATAAGGTGGTTCCCCTCTCTCAGCGAAGTGGTGTTCTTGAATGGTGCACAGGAACTGTCCCCA
TTGGTGAATTTCTTGTTAACAATGAAGATGGTGCTCATAAAAGATACAGGCCAAATGATTTCAG
TGCCTTTCAGTGCCAAAAGAAAATGATGGAGGTGCAAAAAAAGTCTTTTGAAGAGAAATATGAA
GTCTTCATGGATGTTTGCCAAAATTTTCAACCAGTTTTCCGTTACTTCTGCATGGAAAAATTCTT
GGATCCAGCTATTTGGTTTGAGAAGCGATTGGCTTATACGCGCAGTGTAGCTACTTCTTCTATT
GTTGGTTACATACTTGGACTTGGTGATAGACATGTACAGAATATCTTGATAAATGAGCAGTCAG
CAGAACTTGTACATATAGATCTAGGTGTTGCTTTTGAACAGGGCAAAATCCTTCCTACTCCTGA
GACAGTTCCTTTTAGACTCACCAGAGATATTGTGGATGGCATGGGCATTACGGGTGTTGAAGGT
GTCTTCAGAAGATGCTGTGAGAAAACCATGGAAGTGATGAGAAACTCTCAGGAAACTCTGTTAA
CCATTGTAGAGGTCCTTCTATATGATCCACTCTTTGACTGGACCATGAATCCTTTGAAAGCTTTG
TATTTACAGCAGAGG 
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7.4. Own Work  
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7.6. List of abbreviations 
 
Abbreviation Full name 
∆G Binding free energy 
γH2AX S139 phosphorylated H2A histone family member X 
3D Three dimensional 
53BP1 P53-binding protein 1 
5-FU 5-fluorouracil 
ABHD15 Abhydrolase domain containing 15 
ACIN1 Apoptotic chromatin condensation inducer 1 
ADME Absorption, distribution, metabolism, and excretion 
AEN Apoptosis enhancing nuclease 
AKAP11 A-kinase anchoring protein 11 
Akt/PKB Akr thymoma serine/threonine-specific protein kinase; protein 
kinase B 
ANLN Anillin actin binding protein 
AP3D1 Adaptor related protein complex 3 subunit delta 1 
Apaf1 Apoptotic protease-activating factor 1 
APS Ammonium persulfate 
ASL Argininosuccinate lyase 
ASNS Asparagine synthetase (glutamine-hydrolyzing) 
ASS1 Argininosuccinate synthase 1 
ATF7IP Activating transcription factor 7 interacting protein 
ATG5/12/16 Autophagy related protein 5/12/16 
ATM Ataxia telangiectasia mutated protein kinase 
ATP [γ-32P] Adenosine triphosphate, labeled on the gamma phosphate group 
with 32P 
ATR Ataxia telangiectasia and RAD3 related protein 
ATRIP ATR interacting protein 
AURKB Aurora kinase B 
B3GNT1 Beta-1,4-glucuronyltransferase 1 
BCA Bicinchoninic acid 
BCLAF3 BCLAF1 and THRAP3 family member 3 
BECLIN-1 Coiled-coil myosin-like BCL2-interacting protein 
BIR/∆BIR Baculoviral IAP repeat / deletion of BIR domain 
BIRC1/2/3/4/5/6/7/8 Baculoviral IAP repeat containing 1/2/3/4/5/6/7/8 
BRCA1/2 Breast cancer type 1/2 susceptibility protein 
BRIT1 BRCT-repeat inhibitor of TERT expression 1 
BRUCE BIR repeat containing ubiquitin-conjugating enzyme 
BS3 Bis(sulfosuccinimidyl)suberate 
BSA Bovine serum albumin 
C, Cys Cysteine 
C31A Alanine mutation on cysteine 31 residue of Survivin 
CAD Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and 
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dihydroorotase 
CARD Caspase recruitment domain 
CASP8AP2 Caspase 8 associated protein 2 
CCNA2 Cyclin A2 
CDC20 Cell division cycle 20 
CDCA2/8 Cell division cycle associated 2/8 
CDK1/CDC2 Cyclin-dependent kinase 1; Cell division control protein 2 
CDK4 Cyclin-dependent kinase 4 
CDKAL1 CDK5 regulatory subunit associated protein 1 like 1 
CENPF Centromere protein F 
CERS6 Ceramide synthase 6 
CHD2/4 Chromodomain helicase DNA binding protein 2/4 
c-IAP1/2 Cellular-IAP1/2 
CIC Capicua transcriptional repressor 
CPC Chromosomal passenger complex 
CPP Cell penetration peptide 
CPSF7 Cleavage and polyadenylation specific factor 7 
CRKL CRK like proto-oncogene, adaptor protein 
D, Asp Aspartic acid 
D53A Alanine mutation on aspartic acid 53 residue of Survivin 
Da/kDa Dalton/kilodalton 
DAPI 4′.6-diamidin-2-phenylindol 
DAXX Death domain associated protein 
DCA Dichloroacetic acid 
DDR DNA damage response 
DMEM Dulbecco’s modified eagle medium 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
DNA-PKcs DNA-dependent protein kinase, catalytic subunit 
dNTP Deoxynucleotides 
DOCK6 Dedicator of cytokinesis 6 
DOX Doxorubicin 
DSB Double strand break 
DSS Disuccinimidyl suberate 
DTT Dithiothreitol 
E, Glu Glutamic acid 
E29A Alanine mutation on glutamic acid 29 residue of Survivin 
E76A Alanine mutation on glutamic acid 76 residue of Survivin 
E2F1 E2F transcription factor 1 
ECFP/EGFP/EYFP Enhanced cyan/green/yellow fluorescent protein 
ECL Enhanced chemiluminescent 
EGFR Epidermal growth factor receptor 
EGR1 Early growth response 1 
EDTA Ethylenediaminetetraacetic acid 
E. coli Escherichia coli 
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EM/cryo-EM Electron microscopy; cryogenic EM 
ENOX2 Ecto-nox disulfide-thiol exchanger 2 
ERRFI1 ERBB receptor feedback inhibitor 1 
eV Electron volt 
EWS EWS RNA binding protein 1 
F, Phe Phenylalanine 
F27A Alanine mutation on phenylalanine 27 residue of Survivin 
FA Folic acid 
FACS-FRET Flow cytometry-based förster resonance energy transfer 
FAK Focal adhesion kinase 
FAM63A/MINDY1 Family with sequence similarity 63 member a; Mindy lysine 48 
deubiquitinase 1 
FAM129A/NIBAN1 Family with sequence similarity 129 member a; Niban apoptosis 
regulator 1 
FAT FRAP, ATM, TRRAP domain 
FATC C-terminal of FAT 
FATKIN FAT and kinase domain 
FBS Fetal bovine serum 
FHL3 Four and a half LIM domains 3 
FLI1 FLI-1 proto-oncogene, ets transcription factor 
FLNA Filamin A 
FOXM1 Forkhead box M1 
FOXO3/FOXO3A Forkhead box O3/A 
FPs Florescence proteins 
FRET Förster resonance energy transfer 
GIGYF1 GRB10 interacting GYF protein 1 
GPHN Gephyrin 
GPRIN1 G protein regulated inducer of neurite outgrowth 1 
Gscore Glide docking score 
GST Glutathione S-transferase 
GTF3C1 General transcription factor IIIC subunit 1 
Gy Gray 
HBXIP Hepatitis B X-interacting protein 
HCFC1 Host cell factor C1 
HEAT Huntingtin, elongation factor 3, regulatory subunit a of PP2A, TOR1 
hILP2 Human inhibitor of apoptosis-like protein 2 
HIRIP3 Hira interacting protein 3 
HMGA1/2 High mobility group at-hook ½ 
HMGN1/2/5 High mobility group nucleosome binding domain 1/2/5 
HNSCC Head and neck squamous cell carcinoma 
HPGD 15-hydroxyprostaglandin dehydrogenase 
HPMA N-(2-hydroxypropyl) methacrylamide 
HPV Human papillomavirus 
HR Homologous recombination 
HRP Horse radish peroxidase 
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Hsp90 Heat shock protein 90 
HTVS High-throughput virtual screening 
Hydr Hydrophobic 
IAP Inhibitor of apoptosis 
IFI35 Interferon induced protein 35 
IgG Immunglobulin G 
INCENP Inner centromere protein 
IP / co-IP Immunoprecipitation / co-immunoprecipitation 
IR Ionizing radiation  
K, Lys Lysine 
K79A Alanine mutation on lysine 79 residue of Survivin 
Kan Kanamycin 
kb Kilo base pairs 
Kd Dissociation constant (binding affinity) 
KD Kinase-dead 
KDM3A Lysine Demethylase 3a 
kg Kilogram 
KIF20B Kinesin family member 20b 
KIF22 Kinesin family member 22 
KU70/80 Lupus KU autoantigen protein p70/80 
L, Leu Leucine 
L28A Alanine mutation on leucine 28 residue of Survivin 
LAD1 Ladinin 1 
LARP1 LA ribonucleoprotein 1, translational regulator 
LC-MS Liquid chromatography-mass spectrometry 
LEMD3 LEM domain containing 3 
Lig4 DNA ligase IV 
LMNA Lamin A 
LRR Leucine-rich repeats 
LRRC58 Leucine rich repeat containing 58 
LUC7L2 LUC7 like 2, pre-mRNA splicing factor 
MAFG MAF BZIP transcription factor G 
MD Molecular dynamics 
MDC1 Mediator of DNA damage checkpoint protein 1 
MED13L Mediator Complex Subunit 13l 
MKI67 Marker of proliferation KI-67 
MOPS 3-(n-morpholino)propanesulfonic acid 
MSN Mesoporous silica nanoparticle 
MT2A Metallothionein 2A 
MYRF Myelin regulatory factor 
NACHT NAIP-C2TA-HETE-TEP1 nucleotide binding and oligomerization 
domain 
NAIP Neuronal apoptosis inhibitory protein 
NAV2 Neuron navigator 2 
NEO1 Neogenin 1 
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NF-κB Nuclear factor-kappa B 
NHEJ Non-homologous end joining 
NMI N-MYC and STAT interactor 
NP-40 Nonidet P-40 
NSD1 Nuclear receptor binding set domain protein 1 
NUP98 Nucleoporin 98 and 96 precursor 
P, Pro Proline 
PAPOLA Poly(A) polymerase alpha 
PBS Dulbecco’s phosphate buffered saline 
PCBP2 Poly(RC) binding protein 2 
PCL Poly(ε‐caprolactone) 
PCM1 Pericentriolar material 1 
PCR Polymerase chain reaction 
PDK3 Pyruvate dehydrogenase kinase 3 
PECL Poly-(ethylene glycol)-block-poly(ε-caprolactone) 
PEI Polyethyleneimine 
PI3K Phosphatidylinositol-3-kinase 
PIBF1 Progesterone immunomodulatory binding factor 1 
PIKK Phosphatidylinositol 3-kinase-related kinases 
PKA Protein kinase A 
PLK1 Polo-like kinase 1 
PMA Phorbal 12-myristate 13-acetate 
PNKP Polynucleotide kinase-phosphatase 
POLA2 DNA polymerase alpha 2, regulatory subunit 
PRKCE Protein kinase C epsilon 
PRR11 Proline rich 11 
PTTG1 PTTG1 regulator of sister chromatid separation, Securin 
QSOX2 Quiescin sulfhydryl oxidase 2 
R, Arg Arginine 
RAD51 Rad51 recombinase 
RBBP6 Rb binding protein 6, ubiquitin ligase 
RBBP8 Rb binding protein 8, endonuclease 
RBM15 RNA binding motif protein 15 
RBMX RNA binding motif protein x-linked 
RING Really interesting new gene 
RIPA Radio-immunoprecipitation assay 
RMSD Root-mean-square deviation 
RNA Ribonucleic acid 
RNF13 Ring finger protein 13 
RNPS1 RNA binding protein with serine rich domain 1 
RPMI Roswell park memorial institute 
RT Room temperature 
S, Ser Serine 
S20 Serine 20 residue of Survivin 
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S20A Alanine mutation on serine 20 residue of Survivin 
S20D Aspartic acid mutation on serine 20 residue of Survivin 
SAXS Small angle X-ray scattering 
SDS Sodium dodecylsulfate 
SDSL Serine dehydratase like 
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SELENOK Selenoprotein K 
SENP5 Sumo specific peptidase 5 
SLC19A1 Solute carrier family 19 member 1 
SLC35F2 Solute carrier family 35 member F2 
SLC43A1 Solute carrier family 43 member 1 
SLC52A3 Solute carrier family 52 member 3 
SLC7A11 Solute carrier family 7 member 11 
SLC7A6 Solute carrier family 7 member 6 
SLC9A3 Solute carrier family 9 member A3 
SMAC Second mitochondria derived activator of caspase 
SP Standard precision 
SRC C-sarcoma 
SRRM2 Serine/arginine repetitive matrix 2 
SSB Single strand break 
STMN3 Stathmin 3 
STRA13 Stimulated by retinoic acid gene 13 protein 
STX8 Syntaxin 8 
Surv.wt Survivin wild type 
SUV39H1 Suppressor of variegation 3-9 homolog 1 
T, Thr Threonine 
T34A Alanine mutation on threonine 34 residue of Survivin 
T34D Aspartic acid mutation on threonine 34 residue of Survivin 
T117A Alanine mutation on threonine 117 residue of Survivin 
T117D Aspartic acid mutation on threonine 117 residue of Survivin 
TAE Tris acetate EDTA 
TAF15 Tata-box binding protein associated factor 15 
TAT HIV cell penetrating tat peptide 
TBS Tris-buffered saline 
TBS-T TBS-Tween 20 
TCA Trichloroacetic acid 
TCOF1 Treacher collins-franceschetti syndrome 1 
TCRN Targeted charge‐reversal nanoparticles 
TEMED Tetramethylethylenediamin 
TGF-β1 Transforming growth factor beta 1 
THRAP3 Thyroid hormone receptor associated protein 3 
TJP1 Tight junction protein 1 
TMEM167B Transmembrane protein 167B 
TOP2A DNA topoisomerase II alpha 
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TRAFD1 Traf-type zinc finger domain containing 1 
TRD3 Tetratricopeptide repeat domain 3 
TRIP13 Thyroid hormone receptor interactor 13 
TRIS Tris hydroxymethyl aminomethane 
TYMS Thymidylate synthetase 
UBA Ubiquitin-associated domain 
UBC Ubiquitin conjugating domain 
UBE2S Ubiquitin conjugating enzyme E2 S 
USP8 Ubiquitin specific peptidase 8 
UV Ultraviolet 
VS. Versus 
W, Trp Tryptophane 
W67A Alanine mutation on tryptophane 67 residue of Survivin 
wt Wild type 
WWP2 WW domain containing E3 ubiquitin protein ligase 2 
XAF1 XIAP-associating factor 1 
XIAP X-linked inhibitor of apoptosis protein 
XLF XRCC4-like factor 
XP Extra precision 
XRCC4 X-ray cross-complementing protein 4 
ZBTB1 Zinc finger and BTB domain containing 1 
ZC3HAV1L Zinc finger CCCH-type containing, antiviral 1 like 
ZFP36L2 Zinc finger protein 36, C3H1 type-like 2 
ZNF326 Zinc finger protein 326 
ZNF806 Zinc finger protein 806 
ZYX Zyxin 
 
